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ABSTRACT  
   
The treatment of individuals with multiple chronic conditions represents the single 
largest driver of Medicare costs. The use of prescription drugs is a major component in 
the treatment/management of chronic disease in the United States. Medication 
nonadherence, however, is a common problem among older adults and leads to 
significant morbidity and mortality. Whereas, the problem of medication nonadherence 
has been a primary focus of research for the last thirty years, much is still unknown about 
which older adults are most at risk for medication nonadherence, as well as what are 
effective theory-based interventions to improve a person’s medication self-management.  
The purpose of this descriptive explanatory study was to better understand the self-
management behavior, medication adherence, in a sample of frail urban older adults. The 
study used a combination of quantitative and qualitative methods to analyze data from a 
larger twelve-month study of a nurse care coordination intervention. Ryan and Sawin’s 
(2009) Individual and Family Self-Management Theory served as the study’s conceptual 
framework for identifying the context and processes involved in the older adults’ 
medication self-management. Quantitative results found several individual- as well as 
family-level predictors for medication nonadherence. Qualitative analyses identified three 
overarching themes to describe the participants’ struggles along the multistep process of 
medication adherence. Additionally, a cultural domain described the need for more 
information from participants to understand their nonadherence. Integration of the results 
further increased our understanding of medication-self management in these frail older 
adults, and offers direction for clinical practice and future research. 
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CHAPTER 1 
INTRODUCTION 
With the largest cohort of Americans (i.e., the baby-boomer generation) entering 
into older adulthood, it is expected that by 2030, the number of Americans over the age 
of 65 will double to 88.5 million (Vincent & Velkoff, 2010), and will represent more than 
20% of the U.S. population (Anderson, 2010). Among the most significant impacts of 
this aging cohort to our society will be their consumption of healthcare resources.  
Indeed, the Congressional Budget Office (CBO) (2009) estimates that Medicare 
expenditures alone will account for 8% of the nation’s gross domestic product by 2035-a 
percentage comparable to what most industrialized countries incur for their entire 
population’s healthcare. As Anderson (2010) notes, 31% of the healthcare dollars spent in 
the United States is on hospital care. These costs are forcing the Centers for Medicare and 
Medicaid (CMS) to reexamine relationships among patient, providers, healthcare systems 
and payers in order to reduce chronic disease complications and optimize health. The 
treatment of individuals with multiple chronic conditions represents the single largest 
driver of Medicare costs with 79% of all program dollars spent on those older adults with 
5 or more chronic conditions (Anderson, 2010).  
Background  
The use of prescription drugs is a major component in the treatment/management 
of chronic disease in the United States. Because aging is significantly associated with the 
development of chronic disease, it is not surprising that older adults consume nearly 34% 
of prescription drugs in this country yet they only make up 13% of the population 
(Haynes, 2005). A recent update on Medicare’s retail prescription drug expenditures 
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highlights the fiscal significance of this issue:  In 2012, Medicare prescription drug 
coverage cost 68.2 billion dollars and accounted for 12% of the program’s overall 
spending (CMS, 2014). 
In addition to the direct costs associated with these filled prescriptions, however, 
are the indirect costs to the system when older adults do not take their medications as 
prescribed (i.e, medication nonadherence). Medication nonadherence can include both 
under- and over-dosing of one’s prescribed medication and/or not taking it at all. The 
indirect costs of medication nonadherence in the older adult include increased risk for 
emergency department (ED) visits (Hope et al., 2004), hospital admissions (Ho et al., 
2006a; Mojtabai & Olafson, 2003), and/or nursing home admissions (Lynch, 2006). 
Under-dosing can lead to both short term and long term consequences such as increased 
blood pressure, blood glucose levels, arrhythmias, myocardial infarction and stroke. 
The cost of unintentional overdosing is also significant. Indeed a recent analysis of 
emergency hospitalizations for adverse drug events among older adults found that during 
2007-2009, nearly two-thirds of the estimated 99,268 hospitalizations each year were due 
to unintentional overdosing (Budnitz, Lovegrove, Shehab, & Richards, 2011). Most 
importantly, research has also found that low adherers to drug therapy have a 
significantly higher risk of mortality than adequate adherers (Granger et al., 2009; Ho et 
al., 2006b; Ho et al., 2009; Simpson, 2006). Not surprisingly, medication nonadherence 
has been labeled by some researchers as a “silent epidemic” (Murdaugh & Insel, 2009).   
Estimates are that more than half of older adults (53%) do not take their 
medications as prescribed (Roth & Ivey, 2005). Even though the problem of medication 
nonadherence has been a primary focus of research for the last thirty years, much is still 
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unknown about which older adults are most at risk for medication nonadherence, as well 
as what are effective interventions to improve a patient’s medication self-management.  
Behavioral scientists argue that researchers need to deploy a diverse set of methodologies 
in order to not only increase the “quality and scientific power of data” but also to more 
fully understand complex health problems (Creswell, Klassen, Plano Clark, & Smith, 
2011, p.2). Indeed, mixed methods research has emerged within the last decade as a 
promising methodological option to better understand chronic disease self-management 
in older adults (Bogner, Cahill, Frauenhoffer, & Barg, 2009; Gucciardi, DeMelo, 
Offenheim, & Stewart, 2008; Mayoh, Bond, & Todres, 2012). Following this charge, the 
proposed study examined the problem of medication adherence using quantitative and 
qualitative data collected during the original randomized controlled trial of a nurse care 
coordination intervention.  As part of the original study, the intervention nurses collected 
extensive information on the participant’s life context  (i.e., demographics, health 
functioning, and living situation) through the use of standardized instruments (e.g., the 
Geriatric Depression Scale [GDS] (Yesavage et al., 1983), and the Mini-Mental Status 
Exam [MMSE] (Folstein, Folstein, & McHugh, 1975), and conducted bi-weekly pill 
counts to assess medication adherence.   In addition, the nurses further explored the 
processes involved in medication adherence by asking participants at each pill count, the 
reason(s) why they had missed their medication(s). These data sets thus allowed for a 
mixed methods approach to examining the issue of medication self-management in frail 
urban older adults. 
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Purpose Statement 
The purpose of this descriptive exploratory study was to better understand the 
contexts and processes involved in the health behavior of medication self-management. 
Findings from this study can inform the refinement of a nurse-led intervention to 
optimize medication self-management in older adults living with one or more chronic 
conditions. In order to more completely understand older adults’ medication self-
management, the study used a combination of quantitative as well as qualitative data 
from the larger study of a 12-month-long nurse care coordination intervention for the 
following purposes:  
(1) Identify significant risk and protective factors for medication 
adherence/nonadherence in frail urban older adults;  
(2) Describe the processes involved in older adults’ medication self-management; 
and 
(3) Utilize the qualitative findings to enrich our understanding of the quantitative 
findings of the study. 
Conceptual Framework 
Several researchers have noted the complex set of actions involved in taking one’s 
medication (Bergman-Evans, 2004; Russell, Ruppar, & Mattson, 2011). The process of 
medication taking begins with the client receiving a prescription from the provider which 
then assumes that, (1) the client has the ability to pick up the prescription, (2) has the 
money to buy the prescription, (3) can read the label/understand the medication 
directions, (4) can organize the medication by time and dose, (5) remembers to take the 
medication, (6) can recognize side effects and/or adverse reactions, (7) has the 
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opportunity to discuss with provider concerns about medications and/or desire to 
discontinue medications, and finally, (8) remembers to order refills. Much of the research 
assumes that older adults can navigate this multistep process of medication adherence, 
yet we know little about conceptual frameworks that can explain why or why not they are 
able to effectively master this health behavior. For example, Banning (2009) and Haynes 
(2008) argue that the effectiveness of medication adherence interventions to date has 
been limited by the lack of theories to adequately explain the process of medication 
adherence in older adults. Moreover, most research on medication adherence has used 
health behavior change theories that focus on individual-level factors (e.g., 
transtheoretical model, health belief model, theory of planned behavior, theory of 
reasoned action, self-regulation model) rather than use theories that are more multilevel 
focused (Johnson, 2002; Ruppar & Conn, 2011). The problem lies in the fact that leading 
experts in health behavior change posit that the adoption of a health behavior depends not 
only on an individual’s knowledge, attitude, and motivation regarding the behavior, but 
also on the environmental context (or ecological system) in which one lives (Schneider & 
Stokols, 2009). These researchers thus propose that by conceptualizing human behavior 
within the context of a person’s “ecology of health”, researchers are better able to 
determine what are the “high impact leverage points” needed to develop effective health 
behavior interventions (Schneider & Stokols, 2009, p. 87).  
Echoing this recommendation, Russell and colleagues (2011) in their review of 
medication adherence interventions also found that most studies focused on effecting 
change at the level of the individual, (i.e., education, counseling, and problem-solving 
skills) without recognizing the external factors that impact a person’s ability to self-
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manage their medications.  In order to develop more effective interventions, the authors 
thus proposed a paradigm shift in medication adherence interventions from a focus on 
individual-level factors to a focus using a personal systems approach. According to the 
authors, the interventionist would use this approach to guide the client to move beyond 
personal level factors such as motivation and health beliefs by examining their life 
routines around medication taking, and then identifying the personal system changes that 
are needed to promote medication adherence. Preliminary findings from Russell and 
colleagues’ work (2011) suggest that clients have found this approach both acceptable 
and engaging. 
The Individual and Family Self-Management Theory (IFSMT) (Ryan & Sawin, 
2009) is a systems-level framework that offers promise in informing the development of 
an effective medication intervention for older adults. Figure 1 illustrates the model. 
 
Figure 1. Model of the Individual and Family Self-Management Theory 
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The IFSMT recognizes that individuals, especially older adults with chronic 
conditions, often live with and rely on their family members to self-manage their health 
and healthcare needs.  In this sense, medication adherence would then be conceptualized 
as a behavior in which both the individual and family are committed to adopting. In 
addition, the theory proposes that both contextual and process dimensions are involved in 
a patient’s health behaviors such as medication self-management. In this theory, the 
context of a health behavior recognizes the importance of the ecology of one’s health by 
considering the individual and family characteristics, the physical and social 
environment, and the individual’s health condition(s).  The conceptualization of self-
management processes also utilizes a systems-based perspective of health behavior by 
not only considering the individual’s knowledge, beliefs, and skills, but also the social 
facilitators that are involved in the behavior of interest.  
Thus using the IFSMT as a framework, this study conceptualized an older adult’s 
medication self-management as a health behavior that is influenced by both the context 
and processes of the person’s life circumstances. While the study focused on the more 
proximal outcome of medication self-management (operationalized as medication 
adherence), there was the understanding that this proximal health behavior directly 
impacts the more distal outcomes of one’s health status, quality of life or well being, and 
health cost as Ryan and Sawin (2009) conceptualize in their model. Figure 2 illustrates 
the conceptual framework of this study: 
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Research Questions 
The following research questions correspond to the three specific purposes of this 
dissertation study: 
1. What are the context and/or process dimensions that emerge as significant risk 
and protective factors for medication adherence at Month 1 of the study? 
2. What are the context and/or process dimensions that emerge as significant risk 
and protective factors for medication adherence over the course of the study? 
3. What are the themes that describe the participants’ medication self-management 
processes? 
4. How do the qualitative data help explain the quantitative findings and contribute 
to a more complete understanding of the participants’ medication adherence?  
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Assumptions 
 
Researchers in health behavior change argue that in order to promote the adoption 
of health behaviors, clinicians and patients need to consider the “ecology” of a person’s 
health (Schneider & Stokols, 2009). “Ecology” can be conceptualized similarly to what 
Russell and colleagues (2011) call the personal systems of the individual.  These systems 
include: interpersonal/social relationships; living situation; type of caregiver; the type of 
caregiving a person receives; the healthcare system; and health policy.  This study 
assumes that both the participants’ contextual as well as processes dimensions are 
important determinants of a person’s medication self-management behavior (i.e., 
medication adherence). This study also includes an assumption from Ryan and Sawin’s 
IFSMT (2009) that, “Persons engage in behaviors for personally meaningful reasons that 
may or may not be directly related to optimizing health” (p. 21). 
Definition of Variables 
1. MD.2 machine:  The MD.2 machine uses an audio/visual prompt to remind the 
participants when it is time to take their medication. The intervention nurse preloaded the 
MD.2 machine with the participant’s oral medications and then programmed the machine 
to dispense medications in a cup at the time the medications are due.  The MD.2 machine 
uses a flashing light and a voice recorded reminder that goes off every three minutes for 
up to 45 minutes. If the client still has not taken the medication, the machine sends the 
medication to the missed dose compartment and attempts to reach a caregiver to notify 
them that the client has missed a dose.  
2. Mediplanner:  The mediplanner is a visual prompt for the participant to remember to 
take their medication. The planner is a plastic container with 28 individual compartments 
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that correspond to the day of the week and time of day. Each compartment can 
accommodate multiple pills.  
3. Individual Characteristics:  Age, gender, and race. 
4. Condition Specific Characteristics: treatment complexity, cognitive function, physical 
function, psychosocial well-being, visual ability, and hearing ability.   
5. Physical and Social Environment: Participant’s living situation (alone or with 
someone); caregiver living in the home; assistance with activities of daily living (ADL) 
(e.g., bathing, dressing, toileting, bowel/bladder, eating/feeding); assistance with 
instrumental activities of daily living (IADL) (e.g., medications, meals, housekeeping, 
laundry, telephone, shopping, finances). 
6. Medication Complexity Index: A calculation including the total number of medications 
taken each day as well as number of doses and other actions required to administer the 
medications. Used as a measure of the participant’s treatment complexity. 
7. Chronic Condition(s): Diagnosis of a disease or disease state that is ongoing.  
8. Cognitive Prosthesis: The use of a pill organizer to aid in the process of medication 
self-management.  
9. Medication Adherence:  Percentage of the monthly doses taken. Determined by the 
taking the RN’s monthly count of the missed prescribed pill doses and dividing it by the 
number of total monthly pill doses.  
Significance of Medication Adherence 
As previously noted, aging is significantly associated with an increased risk for 
developing one or more chronic conditions. There are several theories of aging that seek 
to explain this risk (Carey, 2003; Miller, 2003), as well as an established body of research 
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on how to prevent and/or delay the risk of developing a chronic condition (World Health 
Organization, [WHO], 2005). Despite advances in the diagnosis and treatment of chronic 
disease, however, the management of these conditions has been unsatisfactory. For 
example, while the percentage of hypertensive older adults with controlled blood pressure 
has significantly increased over the last decade, the majority of adults over the age of 60 
still do not have their blood pressure under control (Yoon, Ostchega, & Louis. 2010). 
Similarly, older adults with diabetes mellitus (DM) often fail to meet targeted clinical 
outcomes for blood pressure, HbA1c, and cholesterol levels, thus reflecting suboptimal 
management of their chronic conditions (Cheung et al. 2009).  
Both health complications and health system costs tend to increase when older 
adults with one or more chronic conditions fail to meet targeted clinical goals. For 
example, diabetes mellitus is one of the most common chronic conditions as well as one 
of the most expensive to our healthcare system.  Currently over one quarter of adults 65 
years of age and over (10.9 million) has diabetes mellitus and another 50% is prediabetic 
(CDC, 2011). More importantly, adults aged 65 years and older account for 
approximately 56% of $116 billion dollars spent annually on diabetes related care (ADA, 
2008). Medication management is a critical component of this chronic disease, and thus 
not surprisingly, a significant predictor of healthcare costs for the older adult with 
diabetes.  Indeed, in their five-year longitudinal study of Medicare Advantage patients 
diagnosed with diabetes, Balkrishnan and colleagues (2003) found that medication 
adherence was the most significant predictor of healthcare utilization. Given that the 
average medical expenditures for diabetic patients are more than twice the nondiabetic 
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patients (CDC, 2011), optimal management of chronic disease is critical to reducing 
overall health expenditures in the US.  
In addition to the costs associated with older adults not taking their medications, 
are the costs associated with an unintentional overdose (i.e, when the older adults takes 
more than their prescribed dosage). Indeed, older adults are not only among the highest 
risk groups for experiencing an adverse drug event (ADE) from their prescription drugs, 
but are also nearly seven times more likely to be hospitalized for an ADE than younger 
adults (Budnitz, et al., 2006). A more recent study by Budnitz and colleagues (2011) 
estimated that annually there were over 265,000 emergency department visits and over 
99,000 hospitalizations due to ADEs in older adults. Two-thirds of the ADE 
hospitalizations (65.7%) were due to unintentional overdose. The authors also found that 
our oldest old, (ages 85 and older) were three and a half times more likely than younger 
Medicare patients (aged 65-69 years old) to be hospitalized (1.3/1000 persons vs. 
4.6/1,000) and that rates of hospitalization were also significantly higher for those 
patients taking five or more medications versus those taking one to four medications 
(54.8% vs. 39.9%). It also appears that older adults in the United States are in need of 
additional teaching on medication self-management given that 95% of the 
hospitalizations involving warfarin, insulin, and oral hypoglycemic ADEs were due to 
unintentional overdose.   
Optimal medication self-management for multiple chronic conditions, however, 
poses a particular challenge to the older adult for myriad reasons.  First, many chronic 
conditions require specialists for consultation and/or management of the patient’s 
treatment plan. Cardiologists often manage patients with CHF and CVD, neurologists for 
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dementia, psychiatrists for depression and other mental health conditions, and 
endocrinologists for diabetes. Indeed, more than half (55%) of older adults with serious 
chronic conditions have 3 or more physicians involved in their care (Anderson, 2010). 
When multiple providers are engaged in prescribing medications, there is a risk of 
unintended drug-drug interactions due to poor communication between prescribing 
providers, as well as between provider and patient about the prescribed medications. A 
second barrier to effective medication self-management is the dilemma of what to do 
when there is a medication interaction between medications prescribed by more than one 
provider. The patient then has to coordinate between prescribers to decide which 
medication to take and which one to stop and/or the options for taking a different 
medication.  
Another common reason many older adults give for not taking their medications 
is the out-of-pocket expense, and the effects of this problem are significant.  Mojtabai and 
Olafson (2003), for example, examined the effects of cost-related nonadherence (CRNA) 
on health and healthcare utilization over a two-year period in 10,413 Medicare recipient 
and found that 7% of the adults reported taking less medication than prescribed due to 
cost (CRNA). The authors extrapolated that this would represent nearly 2 million 
Medicare beneficiaries. The authors also found that CRNA was significantly associated 
with several adverse health outcomes: CRNA adults were nearly twice as likely to 
perceive their health as poor (O.R.=1.86); nearly twice as likely to feel their health got 
worse (O.R.=1.75), and nearly one and a half times as likely to be hospitalized in the last 
year (O.R.=1.49) (all at p<.001). In a similar study, Heisler and colleagues (2004) found 
in a national sample of 7,991 older adults that participants who self-reported restricting 
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their medications due to cost, were two years later nearly twice as likely to experience a 
decrease in their health status (i.e., went from rating their health as good-excellent to fair-
poor) (A.O.R.: 1.76 [1.27-2.44]). Those participants with cardiovascular disease also 
experienced a 50% higher rate of angina and/or episodes of nonfatal myocardial 
infarction/stroke. 
Less is known, however, about ways to promote effective patient self-
management in older adults with chronic conditions.  Whereas medication nonadherence 
is recognized as a significant problem among older adults (Murdaugh & Insel, 2009), a 
recent Cochrane review by Haynes and colleagues (2008) of over three decades of 
medication adherence research found that even the most effective interventions did not 
produce “large improvements” in medication adherence. In addition, whereas many older 
adults rely on their family members and friends when it comes to managing their health 
and healthcare needs, researchers have found that few medication adherence 
interventions have targeted family members and/or caregivers (Ruppar, Conn, & Russell, 
2008; Haynes et al., 2008).  Researchers are now calling for more theory-driven 
interventions with a systems-based approach (i.e., an approach that recognizes the myriad 
factors involved in medication adherence) in order to more effectively address the theory 
of the problem (Ruppar, 2010a; Russell et al., 2011).  To answer this gap in the literature, 
and more importantly to provide new insights in the development of effective 
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Chapter Summary 
Medication nonadherence and its associated morbidity and mortality in the older 
adult are a significant problem in our country. The unprecedented wave of older adults 
enrolling in Medicare, along with the rapid increase in our “oldest old” population (those 
85 years of age and older), underscore the urgency on the part of clinicians and 
researchers to better understand medication adherence in order to develop effective 
interventions that optimize medication self-management and ultimately the health 
outcomes in community-dwelling older adults. Yet, despite more than thirty years of 
research on medication adherence in older adults, there is still a lack of agreement on 
how medication adherence is defined, measured, and operationalized, as well as a lack of 
understanding about what are the critical components of an effective medication 
adherence intervention. Nurses spend more time with patients and families than any other 
healthcare provider, and with their education and training are ideally suited to deliver 
interventions that optimize community-dwelling older adults’ self-management of their 
medications. Most of the research to date, however, has been outcomes-focused without 
attention to the context and processes that impact the older adults’ medication self-
management behaviors. This limited understanding of the problem has hindered nursing 
and behavioral scientists’ ability to develop and implement effective interventions, and 
has resulted in a plethora of interventions demonstrating minimal to no effect on older 
adult’s medication adherence.   
More research is needed, therefore, that not only recognizes the ecology of an 
older adult’s medication self-management, but also adopts a theory-driven approach in 
the development and testing of interventions. This study attempted to fill this gap in the 
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literature by utilizing medication adherence data from approximately three hundred older 
adults who participated in the twelve-month nurse care coordination study (Marek et al., 
2013). The study included both quantitative and qualitative measures from the original 
study. This secondary analysis, guided by the IFSMT, examined and described the 
contexts and processes associated with medication adherence in those frail urban older 
adults who had participated in the two experimental arms of the nurse-led intervention. 
The goal of this current study was to further understand the how and why of our 
phenomenon of interest (i.e., medication nonadherence) in order to inform the 
development of more effective theory-based interventions.  
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CHAPTER 2 
REVIEW OF THE LITERATURE 
 This chapter reviews the literature on the patterns and importance of medication 
adherence, as well as the work that has identified factors that explain variations in 
adherence. First, the chapter examines the ongoing debate over how medication 
adherence is defined and measured, and how this shapes our understanding about the 
significance of the problem. Next, the review identifies the salient contextual factors (i.e. 
the risk and protective factors) associated with medication adherence, as well as the 
processes involved in older adults’ medication self-management. The chapter then 
reviews the important intervention studies aimed at improving medication adherence in 
community-dwelling older adults. Finally, because of the nursing profession’s critical 
role in the delivery of patient health education in the community setting, this review 
concludes with an evaluation of medication adherence interventions conducted by nurse 
researchers within the last ten years in order to identify the gaps in the science.  
Medication Adherence 
The most widely accepted definition of medication adherence comes from the 
World Health Organization which describes adherence as, “the extent to which a person’s 
behaviour – taking medication, following a diet, and/or executing lifestyle changes, 
corresponds with agreed recommendations from a health care provider” (Sabate, 2003, p. 
3).  Researchers who investigate the issues involved in medication adherence and its 
corollary, medication nonadherence, have conceptualized medication adherence as both a 
multistep “process” (Murdaugh & Insel, 2009; Russell et al., 2011), and as an “outcome” 
(George, Elliott, & Stewart, 2008; Haynes, Ackloo, Sahota, McDonald, & Yao, 2008) 
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depending on whether they operationalized medication adherence as a set of mediating 
variables or a dependent variable. When researchers conceptualize medication adherence 
as a multistep process, this set of actions can then be grouped into several different 
behaviors with each component often targeted by a specific intervention. Where the 
larger problem exists, however, is when researchers operationalize medication adherence 
as a single outcome. 
For example, in the literature, adherence to 80% of a prescribed regimen is often 
used as the accepted dichotomous cut point for determining adherence versus 
nonadherence (Berg & Arnsten, 2006; Esposito et al. 2009; Ho et al., 2009). However, 
Wu, Moser, Chung, & Lennie (2008a) found in a longitudinal sample of heart failure 
patients that an even higher medication adherence cut-off (>=88%) produced a 
statistically significant improvement in event free survival. Additional studies have also 
found that medication adherence and its therapeutic effect varies across medications such 
that 95% adherence level may be necessary in order to effectively manage chronic 
diseases, such as HIV (Berg & Arnsten, 2006) and CHF (Esposito, 2009); and that the 
measurement threshold of 80% is “arbitrary” (Ho et al., 2009). Health related outcomes 
of medication adherence, notwithstanding, there are also economic implications for how 
we measure medication adherence. For example, Esposito and colleagues (2009) found in 
their study of adults with CHF that when “adherent” patients were further stratified into 
groups  “>95% adherence” vs. “80-95% adherence”, patients in the former group had 
significantly lower annual healthcare costs than the latter group ($17,665 vs. $20,747, 
p<.01).  
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In addition to the inconsistency related to how medication adherence is 
operationalized (dichotomous, categorical, or continuous), significant debate exists in the 
scientific community on the reliability and validity of the divergent measures used to 
indicate medication adherence.  The only agreement appears to be that each method 
comes with its own set of strengths and limitations. The following briefly describes each 
of these types of measures, starting with self-report, which is generally regarded as the 
least reliable indicator of medication adherence (United States Department of Health & 
Human Services [USDHHS], 2010). 
Self-report measures vary in the literature from single question (Kennedy, Tuleu, 
& Mackay, 2008; Lewis, 2010; Wu et al., 2008a) to multi-item surveys such as the Hill-
Bone Compliance questionnaire (King, 2010; Krousel-Wood, 2005).  One of the most 
common self-report measures is the Morisky-Self Report scale (Morisky, Green, & 
Levine, 1986), a brief 4-question assessment of a person’s medication-taking behavior. 
The survey assesses reasons a person might miss or stop taking medications and includes 
structured responses such as forgetfulness, carelessness, feeling better and/or feeling 
worse. The benefits of self-report measures are that data collection is less time-intensive 
to the patient and staff and the surveys are often brief and easy to administer (Berg & 
Arnsten, 2006).  The use of self-report, especially single-item reports, however, could 
significantly bias study results. Indeed Wu and colleagues (2008a) examined medication 
adherence in a group of heart failure patients (N=134) and found that self-report 
medication adherence (a single question from the MOS-Specific Adherence Scale) did 
not predict event-free survival, whereas the MEMS adherence data (an objective 
measure) did. Some researchers speculate that self-reports are more likely to overestimate 
                                                                  
 
       
	   	  	  20	  
the actual level of adherence for numerous reasons, including social desirability and/or 
recall bias (Berg & Arnsten, 2006;Wu et al., 2008a), and thus caution against its use.  
 Moving away from self-report, researchers have also used objective 
measurements of medication adherence that have included pharmacy refills, pill counts, 
and the Medication Event Monitoring System (MEMS) caps; but as with self-report, each 
of these specification strategies also introduce measurement bias. For example, pharmacy 
refill (which is the most often used measure for medication adherence in pharmacy 
studies) is often calculated as a percentage of medications the patient had obtained over 
the number of days between refills. This is typically referred to as the medication 
possession ratio (MPR). Studies that have used the MPR as the dependent variable have 
usually defined MA as a dichotomous outcome with >=80% MPR as the cut-off (e.g., 
Choudhry et al., 2011; Doshi, Zhu, Kimmel, & Volpp, 2009; Egede et al., 2011).  The use 
of pharmacy refills, however, only assesses the act of filling prescriptions, and can 
potentially overestimate the actual pills taken (MacLaughlin et al., 2005). 
Pill counts are another common objective measure of adherence because they can 
be performed on many devices including prescription bottles, mediplanners, and/or 
pharmacy blister packs. Nevertheless, with pill counts there could also be an 
overestimation if the participant took the medication out, but then dropped it and/or lost 
it, and thus never actually took the medication. Conversely, pill bottle counts could 
underestimate medication adherence when patients obtain refills on their medications 
before they have finished the last dispensed bottle (Grymonpre et al., 1998). 
Compounding the problem is the fact that many older adults lack a complete and accurate 
medication regimen because they have prescriptions from more than one provider (Vik, 
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Maxwell, & Hogan, 2004). Another reason for pill bottle count overestimation stems 
from individuals who choose to hide or hoard their missed doses (Urquart, 1994).  
Another threat to reliability with pill counts, is the need for more than one client 
encounter in order to ensure accuracy in the medication regimen. For example, when Vik 
and colleagues (2005) conducted an in-home cross-sectional study of 319 urban and rural 
adults aged 65 years or older, the authors found that pill counts to assess medication 
adherence were either not feasible or were inaccurate in more than one third of the 
sample (34.7%). Artinian and colleagues (2003) noted similar difficulties with pill 
counts, noting that they were unable to assess adherence across their study participants 
because “most patients did not follow our instructions” (p. 231). Therefore, medication 
reconciliation prior to pill counts is a crucial first step in obtaining accurate pill counts.   
More recently, researchers have utilized the MEMS caps (Aardex, 2005) because 
of the microprocessing chip’s ability to capture and save several pieces of information, 
such as date and time bottle cap was removed. The MEMS cap has been called the “gold 
standard” for measuring adherence (Ogedegbe, 2012), although the system has two 
important limitations.  First, in most studies, only one medication had a MEMS cap 
attached to the bottle, so adherence with the other medications taken could not be 
monitored. This monitoring limitation might affect the validity of the measure given that 
nearly 40% of adults aged 60 years and over take at least five medications (Gu, Dillon, & 
Burt, 2010), and among adults 65 years and older, 18% take ten or more medications 
(Sloane Survey, 2006). Second, Bova and colleagues (2005) reported that in their study, 
the MEMS cap did not always record the opening of the bottle, which may have 
underestimated adherence. Furthermore, MacLaughlin and colleagues’ review (2005) 
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cited several additional limitations to the MEMS cap for both research and practice:  (1) 
The cap only monitors the opening and closing of the cap, and not whether or not the 
medication was actually taken; (2) For older adults already using mediplanners, the 
addition of a MEMS cap could interfere with already established routines; and (3) The 
cost of the cap at $80-$142 each may not be scalable for adoption in clinical practice.  
The review of the literature illustrates two important issues that impact our 
understanding of medication adherence as a health behavior: (1) The inconsistency in the 
definition of medication adherence; and (2) The questionable reliability and validity of 
the multiple measures used to assess medication adherence. Working toward the 
resolution of these issues is a critical step toward identifying the risk and protective 
factors associated with medication adherence and the development of more effective 
interventions for community-dwelling older adults. 
Causative Factors of Medication Nonadherence 
Whereas research has consistently demonstrated that nonadherence to medication 
regimens is a risk factor for adverse health outcomes and for increased healthcare 
utilization, there remains inconsistency in identifying protective/risk factors for 
medication adherence in older adults. Therefore, the findings to date on the individual- 
and family-level factors are discussed in further detail to identify the gaps in the 
literature. 
Individual-level Characteristics. Whereas some research has found individual 
demographic variables to be poor predictors of medication adherence (Russell et al., 
2011; Vik et al., 2004), several studies have linked individual-level characteristics 
medication adherence and nonadherence, including:  age, gender, financial limitations, 
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and education. Most researchers examining these factors have conducted multivariate 
analyses to assess the independent effects of each of these variables.  
Choudhry and colleagues (2011) conducted multivariate analyses in a larger 
sample of older adults (N=3.3 million; mean age 63 years old) to assess the effect of 
therapeutic drug regimens on longitudinal adherence. The authors measured medication 
adherence as the “proportion of days covered” (i.e., when patients obtained refills), and 
then examined individual-level characteristics that predicted the adults’ adherence rate 
over 12 months. Age was found to be a significant and positive predictor of adherence to 
statins and ACEI/ARBs (both p<.001).  The authors also found that female gender was a 
significant positive predictor of medication adherence. 
Contributing to these age and gender findings, Ho and colleagues (2006b) 
examined medication nonadherence (measured as discontinuation of cardiac medications 
one month post-discharge) in a sample of 1,521 adults who were hospitalized for acute 
myocardial infarction and found an interesting gender by age interaction. Specifically, the 
authors found that for every 10 year increment, women had a 1.77 odds ratio (95% 
C.I.=1.34-2.34) of discontinuing their medications, whereas for men the odds ratio was 
only 1.  
 Several recent studies also found that African American race is an important 
predictor of medication adherence in older adults (Egede et al., 2011; Gazmararian et al., 
2007; Gerber, Cho, Arozullah, & Lee, 2010; Krousel-Wood et al, 2005; Wu et al., 
2008b). For example, in a five year longitudinal study, Egede and colleagues (2011) 
examined the racial differences in medication adherence in a nationwide sample of 
veterans diagnosed with type 2 DM (N=690,968).  The mean age of the veterans was 
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65.77 (11.28 S.D) years old. The researchers measured medication adherence as a 
continuous variable by calculating the veteran’s annual medication possession ratio 
(MPR) per drug class per year. Across all races, African Americans had the lowest MPR-
--6% lower than Non-Hispanic Whites.  
 Bosworth and colleagues (2006) similarly found in their sample of older military 
veterans (N=569) that African Americans were nearly twice as likely as their White 
counterparts to be nonadherent to their blood pressure medicines (O.R. 1.81, C.I. [1.28-
2.58]). In that study, the authors had assessed participants’ adherence by creating 
dichotomized scores from the self-report Morisky scale. Krousel-Wood and colleagues 
(2005) similarly controlled for other demographic variables and found that African 
Americans had more than twice the risk for nonadherence (O.R.=2.53, C.I.=1.37-4.66).  
More recently, Bautista and colleagues (2011) also found among a cohort of middle aged 
adults living with epilepsy that African American race was significantly associated with 
lower medication adherence (p=.037). Gerber (2010) hypothesized that race would no 
longer be a significant predictor of nonadherence, once they controlled for other 
sociodemographic variables, but in a sample of 489 veterans, the authors found that 
African American patients were still more than twice as likely as Whites to report being 
nonadherent due to not following their physician instructions on how to take their 
medications (O.R.=2.49; C.I.=1.07-5.80).  
Recent descriptive and qualitative studies may help explain these disparities in 
medication adherence.  Lewis and colleagues (2010) conducted three focus groups with 
40 hypertensive low-income African Americans (mean age: 57.2 +=12.7 years old). 
Adherence was ascertained by a single yes/no question about whether the individual had 
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taken their medication every day as prescribed.  In this sample, only 65% of the 
respondents reported they were adherent. Participants specifically discussed their distrust 
of healthcare providers along with longstanding issues of racism as reasons for 
nonadherence. Similarly, Lukoschek (2003) found in a sample of hypertensive African 
Americans that distrust of the physicians and the pharmaceutical industry along with poor 
communication with one’s physician were important reasons for nonadherence. With the 
population of African American elderly expected to triple from 2.9 million in 2000 to 8.9 
million by 2050 (Yee, 2006), there is an urgent need to further understand these 
disparities in medication adherence. 
Low Health Literacy and Education Level. Estimates are that 90 million 
Americans have difficulty reading and/or processing health information (NCPIE, 2007), 
and low health literacy is linked to increased risk for medication nonadherence 
(Armstrong, 2010; Kripalani et al., 2006).  Education was examined as a risk for 
medication nonadherence but the findings are mixed. For example, Catz, Heckman, 
Kochman, & Dimarco (2001) reported that their multivariate analysis of middle and older 
adults (M age 53.8 SD=5.5 years) demonstrated that higher education significantly 
predicted better self-reported medication adherence (O.R.=1.42, p<.009).  Similarly, 
Schoenthaler and colleagues (2009) found that low education significantly predicted self-
reported low MA. When Insel and colleagues (2006), however, included education in 
their hierarchical regression model predicting medication adherence (by MEMS cap), the 
authors found education made no significant change in the model. Krousel-Wood (2005) 
also did not find education was a significant predictor of MA as measured by the self-
reported HBC subscale.  
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Financial Limitation. Cost-related nonadherence (CRNA) is another common 
factor, but particularly among financially vulnerable older adults. For example Piette and 
colleagues (2004) conducted a nationwide survey of adults ages 50 years and older 
(N=4,055) to examine the problem of cost-related adherence and found that 18% of 
adults reported at least one episode of CRNA in the prior year.  Of those who reported 
cutting back on their medications, 78% of them reported doing so at least once a month.  
In a multivariate analysis, the authors found that income and monthly expenses were 
significant while race, gender, and educational attainment were not significant predictors 
of CRNA. The findings from this study may actually underestimate the problem, 
however, as the respondents to this online survey were significantly more likely to be 
White, older and have more education. Indeed, the authors suggest that older adults who 
have access and are comfortable with the internet may not truly represent older adults 
most at risk. Supporting this assumption, Soumerai and colleagues (2006) found that 
older adults most likely to report CRNA are from the more vulnerable groups (i.e., 
having low income; being African American; having more than one comorbidity; and/or 
having difficulty with one or more ADLs).  
In January 2006, CMS implemented the Medicare Prescription Drug Coverage 
(Part D) to assist older adults with the high cost of prescriptions.  In order to participate in 
this program, older adults were required to pay a monthly premium, drug copayments, 
and when their drug costs during the year exceeded $2,830, no coverage would be 
available until their drug costs reached $4,550 in year. Once the Medicare participant 
reached this out-of-pocket drug expense level, they would become eligible for the 
“catastrophic coverage” and would only pay a copay toward each subsequent prescription 
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(CMS, 2010). Older adults who qualified for Medicaid were automatically eligible to 
receive “Extra Help” which included assistance with their monthly premiums and annual 
deductible, and were exempt from the coverage gap.  Interestingly, in a 2004 CMS 
national panel survey, Kennedy and colleagues (2008) found that dual-eligible 
Medicare/Medicaid enrollees were significantly less likely to fill their prescriptions than 
those Medicare enrollees not on Medicaid (6.3% vs. 4.0% P = 0.001). The study did not 
explain why these differences occurred.   
Since then, however, several studies have attempted to further describe the 
relationship between CRNA and copays.  For example, in a sample of 3,240 adults, Shah 
et al. (2009) examined the effect of financial factors on first-fill adherence and found that 
adults who had copays of more than $10.00 were less than half as likely to be adherent 
(i.e., to fill their prescriptions within 30 days (p<.0001) when compared to those whose 
copays were less than $10.00). Doshi and colleagues (2009) also found in a sample of 
5,604 veterans with medication copayments that an increase from $2 to $7 per copayment 
significantly decreased the odds of being at least 80% adherent by nearly a half  
(O.R.=0.58, p<.0001). With the passage of the 2010 Patient Protection Affordable Care 
Act (PPACA), Medicare recipients are now receiving additional assistance from the 
federal government to help with the “donut hole”, and by 2020 recipients will be 
responsible for only 25% of their total prescription drug costs (Medicare Rights Center 
[MRC], 2014).  
Condition-Specific Factors. Research has also found that condition specific 
factors including: a person’s health status (e.g., depression, cognitive impairment, 
physical functioning, and/or number of comorbidities); and complexity of medication 
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regimen (number of medications and doses) can be significant predictors of medication 
adherence. Each of these will also be briefly reviewed. 
Health Status 
Cooper and colleagues (2005) conducted a multinational study, (the Aged in 
Home Care project [AdHOC]), with 3,643 older adults from eleven countries to examine 
risk factors for self-reported nonadherence (i.e., <80% of doses taken in the last week).  
Using multivariate logistic regression, the authors found that those with ADL and/or 
cognitive impairment were significantly more likely to be nonadherent, however, those 
with vision impairment were no more likely to be nonadherent. Conversely, Schuz and 
colleagues (2011a and 2011b) examined the relationship of multi-morbidity and 
medication adherence and found that decreases in functional health were associated with 
increased medication adherence. The authors hypothesized that worse health led to belief 
in the medication necessity and in turn to an increase in adherence. 
Depression has also been linked to medication taking/health behaviors. For 
example in a prospective observation study, Kronish and colleagues (2006) examined 
medication adherence among 492 older adults (mean age 60.6, S.D.=12.2 years) who 
were three months post acute coronary syndrome and found persistently depressed older 
adults were only half as likely to taking their medications as prescribed compared to 
those where persistently non-depressed (O.R.-0.50, [95% C.I.=0.27-0.95]). Similarly, 
Gonzalez (2007) studied 879 older adults living with Type II DM (mean age 66.22, 
S.D=12.4 years) and found that those adults with major depression scores (i.e., scoring 
>=9 on the Harvard Department of Psychiatry/National Depression Screening Day Scale 
[HANDS]) were more than twice as likely to have reported missing medications in the 
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last week when compared to those with HANDS scores <9: (O.R.=2.31, [C.I.=1.50-3.56], 
p<.001). More importantly, the authors also found that increases in depressive symptoms 
significantly increased the risk for missing medication in the previous week (p<.001).   
Of note, in a study of 167 older African Americans with hypertension, 
Schoenthaler and colleagues (2009) found that depressive symptoms significantly 
predicted low medication adherence, however, this relationship was mediated by self-
efficacy such that once this individual-level factor was included in the model, the 
relationship to adherence was no longer significant.  This has important implications for 
Ryan and Sawin’s (2009) theory that suggests a person’s knowledge and beliefs (i.e., 
self-efficacy and goal congruence) can improve one’s self-management behavior.  
Maddigan, Farris, Keating, Wiens & Johnson (2003), on the other hand, examined 
adherence rates after patients had participated in a medication self-management program 
and found the opposite relationship with the diagnosis of depression predicting increased 
adherence. The authors acknowledged, however, that because their study was 
retrospective chart review it is possible that depression might not have been a current 
health condition for some of the participants. In addition, their study design did not 
include pre-intervention data that might have helped interpret this unexpected 
relationship.  
Cognitive Impairment . Stilley and colleagues’ (2010) pooled-analysis of three 
recent studies on medication adherence demonstrates the difficulty in measuring the 
effect of cognitive functioning on medication adherence.   In the team’s findings, all four 
of the cognitive processes tested (i.e., attention/psychomotor speed, mental 
flexibility/working memory, verbal learning and memory, and executive functioning) 
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significantly predicted medication adherence, in at least one of the three study samples, 
but the significance of the relationship often varied between each specific aspect of 
cognitive processing and a particular measurement of medication adherence.  For 
example, in only one of the three studies, did attention/psychomotor speed significantly 
predict percentage of days with a correct dose.  In two of the studies where medication 
adherence was defined as “percent of prescribed number of doses” and “percent of days 
with a correct dose”, executive functioning predicted medication adherence, but in only 
one study was the relationship significant. One possible reason for the differences in 
findings is that different aspects of cognitive functioning may affect different aspects of 
the medication-taking process.  
  The Mini-Mental Status Exam (MMSE) (Folstein, Folstein, & McHugh, 1975) is 
a common screening test that researchers and clinicians use to assess cognitive 
functioning in older adults and may be an easy clinical tool for identifying adults at risk 
for medication nonadherence. Indeed when Insel, Morrow, Brewer, and Figueredo (2006) 
conducted their medication adherence study with community-dwelling older adults 
(N=95), their initial analysis, using hierarchical linear regression, found MMSE to be a 
significant predictor of adherence. However, when the authors simultaneously entered the 
executive functioning working memory composite score (EWM) before MMSE, the 
effect of MMSE on medication adherence disappeared.  Of note, the bivariate correlation 
between the MMSE and the EWM was strong (r=.61, p<.01), and this overlap may 
explain why the MMSE effect disappeared in the final model. While the EWM may be a 
better predictor medication adherence, the complicated calculation of the EWM 
composite score may also limit its translation to clinical practice.  
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Similarly, Park, Willis, Morrow, Diehl, and Gaines (1994) have also noted that 
the process of medication-taking includes both literal and inferential cognitive ability. In 
their study, the team compared a group of “normal” older adults to a group of adults with 
early Alzheimer’s Disease (i.e., median group MMSE score of 17) on their ability to 
answer literal versus inferential questions. Literal questions referred to facts on a label 
such as the medication’s side effects, whereas, inferential questions required the older 
adult to calculate how many pills would be needed for a specific time period. The authors 
found that the early AD adults were much less likely to correctly answer both literal and 
inferential questions: The “normal” older adults answered the literal questions 97% of the 
time compared to only 79% of the time for the early AD adults.  Even more compelling, 
when the team posed inferential questions to the older adults, the “normal” older adults 
gave the correct answer 84% of the time, but the early AD adults were only half as likely 
(42%).   
Ownby, Hertzog, Crocco, and Duara (2006) later used the Park and Jones (1997) 
model to examine factors associated with medication adherence in a cross-sectional 
convenience sample of adults referred to their memory clinic (N=63). The sample was 
predominately Anglo (55.6%), female (71.4%) and included (22.2%) with a primary 
diagnosis of a psychiatric illness.  For this study, the team assessed the medication 
adherence rates for each participant’s prescriptions by asking the caregiver and 
participant to rate adherence on a 5-point likert scale between “Almost never” to “Almost 
always”. Using the MMSE to measure cognitive status, the authors found an indirect 
relationship between cognitive function and medication adherence. While the multilevel 
regression model did not show that MMSE scores significantly predicted medication 
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adherence, it did show that the participant’s reliance on self to take medications was 
significantly and positively associated with medication adherence. Thus, for older adults 
with even mild cognitive impairment, living alone could be a tipping point if there were 
no one else available to help them manage their medications.  
In a study of community-dwelling older adults (N=771), Jerant, Chapman, 
Duberstein, Robbins and Franks (2011) found that low cognitive functioning significantly 
predicted medication nonadherence (p<.04). In addition, Fitten, Coleman, Siembieda, Yu, 
and Ganzell (1995) tested older adults on their ability to self-manage their medications 
and found that both manual dexterity and the ability to read/comprehend a prescription 
correlated significantly with MMSE scores. More research is therefore needed to 
understand the impact of cognitive impairment, and the MMSE in particular, on 
medication adherence in older adults. 
Medication Regimen Complexity. Another condition specific factor that has been 
identified in the literature is the complexity of a person’s medication regimen. A common 
measurement is the medication complexity index (MCI). Maddigan, Farris, Keating, 
Wiens, and Johnson (2003) conducted a retrospective chart review on 301 older Canadian 
adults at a rehabilitation hospital and found that MCI score alone did not predict a 
person’s risk for a medication self-management error. There was an interaction effect, 
however, with cognitive impairment and MCI on medication errors.  Among older adults 
with moderate to severe cognitive impairment, the risk of medication error was similar 
regardless of the patient’s MCI score.  In those adults with mild cognitive problems, 
however, there was a statistically significant increased risk (p=.019) in making a 
medication error once the MCI score was greater than 26. Similarly, Hinkin and 
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colleagues’ (2002) work with HIV + adults found that cognitive functioning and 
medication complexity had an interaction effect on medication adherence such that 
adherence dropped significantly among the cognitively impaired adults once the 
treatment regimen comprised three or more doses a day.  Age, on the other hand, was a 
positive predictor of adherence in this group such that those aged 50 years and over had 
significantly better adherence.  
Social Environment Factors. Social Support has also been identified as a 
significant predictor of health promoting behaviors in older adults (Carlson et al., 2012; 
Hopman-Rock, Vries, Bakker, & Ooijendijk, 2012; Resnick, Orwig, Magaziner, & 
Wynne, 2002).  The findings for social support as a predictor of medication adherence, 
however, are mixed.  For example, Tang and colleagues (2008) found in their cross-
sectional study of African American (mean age 60 years) that nonsupportive social 
support had a negative effect on medication adherence (r=-.348, p<.01). Conversely, 
positive social support had no effect on medication adherence. Sayers, Riegel, 
Pawlowski, Coyne, & Samaha (2008) also tested the effects of different forms and 
sources of social support on medication nonadherence using the Morisky self-reported 
measure for medication nonadherence and the Multidimensional Scale of Perceived 
Social Support (MSPSS) to measure both emotional and instrumental support. The 
authors found that as emotional support increased, medication adherence increased.  
Instrumental support, however, had no significant effect on medication adherence. 
Similarly, Siegel, Turner, and Haselkorn (2008) examined the relationship of medication 
adherence and the specific aspects of the caregiver relationship (i.e., medication-specific 
support and relationship qualities of support and/or conflict) in a group of 54 veterans 
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with multiple sclerosis. Medication adherence was a single self-reported question of how 
many doses the person missed in the past month.  Using multivariate logistic regression, 
the authors found that among the three types of social support, only supportive qualities 
(e.g., willing to listen, provide advice, and help with a problem) significantly predicted 
medication adherence (odds ratio [OR] = 3.58, 95% CI= 1.09-11.80). Of note, these are 
skills that perhaps a nurse or informal caregiver could provide in the absence of a friend 
or family member.  
The effect of social support may also vary based on other individual-level 
characteristics such as personal health beliefs.  Indeed, Voils, Steffens, Flint, and 
Bosworth (2005) examined the interaction effect of social support and a patient’s internal 
locus of control (LOC) and found that for those patients with high internal LOC, social 
support was significantly associated with medication adherence, but for those with low 
internal locus of control, the relationship was no longer significant.  
Living Situation. Similar to social support, family living environment has been 
found to have both a positive effect (Wen, Parchman, & Shepherd, 2004) and a negative 
effect on older adults’ self-management behaviors (Dunbar-Jacob, Bohachick, Mortimer, 
Sereika, & Foley, 2003). In studies examining the impact of older adults’ living situation 
on health outcomes, the findings have also been mixed. For example, Naylor and 
colleagues’ (1999) randomized clinical trial of comprehensive discharge planning and 
home follow-up for older adults found that living with others decreased the risk for first 
hospital readmission by half (Incidence Density Ratio=0.50, p=.009). Yet, five years 
later, Naylor’s team (2004) found that living alone decreased the risk for first hospital 
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readmission or death by nearly 40% (Incidence Density Ratio=0.59, p=.043) (Naylor et 
al., 2004).  
Vik and colleagues (2006) similarly found in their study of Canadian community-
dwelling older adults (N=319) that living in a communal senior setting versus a private 
home was protective and reduced the risk for nonadherence by more than half (O.R.=.46; 
C.I.=.27-.78). To help explain these findings, the authors also found that those adults who 
reported receiving assistance with their medications were half as likely to be nonadherent 
(O.R.=.49; C.I.=.29-.82). With regard to adherence to medical treatment, a meta-analysis 
of 17 studies by Dimatteo (2004) found that adults living with others had a modest, yet 
statistically significant increase, in treatment adherence (O.R.=1.38, C.I. [1.04-1.83]). 
The author cautioned, however, that living with others was more likely to positively 
affect behavioral regimens than to affect medication regimens.  
Qualitative Studies on Medication Self-Management 
The context of risk and protective factors (i.e., individual characteristics, social 
environment, and condition-specific factors), however, does not alone explain older 
adults’ medication self-management behavior. Indeed, medication nonadherence can also 
be an intentional act to not take one’s medications, and stem from the patient’s 
knowledge, attitudes, and beliefs about their medications. These factors, however, are 
often more difficult to measure because of the nuanced reasons people have for not taking 
their medications exactly as prescribed.  Several qualitative research findings thus aid in 
our understanding of why older adults either intentionally or unintentionally miss and/or 
are late taking their medications. For example, August (2005) conducted a qualitative 
study using focus groups with 49 community-dwelling older adults (aged 65 years or 
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older) and identified several individual-level factors that were barriers to medication 
adherence. Analysis of the older adults’ responses identified the following risk factors in 
rank order of frequency (1) cognitive factors (e.g, forgetting); (2) physical factors (e.g., 
dexterity/seeing); (3) cost factors; and (4) other factors (e.g., side effects or disliking 
taking the medication).  
 Similarly, Vik and colleagues (2005) examined older adults’ reasons for not 
taking their medications and found the participants had both intentional and unintentional 
reasons for not taking their medications.  The most common intentional reasons were: 
nonadherence due to side effects; altering dose as they saw fit; and/or did not think the 
medication was effective.  Unintentional reasons offered included: forgot, confused, and 
ran out of medication.  When viewed as processes some adults are actively self-managing 
their medications by intentionally choosing to be nonadherent, while others perhaps are 
attempting to self-manage, but not effectively enough to be adherent.   
Research examining healthcare provider relationships also found a significant 
effect on medication adherence in older adults.  In a qualitative study with 98 
community-dwelling cardiac patients, Gordon, Smith, and Dhillon (2007) found that 
most individual are indeed self-managing their medications, but often without seeking the 
advice and/or informing their healthcare provider of their dosage adjustments. Moreover, 
those individuals who did report speaking with their clinician also expressed 
dissatisfaction with their encounters (i.e., not feeling their particular medication questions 
or concerns were adequately addressed by their provider). Many of the adults also 
expressed the desire to be active participants in their medication self-management, but 
reported several barriers to effective communication with their provider: being confused 
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by the medical jargon; feeling inferior to their physician; and receiving inconsistent 
advice from different providers.  From these individuals’ experiences, the authors 
observed that medication-taking is a dynamic process for an individual, and thus requires 
regular ongoing consultation with clinicians in order to meet their unique healthcare 
needs.   
Rifkin and colleagues (2010) similarly provide insight into the interaction 
between the context and processes of self-management. In a set of semi-structured 
interviews with older patients diagnosed with chronic kidney disease (N=20), the authors 
specifically describe how the interactions between social environment (i.e., access to 
provider and provider relationship) and patient processes (knowledge/beliefs and self-
regulation skills) can lead to medication nonadherence. The patients were on multiple 
medications, and shared that they even though they intended to take all their medications, 
they would also prioritize medications, and sometimes skip the ones they felt were less 
important. In addition, the patients reported that medication side effects were common 
and provoked feelings of anxiety. Unfortunately, the patients also reported that 
conversations with their providers were often delayed and/or unfulfilling.  
Wilson and colleagues’ (2007) nationwide study of 17,569 community-dwelling 
older adults from high-poverty neighborhoods also illustrates the benefits of patient-
provider communication about medication management issues. The researchers examined 
patient self-reported rates of medication nonadherence as well as the effect of patient-
physician dialogue on the provider switching to a lower cost medication. The authors 
found that 40% of the older adults reported being nonadherent at least once in the last 
year, and among those with three or more chronic conditions, more than half (52%) 
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admitted to being nonadherent. There were also differences in the rates of patient-
initiated dialogue depending on the type of reported nonadherence. For example, older 
adults with cost-related nonadherence were less likely to have had a discussion with their 
physician (61%) than those who had experienced side-effects from the medication (73%). 
Nevertheless, as the number of reasons increased for why an older adult engaged in 
CRNA, the more likely they were to report having a dialogue with the physician about 
the medication management issue. The authors demonstrated that older adults with 
CRNA could ultimately benefit from these dialogues: Their multivariate analysis found 
that having a patient-physician dialogue resulted in a five-fold increase in a patient being 
switched to a lower-cost medication (O.R. 5.04 [C.I. 4.28-5.93, p<.001]). What is not 
known from this study, however, is what impact these dialogues ultimately had on the 
older adult’s subsequent medication adherence.  
Medication Adherence Interventions Targeting Older Adults 
As previously noted, medication adherence (i.e., the process of taking the correct 
medication at the correct time and dosage) requires the older adult to perform a complex 
combination of cognitive and behavioral activities (Alspach, 2011; Marek & Antle, 
2008), and when the older adult lacks the requisite skills and/or resources, the risk for 
nonadherence increases. Several recent reviews of the literature have attempted to 
identify what works and what is still unknown, and these are briefly summarized below. 
In 2008, Marek and Antle conducted an evidence-based review of interventions 
targeting medication management in the community-dwelling older adult, and identified 
52 studies published between 1990 and 2005.  The inclusion criteria limited the analysis 
to those studies published in English and included participants ages 65 years and older. 
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The majority of the interventions were randomized controlled trials delivered by nurses 
and pharmacists.  The authors’ in-depth analysis of the interventions identified several 
strategies for promoting medication adherence (e.g., assistance with medication 
reconciliation and procurement; assessment of knowledge, physical and cognitive 
deficits; and ongoing monitoring).  The authors also noted that while the most effective 
interventions included multiple components, they could not assess the effectiveness of 
individual components due to the lack of studies that separately tested each individual 
component.  
Haynes and colleagues (2008) also conducted a systematic review of the 
literature, but found that the interventions varied too much to conduct a quantitative 
analysis of the findings. Nevertheless, similar to Marek and Antle (2008), their 
qualitative analysis found that numerous medication adherence strategies had been 
employed including: patient education and counseling; telephone and packing reminders; 
simplified dosing; and patient self-monitoring of health. The authors also found that long-
term therapy interventions are often complex and labor intensive, yet the evidence of 
what constitutes an effective intervention “remains surprisingly weak” (p. 17): Less than 
half the studies demonstrated a significant improvement in medication adherence, and 
less than a third showed significant improvement in the targeted health outcome. The 
authors concluded that the following methodological issues need to be resolved 
including: agreement on a reliable and valid measurement of medication adherence; 
ensuring adequate power in the sample sizes to detect clinically significant differences; 
and designs that actually test the effects of the individual components of an intervention.  
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Coleman and colleagues’ (2009) review of the literature raised another important 
criticism about current adherence interventions. Most programs still target the patient 
without focusing attention on the development of practice designs that could better meet 
the patients’ needs. This is in spite of the fact that several studies have found that the 
quality of the patient-provider relationship significantly impacts a patient’s adherence 
behaviors (Drennan et al. 2011; Gordon, et al., 2007; Lewis et al., 2010), and that the 
Chronic Care Model (Bodenheimer, Wagner, & Grumbach, 2002), a model 
recommended by both the IOM and RWJF, emphasizes the importance of the healthcare 
system in providing self-management support.   
In addition, a review by Schlenk, Bernardo, Organist, Klem, and Engberg (2008) 
suggests that more research is needed regarding the effect of ongoing self-management 
support. The concern is that most studies have not produced sustainable patient behavior 
change (i.e., once the intervention ends, so does its effects).  For example, Lee, Grace, 
and Taylor (2006) conducted an elegant design where all patients received the pharmacy 
care intervention for six months, and then the patients were randomized into two groups 
where one group went back to usual care and the other group continued with the 
intervention.  At the end of the first phase the average adherence rate was 96.9%, but 
once the usual care group lost the support, their adherence rates dropped down near 
baseline, whereas the intervention group maintained adherence: 69.1% (16.4) vs. 
95.5%(7.7%). Murray and colleagues (2007) and Schulz, Porter, Lane, Cornman, and 
Branham (2011) similarly found that once their interventions ended, the intervention 
effects were no longer significant.   
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Finally, Ruppar, Conn, and Russell (2008) reviewed 63 intervention studies and 
found that medication adherence strategies fell into three categories:  patient focused 
factors, medication factors and medication administration factors.  The authors also 
concluded that more studies are needed that acknowledge informal caregivers and the 
social context surrounding medication adherence.  They further observed that nurses in 
the hospital setting are the primary health professional working with patients as clinical 
educators, discharge planners, case managers, inpatient medication management, and in 
the outpatient setting as home health nurses, community health nurses and parish nurses. 
Thus nurses are ideally suited to provide ongoing medication management support. 
Interestingly this observation stands in contrast to a review by Hughes (2004) that did not 
acknowledge the role of the nurse on the healthcare team, and only discussed the 
relationship between the pharmacist and physician.  
Nursing Interventions on Medication Adherence in Older Adults 
In addition to the several meta-analyses reviewed here, this author conducted a 
search of recent (within the last ten years) nursing interventions and found only five 
nurse-led interventions designed to increase medication adherence in community-
dwelling older adults. Specific inclusion criteria for this search were: 
1. Participants were community-dwelling older adults (mean age 60 years or 
older) living in the United States; 
2. Nursing care (including patient education) was an active ingredient of the 
intervention; 
3. Medication adherence was a targeted outcome. 
                                                                  
 
       
	   	  	  42	  
Originally, a total of five studies met inclusion criteria, but upon closer 
examination, Artinian and colleagues’ study (2003) did not meet inclusion criteria 
because the control group in the study had failed to accurately complete their pill counts. 
The study characteristics of the remaining four interventions are summarized below: 
Study Design and Theoretical Framework. Three of the studies used a 
randomized controlled trial design (Barnason, Zimmerman, Hertzog, & Schulz, 2010; 
Ruppar, 2010b; Wu, Corley, Lennie, & Moser, 2012), and one study was quasi-
experimental with a pre-post test design (Kim, Han, Park, Lee & Kim, 2006).  All four 
studies focused on patients with heart disease (either heart failure or hypertension). In 
addition, all four studies used individual-level theories/models for their conceptual 
framework including: Social Cognitive Theory (Barnason et al., 2010); Theory of 
Planned Behavior (Wu et al., 2012); Leventhal’s Self-Regulation Model (Ruppar, 
2010b); and Braden’s Self-Care Model of Learned Response to Chronic Illness (Kim et 
al. 2006).  Wu and colleagues (2012) did note, however, the importance of social norms 
in health behavior change, and thus had invited significant others to participate in the 
education and counseling sessions.   
Setting and Study Population. Two of the interventions were delivered in the 
participants’ private homes (Barnason et al., 2010; Ruppar, 2010b; Wu et al., 2012), one 
by telephone (Barnason et al., 2010), and one was delivered in a group community setting 
(Kim et al., 2006).  Only two of the researchers specifically targeted patients with 
adherence issues. Barnason and colleagues (2010) included only those heart failure 
patients who were recently discharged (within 48 hours), had at least five medications, 
and at least one of the medications with twice or more daily dosing. Ruppar (2010b) 
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conducted a one-month run-in with the MEMS caps, and only included those participants 
who were less than 85% adherent with their hypertension medication. Wu and colleagues 
(2012), on the other hand, included both adherent and nonadherent (defined as having 
less than 88% adherence during the MEMS cap one-month run-in) patients, but stratified 
the two groups prior to their randomization.  
In three out of the four studies older adults with cognitive impairment were 
excluded: Barnason and colleagues (2010) and Ruppar (2010b) both screened participants 
with the Short Portable Mental Status Questionnaire (SPMSQ); and Wu and colleagues 
(2012) used the Mini-Cog Exam. Three of the studies were pilot studies so their sample 
sizes were small (<50 participants).The exception being Wu and colleagues’ (2012), 
whose sample included 82 older adults. Racial diversity was also uneven among the 
studies.  For example, Kim and colleagues (2006) study sample comprised solely of 
Korean Americans (N=31), whereas Barnason and colleagues (2010) did not report the 
racial composition of their 40 participants.  Ruppar’s (2010b) study sample of 15, 
however, included 5 African Americans and 1 Pacific/Islander, and Wu and colleagues’ 
study (2012) included 17 African Americans.  
Medication Adherence Measurement. Similar to the studies’ settings and 
samples, measurement of adherence also varied.  Barnason and colleagues (2010) used a 
self-report assessment tool, the Brief Medication Questionnaire (BMQ), to measure 
medication adherence as the percentage of medications taken in the last week. The 
authors measured both medication adherence at baseline, one month and three months. 
Kim and colleagues (2006) also used a self-report measure, the medication-taking 
subscale of the Hill-Bone Compliance to High Blood Pressure Therapy scale (Kim et al., 
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2000). The researchers collected medication adherence scores at baseline (pre-test) and at 
six month follow up (post-test). Ruppar (2010b) and Wu and colleagues (2012), on the 
other hand, used the MEMS cap in order to calculate the percentage of medications taken 
correctly. Both studies, however, only tracked one prescription per participant regardless 
of the number of medications prescribed. Ruppar (2010b) assessed medication adherence 
over several data points (i.e., baseline, 4 weeks, 8 weeks, 12 weeks, and 20 weeks), 
whereas, Wu and colleagues (2012) collected medication adherence data at baseline, 2 
months and 9 months. The former study, however, analyzed medication adherence as a 
continuous variable while the latter dichotomized the variable.  
Intervention Components. All four studies used theory to inform the 
intervention components, but differed in the dosage and/or active ingredients.  For 
example, Barnason and colleagues (2010) developed an algorithm for the nurse 
intervener in order to individually tailor the medication self-care modules to the 
participants’ self-care needs. The authors did not describe the details of the algorithm, but 
explained that the educational program was based on recommendations by the Heart 
Failure Society of America, and focused on promoting participant self-efficacy and 
problem-solving regarding barriers to adherence.  In total, the intervention consisted of 
three self-care modules that the nurse delivered over the course of two telephone calls 
lasting 20-30 minutes each.  The authors also did not describe the interval between the 
two calls.  
Ruppar (2010b) delivered a five-component biobehavioral feedback intervention 
through a series of four biweekly home visits. Based on the intervention’s guiding theory 
that a person’s health behavior is influenced by perceived symptom feedback, the author 
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chose to use MEMS Smart Caps with LCD display, which not only allows the 
participants to see when they had last taken their medications, but also the nurse to 
download biweekly data on the participant’s medication taking habits and discuss the 
results with the participant.  In addition to the medication adherence assessment, the 
nurse conducted biweekly blood pressure readings to share the results with the 
participant.  Additional intervention components included assessment of medication-
taking skills, habit adjustments, and education on hypertension and the participant’s 
specific medications. 
Kim and colleagues (2006) similarly designed an intervention to promote the 
participants’ self-help skills in medication adherence in managing their hypertension.  
The intervention nurse conducted group seminars designed to educate the participants on 
a variety of medication self-management strategies including increased knowledge about 
hypertension, skills needed to self-monitor their blood pressure at home, and general 
problem-solving skills. Social support from a bilingual nurse was also thought to promote 
adoption of the participant’s self-help skills. The nurse delivered the two-hour education 
and skills sessions once a week over the course of six weeks, and then offered monthly 
one-hour support group sessions. The only home visit the nurse conducted was after the 
first education session in order to assess the participant’s ability to properly use the 
home-based blood pressure medication adherence machine.  
Wu and colleagues (2012) conducted a three-arm intervention in order to assess 
whether the education plus MEMS feedback group (PLUS) would achieve higher 
adherence rates than those in either the education alone group (LITE) or the usual care 
group (UC). Based on the Theory of Planned Behavior (TPB), the authors hypothesized 
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that education and counseling would foster the participant’s positive personal beliefs as 
well as subjective norms regarding medication adherence, and that this would in turn lead 
to positive intention and ultimately behavior change.  In order to promote positive 
subjective norms, the participants were encouraged to identify those supportive persons 
who could help them with optimizing their medication-taking behavior.  Supportive 
others were also invited to attend the education sessions. In total there were four 
biweekly sessions: Two one-hour home visits (1st and 3rd sessions) and two telephone 
calls (2nd and 4th sessions) that lasted approximately 15-20 minutes each. The PLUS 
group participants also received MEMS cap data feedback from the nurse at the two 
home visits in order to discuss the reasons why doses were missed, and thus provide 
additional insight into ways to reduce barriers to adherence.  
Intervention Effects on Medication Adherence. Barnason and colleagues’ 
(2010) initial multivariate analyses using ANOVA found no significant intervention 
effect on medication adherence. The team then measured medication adherence as a 
dichotomous variable using Wu and colleagues’ (2008) >=88% cut-off for heart failure 
adherence, and found significant group differences at one month (p=.003) and three 
months and (p=.03).  Because of the small sample size (N=15), Ruppar (2010b) used 
nonparametric testing (i.e., Mann-Whitney) in order to assess intervention effects over 
time (i.e., from baseline to Week 20), but only found significant median group 
differences at Week 8 (p=.013).  Wu and colleagues (2012) used repeated measures 
ANOVA and found that participants in the PLUS group had a significantly higher mean 
adherence rate than the control group at both 2 months (p=.05) and 9 months (p=.021), 
but the LITE group only had a significantly higher rate at 9 months (p=.04). Kim and 
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colleagues (2006), however, found no significant intervention effect when they compared 
the pre-test post-test scores on the HBC medication-taking scale.  
Synthesis of the Intervention Findings. Unlike the majority of pharmacy-based 
interventions that target pharmacist behaviors in order to increase patient medication 
adherence, nursing science, has moved beyond treating the patient as a passive recipient 
and toward recognizing the patient as an active participant in the management of their 
medications. These four interventions thus focused on developing patient self-capacity 
through knowledge and skills training as a way to optimize adherence.  This emphasis by 
the nursing profession is further reflected in recent qualitative studies (Lewis et al., 2010; 
Gordon et al., 2007) where nursing researchers specifically elicited the patient’s 
perspectives on medication management in order to develop more effective patient-
centered interventions. 
 There are several limitations, however, to these intervention findings. In general, 
the studies had small sample sizes, and this may have limited their power to detect 
significant intervention effects.  In addition, for most of the studies the participants’ 
baseline adherence rates were already high and this may have caused a ceiling effect.  For 
example, Barnason and colleagues (2010) reported that the mean baseline adherence rates 
for the intervention and usual care group were 98.3 (SD=.1) and 93.7 (SD=.1) 
respectively. Despite the importance of social environment-especially social support, 
only one study encouraged the participation of a supportive other. In addition, none of the 
studies reported whether or not there were qualitative findings to help explain what 
worked and what did not work in the intervention.  
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Chapter Summary 
 This review of the literature identified several gaps in the science: (1) There 
remains inconsistency in how medication adherence is measured; (2) There is 
questionable reliability and validity of the existing measures of medication adherence; (3) 
There is conflicting evidence and/or lack of evidence on what are the significant 
protective/risk factors as they relate to medication adherence; (4) There continues to be a 
lack of evidence on effective interventions for older adults who have difficulty self-
managing their own medications; and (5) Few nursing interventions have been developed 
and tested in the United States, and of those identified in the literature, the sample sizes 
were either too small and/or homogenous to evaluate their effectiveness. 
 This review underscores the need for a mixed-methods study that has the power not 
only to identify which older adults are at risk for medication nonadherence, but also the 
data to explain why these older adults are at risk.  The current study, with its larger 
sample size and qualitative component, has the potential to make a significant 
contribution to nursing science and to the development of more effective interventions for 
older adults in the self-management of their medications. The study contributes to the 
state of the science by attempting to: 
1. Increase our understanding of the contextual factors associated with medication 
adherence in frail urban older adults.  
2. Describe the processes involved in older adult’s medication self-management. 
3. Utilize the qualitative data to better understand why older adults missed their 
medications.  
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CHAPTER 3 
METHODOLOGY 
This chapter describes the study design, population, data collection, protection of 
human subjects, and data analysis. The study took an alternative approach from that of 
the standard postpositivist (i.e., quantitative) stance by integrating a qualitative 
component for the purposes of developing a more complete understanding of medication 
adherence in older adults. The “mixed methods” approach is often referred to as 
“pragmatic” because the design of the study is guided by a “what works” paradigm in 
order to inform real-world practice (Creswell & Plano Clark, 2011, p. 41). The 
philosophical assumptions of a pragmatic approach are that multiple realities exist for any 
given phenomenon, and that in order to capture these varied perspectives, mixed methods 
are needed to more fully explore the phenomenon (Creswell & Plano Clark, 2011). 
Similarly, Tashakkori and Teddlie (1998) argue, “The best method is the one that 
answers the research question(s) most efficiently, and with foremost inference quality 
(trustworthiness, internal validity)” (p.167). Thus, taking a pragmatic stance, informed by 
Ryan and Sawin’s (2009) Individual and Family Self-Management Theory, the study 
used a mixed methods design in order to better understand the complex phenomenon of 
medication adherence in older adults. As previously noted, the specific purposes of the 
study were to: 
(1) Identify significant risk and protective factors for medication 
adherence/nonadherence in frail urban older adults;  
(2) Describe the processes involved in older adults’ medication self-management; 
and 
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(3) Utilize qualitative findings to enrich our understanding of the quantitative 
findings of the study. 
Design 
  A common criticism of randomized-controlled trials is the standard “black box” 
approach in which the researchers generate statistically significant findings through the 
use of quantitative methods, but then lack the ability to explain how or why the 
intervention worked (Sidani & Braden, 1998).  Qualitative studies, on the other hand, 
provide researchers with a better understanding of the “nature” of the problem by 
examining the perspectives of the person(s) experiencing the problem (Strauss & Corbin, 
1998, p.11). In response to this challenge, social science researchers are increasingly 
using a mixed methods approach in order to provide “a more comprehensive account” of 
the phenomenon of interest (Creswell & Plano Clark, 2011, p. 62).  
Ascribing to this argument, this study utilized an explanatory sequential mixed 
methods design in order to describe as well as explain the context and processes involved 
in the participants’ medication self-management. As previously noted, the Individual and 
Family Self-Management Theory (IFSMT) (Ryan & Sawin, 2009) was specifically 
chosen to inform this study because the theoretical propositions for medication self-
management go beyond the individual-focused approach that has dominated most of the 
adherence research to date. If the ultimate goal of research in chronic health conditions is 
to increase self-management, we must first recognize that the majority of older adults are 
indeed “members of a social unit” (Ryan & Sawin, 2009). Based on this understanding, 
we must then acknowledge that older adults’ health behaviors are influenced by the 
contexts of their social environment. The constructs and propositions of the IFSMT thus 
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served as a conceptual lens in the analysis of both the quantitative and qualitative 
components of the study. 
With its sequential design, the study first used the quantitative data from this 
sample of frail older adults to identify “who” was at risk for medication nonadherence 
(based on measured factors), at Month 1 as well as over time. The quantitative 
component alone, however, could not explain the underlying processes driving the 
relationships. To address this methodological limitation, the qualitative component 
attempted to explain the “why” by analyzing and describing the reasons the participants 
gave for missing their medications.  
Study Population. The population of interest for the original study were frail 
older adults living in a Midwestern metropolitan area who had been recently discharged 
from one of the area’s three home health care agencies, and who at discharge were 
identified as having an impaired ability to manage their medications.  Specific inclusion 
criteria were:  
1. Age 60 years or older; 
2. Medicare as the primary payer; 
3. Impaired medication management (i.e., a score of 1 or higher on the OASIS-
B1 (USDHHS, 2001) assessment item [M0780)] indicating an inability to 
correctly take oral medications at the prescribed dosages and times); and/or 
4. Mild cognitive impairment (i.e., a score of 1 or 2 on the OASIS-B1 item 
[M0560] indicating need for prompting and/or assistance with focusing 
attention on an intended task); and  
5. A working telephone.  
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Exclusion criteria were: 
1. Not English speaking; 
2. Having a terminal diagnosis (a risk for attrition); 
3. Already using another device for medication management; 
4. Enrollment in a Medicare Advantage plan.  
Participants were randomized to either one of two intervention groups (mediplanner or 
MD.2 machine) or to a usual care control group.  For the present study, only the data 
from the two intervention groups were included as the data for the dependent variable, 
medication adherence, were not collected in the usual care group.   
Setting and Sample Size. The time period for the initial study began in May 
2006, and concluded with the last data collection in May 2010.  Participants enrolled in 
the study were followed by the research team for a total of 12 months or until they 
withdrew from the study (either voluntarily, were hospitalized, moved, or expired). The 
setting of the initial randomized controlled trial was a nurse care coordination program. 
As a result, all study staff conducted home visits in order to collect the data and to deliver 
the intervention. Once participants enrolled in the study, the intervention nurses made 
home visits at least biweekly, and then anytime there was a medication change and/or the 
participant’s clinical condition warranted additional visits. Data collectors made quarterly 
home visits in order to complete the various study instruments.  
To give the original study an 85% probability of detecting a 2-point difference 
among the three group’s mean SF-36 PC and MC subscale scores and a <5% probability 
of a Type I error, a final analytic sample size of 300 was required. Based on experience 
from a previous study of chronically ill older adults, the team anticipated a 25% attrition 
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rate over a one-year period (Marek, Popejoy, Petroski, & Rantz, 2006; Marek et al., 
2005), and thus enrolled an additional 100 participants to account for the expected 
attrition. Whereas the targeted sample size was originally 113 participants for each of the 
three study groups (N=339), the actual final sample size for those who completed the 
study was 414. For the current study, the estimated sample size needed for multivariate 
analyses was based on Mertler & Vannatta’s (2010) recommendation of at least 15 cases 
per independent variable tested.  The inclusion of up to fourteen variables in the 
predictive models required a minimum of 240 participants.  The total number of 
intervention participants included in this study (N=268) met the threshold.  
Procedures for Data Collection 
The data for this current study were collected as part of a larger repeated-
measures randomized controlled trial (i.e., the Home Care Medication Management for 
the Frail Elderly Study) that tested the effects of a nurse care coordination intervention on 
health outcomes, and cost outcomes of frail older adults. Approval to conduct a 
secondary data analysis was obtained from the Institutional Review Board (IRB) at 
Arizona State University under an expedited review process.  
For the quantitative component, the data collectors obtained the baseline 
independent variable data during a home visit with the study participants. Data related to 
the dependent variable, medication nonadherence, were collected every two weeks for the 
mediplanner group at the home visit as the nurse interventionist filled the mediplanner. 
For the MD.2 group, the MD.2 machine notified the nurse by phone when the participant 
missed a dose.  
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For the qualitative component of the study, the intervention nurses collected the 
data at the biweekly home visit. The setting of the participants’ home was especially 
important for collecting this data as it provided a safe, nonthreatening environment that 
would be more likely to promote an honest disclosure by the participants about their 
medication nonadherence (Hammersley & Atkinson, 1995). Every two weeks, the 
intervention nurse documented the number of medication doses missed, and then asked 
the participant if there was a reason for missing the medication dose(s). The nurse then 
entered the number of missed doses and the responses into the participant’s electronic 
health record (Carefacts®). Participant responses were later extracted/transcribed into a 
secured file that included: the participant’s ID, the month they missed the medication 
dose(s) and the participants’ reason(s) for why they missed the medication doses. 
Protection of Human Subjects 
 This study posed minimal risk to human subjects. The quantitative data were in a 
SPSS dataset with only the participant study ID as a link to the variables of interest. 
Similarly, the qualitative data were de-identified prior to analysis: The study file, and 
spreadsheets only had the participant’s study ID linked to his/her monthly response(s). 
There is always the small possibility that participants might recognize themselves in the 
qualitative analysis, but it is unlikely.  
Data Analysis 
The data for the quantitative and qualitative components of this study were 
collected concurrently as part of the original study. For the purposes of the present study, 
the quantitative and qualitative data were incorporated into an explanatory sequential 
design with the qualitative analyses primarily used to deepen our understanding of the 
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quantitative results. Thus, the quantitative data were examined first in an effort to answer 
the initial two research questions. Once the quantitative findings were generated, the 
qualitative data were then analyzed with the dual purposes of: (1) Exploring and 
describing the diverse processes the participants used to self-manage their medications; 
and (2) Explaining the significant risk and/or protective factors identified by the 
statistical modeling. For example, for each independent variable that significantly 
predicted medication adherence, the participant responses were compared/contrasted 
along the variable in order to identify any underlying processes that might account for 
quantitative differences. With this sequential mixed-methods design, the findings from 
the quantitative component largely guided the analysis of the qualitative data. The two 
design elements were then further integrated in the final discussion of the study findings.  
Quantitative Component. The two Research Questions were: 
1. What are the contextual and/or process dimensions that emerge as 
significant risk and protective factors for medication adherence at Month 1 of the 
study? 
2. What are the contextual and/or process dimensions that emerge as 
significant risk and protective factors for medication adherence over the course of the 
study? 
Dependent Variables for Research Questions 1 and 2. Medication adherence was 
measured as a monthly percentage. During the biweekly visit, the nurse would count how 
many pill doses were missed, and then enter this count into the participant’s electronic 
health record. The monthly medication adherence rate was then calculated by taking the 
monthly count of missed prescribed pill doses and dividing this by the total number of 
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monthly prescribed pill doses. These monthly percentages were then entered into the 
study’s SAS file. For Research Question 1, the dependent variable was the participant’s 
Month 1 medication adherence percentage. For Research Question 2, the dependent 
variable was the average of the participant’s monthly medication adherence percentages.   
Measurement Tools for the Independent Variables. This study used data from a 
combined set of data collection forms and measurement tools included in the original 
study. The primary data collection form was the discharge version of the Outcome and 
Assessment Information Set (OASIS-B1), (USDHHS, 2001). The specific variables of 
interest and the instruments are further described below.  
Individual Characteristics. Individual characteristics included participant age, 
race, and gender. All three of these variables were taken from the OASIS-B1. In 2004, 
Hittle and colleagues reported excellent interrater reliability (1.00) for both race and 
gender.  Because the dependent variable for Question 2 was medication adherence over 
time, a continuous variable “number of months in study” was also created to account for 
the participants’ differential opportunities over time.  
Condition-Specific Variables. Condition-specific variables included cognitive 
functioning, physical functioning, psychosocial well-being, medication regimen 
complexity, and vision problems and hearing problems. The data for each of these 
variables were taken from the participant’s baseline measurements. Vision and hearing 
were taken from the OASIS-B1. Hittle and colleagues (2004) reported an interrater 
reliability of .85 for vision and .69 for hearing. For the remaining variables, their 
corresponding measures are further described below. 
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Cognitive Functioning was measured using the Mini Mental Status Examination 
(MMSE) as it has been found to be "useful in quantitatively estimating the severity of 
cognitive impairment" (Folstein et al., 1975, p. 196). The instrument is a widely used 11-
item measure of a person's cognitive ability across five domains (orientation, registration, 
attention and calculation, recall, and language). The MMSE has a maximum score of 30, 
but can be scored as a dichotomous, categorical, or continuous. A comprehensive review 
of the MMSE by Tombaugh & McIntyre (1992) found test-retest reliability between .80 
and .95 among studies where the retest interval was two months or less, and when the 
authors examined the evidence for construct validity, they found correlations with other 
cognitive screening tests in the range of .70 to .90. The authors also found that criterion 
validity (i.e., sensitivity and specificity to detect dementia) was at least 79% for 70% of 
the studies when the cut-off criterion for the MMSE was set at 23 or less.   
Psychosocial well-being was measured by the Geriatric Depression Scale (GDS).  
The GDS is a 15-item yes/no dichotomous questionnaire that is a widely used as a 
screening tool for late life depression.  Friedman and colleagues (2005) tested the 
psychometric properties of the GDS on a sample of N=960 cognitively intact, 
community-dwelling patients ages 65 and older.  The authors found good internal 
consistency reliability (alpha=.75) as well as good construct validity for measures of 
major depression, depressed mood, low life satisfaction, and suicide ideation.  The 
authors also found the GDS to have an acceptable criterion validity (sensitivity=.814 and 
specificity=.754) at a cutoff value of 6.  
Physical functioning was measured by the 7-item Physical Performance Test 
(PPT) (Reuben & Siu, 1990) which allows for direct assessment of an older adult’s 
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ability to complete various tasks such as writing a sentence, putting on a coat, and 
simulating eating. Reuben and Siu (1990) tested the PPT in 183 older adults across a 
variety of settings, and reported acceptable levels of reliability and validity for the 
instrument including: Interrater reliability of 0.93; Cronbach’s alpha of .79; and .80 
construct validity with the Tinetti gait score.  
Medication Regimen Complexity was measured by the Medication Complexity 
Index (MCI) (Kelley, 1988) which is based on a composite score of the patient’s number 
of medications, doses, and instructions. For example, if a medication is prescribed three 
times daily, the medication receives a score of 3 versus a score of 1 if only a once daily 
dose. Conn, Taylor, & Kelley (1991) reported excellent validity and reliability with this 
scale: An expert’s ranking of medication regimens and their corresponding MCI scores 
correlated at .89, and the test-retest reliability after one week ranged from .80-1.00.   
Social Environment. Social Environment was measured by four dichotomous 
variables that are part of discharge version of the Outcome and Assessment Information 
Set (OASIS-B1) (USDHHS, 2001) including: living situation; caregiver residence; 
receiving ADL assistance; and receiving IADL assistance. 
Process Dimension. The process of medication self-management can include the 
use of cognitive prostheses (i.e., calendars, alarms, pill organizers) to optimize 
medication adherence. In this study, process was measured by the participant’s 
intervention group assignment: MD.2 or mediplanner.  
Table 1 describes the variables and measures to be used in the quantitative 
component of the study.  
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Table 1  
Variables and Measures 
_________________________________________________________________ 





   Age      OASIS-B1 (M0066)  - 
   Race      OASIS-B1 (M0140) Test-Retest Reliability=1.00 
   Gender      OASIS-B1 (M0069) Test-Retest Reliability=1.00 
Condition-Specific Characteristics 
     Cognitive Functioning  
MMSE       Baseline MMSE   Test-Retest Reliability =0.80-0.95 
        Construct Validity=0.70-0.90 
     Psychosocial Well-being 
GDS        Baseline GDS  Cronbach’s alpha=0.75 
Criterion Validity 
(sensitivity =.814; specificity=.754) 
      Complexity of Treatment  
MCI      Baseline MCI   Test-Retest Reliability=0.80-1.00 
      Physical Functioning   
PPT      Baseline PPT  Cronbach’s alpha = 0.75 
        Interrater reliability = 0.93 
        Construct Validity = 0.80 
       Visual Acuity     
Vision     OASIS-BI (M0390_1) Interrater Reliability=.85  
       Hearing Acuity   
Hearing     OASIS-B1 (M0400_1) Interrater Reliability=.69  
(table continues) 
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Table 1 (continued) 
________________________________________________________________________ 
Framework  Variable          Instrument/Source Reliability & Validity 
Construct 
______________________________________________________________________________________ 
Physical & Social Environment 
     Living Situation  
Lives Alone  OASIS-B1 (M0340_1)  - 
     Caregiver Residence   
In-Home CG OASIS-B1 (M0350_2)  - 
     Supportive Assistance   
ADL Support OASIS-B1 (M0380_1)  - 
   IADL Support OASIS-B1 (M0380_2) 
Process 
     Cognitive Prosthesis   
Pill Organizer Group Assignment   - 
Proximal Outcome 
     Month 1 Adherence     
MNA  Month 1 Percentage   - 
     Adherence Over Time   
MAOT  Average Adherence Percentage  - 
_____________________________________________________________________ 
Pre-Analysis Data Screening 
The quantitative component of this study included descriptive statistics and 
multiple regression equations in order to identify those participant and family 
characteristics that significantly predicted risk for medication nonadherence at Month 1 
as well as over time in this sample of frail urban older adults.  In order to answer 
Research Questions 1 and 2, the data were first examined for any missing values among 
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the independent and dependent variables.  Even though all participants in the original 
study were required to complete baseline questionnaires, there were five cases where the 
participant either did not complete a baseline MMSE (N=4) or PPT (N=1) as they were 
aphasic and/or unable to complete.  These five participants were not included in the 
study, because it was not possible to estimate or impute their scores without introducing 
bias into the models. An examination of the data also found that eight participants had 
missing adherence for Month One. The adherence percentage from the next measured 
month was then used as the Month One adherence rate. For seven of the participants, the 
Month 2 adherence percentages were used, and for one case the Month 3 adherence 
percentage was used.  
Next, ordinary least squares regression models were run for Research Questions 1 
and 2 to identify any outliers that might put undue influence on the two full models as 
well as any potential multicollinearity among the predictor variables (Field, 2005; Mertler 
& Vannatta, 2010). Residuals statistics (i.e., Cook’s Distance and its standardized version 
DFBeta) were first examined for cases that might be exerting undue influence on the 
model.  Field (2005) recommends that cases with a Cook’s Distance and/or DFBeta > 1 
should be further examined, however, all cases fell below that threshold (data not shown).  
A second recommended check for outliers, the calculation of Mahalanobis’ distance, 
(Mertler & Vannatta, 2010) also found no outliers (i.e., none of the cases exceeded the 
X2(14)=36.123 threshold at p<.001). Diagnostics on both models also found no 
collinearity problems with VIF scores all less than ten and tolerance scores all greater 
than 0.1 (Field, 2005).  
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Qualitative Component 
Qualitative data analysis is a multilevel process that begins with data management 
and/or organization of the data, follows with reading and reflecting on the text, 
classifying and interpreting the data, representing the data in the form of a table or figure, 
and then discussing the findings (Creswell, 2007). Because the primary purpose of the 
study’s qualitative component was to enrich our understanding of the quantitative 
findings, the qualitative analysis focused on why the participants experienced an 
episode(s) of medication nonadherence. Content analysis is a systematic approach that 
identifies, organizes, and clusters units of meaning within a text in order to describe a 
phenomenon (Hsieh & Shannon, 2005; Lincoln & Guba, 1985). A specific type of 
content analysis, directed content analysis, is often used when the goal is to validate or 
extend existing theory and/or the state of the science (Hsieh & Shannon, 2005). Directed 
content analysis follows a more deductive approach to content analysis with the use of 
initial codes (generated from a theory and/or existing research) to begin moving the data 
inferentially from themes, to categories, to overarching themes that support or extend a 
theory or conceptual framework (Zhang & Wildemuth, 2010). The use of existing theory 
and research in this study’s coding process allowed for not only a discussion of how the 
findings enhanced our understanding of medication nonadherence in this group of frail 
older adults, but also how the findings compare with and/or extend the existing science 
on medication adherence.  
The two research questions guiding this inquiry were: 
Question 3: What are the themes that describe the participants’ medication self-
management processes? 
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Question 4: How do the qualitative data help explain the quantitative findings and 
contribute to a more complete understanding of the participants’ medication 
adherence?  
Definition of terms for qualitative analysis. 
 Below is a list of terms to describe the major components of my 
qualitative analysis. I present the terms in the order in which I organized, 
categorized, and interpreted the data.  
Participant Response:  An extracted nurse’s note from the participant’s electronic 
health record, under the Care Plan note: “Number of Missed doses and Why”. In 
some instances, the note contained only the nurse’s description of the participant’s 
answer. In other instances, the nurse included direct quotes of the participant’s 
response to the question. 
Domain Analysis: An analytic procedure that “makes use of the semantic 
relationships” between the words used by a group of individuals for the purposes 
of gaining a deeper understanding of the cultural scene (Spradley, 1979, p. 107). 
For example, in the case of “nurse” and “healthcare provider”, the domain is 
“healthcare provider”, the semantic relationship is “a kind of”, and “nurse” is a 
type of healthcare provider. 
Meaning unit: A word an/or phrase within the participant response that describes 
the reason why the participant missed his/her medication dose(s) (Miles & 
Huberman, 1994).  
Theme: A recurring idea in the data (Ryan & Bernard, 2003).  
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Code: A label assigned to a meaning unit, representing a theme (Miles & 
Huberman, 1994).  
Category/Domain: A cluster of at least two or more themes that share conceptual 
similarities, and are linked by a single semantic relationship (Spradley, 1979).  
Start List of Codes: A “provisional” list of categories and themes used to describe 
and label the participant reasons (Miles & Huberman, 1994).  
Overarching Theme: A clustering of the categories (domains) that captures the 
meaning of the processes involved in medication nonadherence (Fereday & Muir-
Cochrane, 2006). Overarching themes represent an overlap between two or more 
domains, and convey a higher “degree of generality” (Spradley, 1979, p. 186).  
  Procedures. An important assumption of this study’s conceptual framework is 
that, “Persons engage in behaviors for personally meaningful reasons that may or may not 
be directly related to optimizing their health status” (Ryan & Sawin, 2009, p. 21).  This 
assumption follows a similar tenet of the theory of Symbolic Interactionism that “human 
beings act toward things on the basis of the meanings that things have for them” (Blumer, 
1969, p. 2). Based on these two propositions about human behavior, I took an 
ethnographic approach to this qualitative inquiry in order to understand from the 
participants’ point of view why this highly managed group of frail older adults still 
experienced episodes of medication nonadherence. An “efficient” ethnographic strategy 
for understanding meaning within a culture is the use of a domain analysis because it 
provides a systematic procedure for examining the symbolic nature of words, and the 
identification of folk domains (Spradley, 1979, p. 107). In this case, I used a domain 
analysis worksheet to systematically examine the participant responses in order to 
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increase our understanding of why the older adults were nonadherent. To further 
strengthen my systematic approach to the data, I also followed steps outlined by Hseih & 
Shannon (2005) and Zhang and Wildemuth (2010) for qualitative content analysis. Figure 
3 provides a diagram of the analytic process.  
 
Figure 3. Diagram of Analytic Process. 
In Step 1, Participant responses were extracted from their electronic health 
records and then entered into an Excel spreadsheet. The spreadsheet was organized with 
Participant ID in the first column, and then subsequent columns of the participant 
responses followed a temporal order: Month 1-13. For each visit the nurse provided a 
note, I entered that participant response under the corresponding month. Participants had 
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anywhere from zero to 4 responses per month. Next to each participant response was a 
blank cell for its assigned code.  
Once I entered all the data, I proceeded to Step 2, which was to create a start list 
of codes derived from my review of the literature and the relevant constructs identified in 
the IFSMT.  The inclusion of the theoretical constructs provided an organizing structure 
to the data analysis process, and allowed me to test how well the IFSMT fit or did not fit 
the data (i.e., explained the behavior of medication self-management) (Evans, Coon, & 
Ume, 2011).  I used a domain analysis worksheet as the organizing template for my start 
list of codes (Crabtree & Miller, 1999). The domain analysis worksheet included each 
category (domain), its operational definition, and the themes belonging to that category 
based on a specific semantic relationship. For example, “rationale” is a type of semantic 
relationship whereby “X is a reason for doing Y” (Spradley, 1979, p. 111). Each theme 
on the domain analysis sheet had a coding number for notation purposes, its operational 
definition, and then an exemplar of the theme.  
I next proceeded to Step 3. Using the start list of codes, I began reading through 
the first month of the participant responses, and then attempted to assign a code to each 
response. For each response that fit a theme’s operational definition, I entered the 
assigned code on the right hand column of the Excel spreadsheet.  When a participant’s 
response did not fit one of existing themes, I then made a marginal remark, and continued 
reading through the participant responses. Once I had read the first month’s reasons, I 
went back and reviewed the marginal remarks to develop additional themes for the 
participant responses. I then added these themes to the domain analysis worksheet.  In 
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concert with this process, I also maintained a reflective log with notes to myself 
documenting my reactions, reflections, and decision-making processes.  
In order to maximize the dependability of this coding process, I followed Miles 
and Huberman’s (1994) recommendations for testing both the intra- and intercoder 
reliability. To test intracoder agreement (internal consistency), I returned to this initial set 
of participants, a few days after the initial coding, and using a clean, unmarked Excel file, 
recoded the participant responses. Once I had achieved 90% intracoder agreement, I then 
checked for intercoder reliability by asking a trained second-reader to code this same set 
of participant responses.  This process of check-coding with another researcher 
contributed to the dependability of the study findings by showing where disagreement 
occurred and allowed for refinement of codes and definitions. Once 90% intercoder 
reliability had been achieved, I proceeded with coding the remaining monthly participant 
responses.  Again, any participant response that did not fit one of the initial start codes 
was assigned a new code that best reflected the statement, and this new code was then 
added to the working list of codes (Hsieh & Shannon, 2005). After all coding was done, I 
conducted another round of check-coding with Month 8 of the data set to increase the 
dependability of the analysis, and again achieved 90% agreement. 
The list of themes and categories expanded as part of the iterative process 
inherent to qualitative inquiry (Bradley, Curry, & Devers, 2007). Table 2 illustrates the 
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Table 2  
Domain Analysis: Themes and Categories 
1 Experiencing Problems with Planning and/or Action 
(unintentionally missing a prescribed medication dose due to forgetting 
and/or a disruption) 
^is a reason for^ 
Code 
Number 
Definition of the Theme 
 
Exemplar 
  1B Having no daily routine - 
Missing a medication 
because there is no routine 
associated with the 
medication-taking process  
 
“I don’t take them at the same time 
each day” 
  1C Experiencing disruption in 
daily routine – 
Missing a dose because of a 
healthcare related event or 
being distracted by other 
event 
 
“I had a doctor’s appointment”; 
“Participant was at dialysis”; “got 
busy with granddaughter” 
  1D Leaving home without 
medication – Missing a 
prescribed dose because they 
were out for the day or on a 
trip and did not take their 
medication with them 
“I went on a trip and forgot to pack 
them”; “pt was not home & forgot to 
early dose” 
 
   
  1G Falling asleep – Missing a 
dose because they were 
asleep at the time it was due 
 
“Fell asleep before the machine went 
off”;  
sleeping and didn’t hear machine”; 
slept late. 
  1H Forgetting – Not 
remembering to take a dose, 
but either the participant did 
not offer a reason why they 




   
   
   
(table continues) 
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Table 2 continued  
Code 
Number 
Definition of the Theme 
 
Exemplar 
  1I Dispensing dose from MD.2 
then forgetting – Participant 
acknowledged dispensing the 
medication but then forgot to 
actually take the dose 
 “pt took from machine then forgot to 
take” 
 
  IJ Forgetting Other Reason – 
Participant offered reason for 
why they forgot that does not 
correspond to other theme 
related to forgetting 
“Put in his pocket and forgot”; “one 
nexium (accident)”; “forgot to take 
additional doses out of bottle” 
 
 
2 Not Possessing the Medication 
(unintentionally not having enough medication to take scheduled dose) 
^is a reason for^ 
  2A Lacking transportation to pick 
up new prescription – Note 
indicated that transportation was 
the reason participant ran out of 
medication 
 
“My daughter works and couldn’t 
take me to the pharmacy” 
  2B Lacking a refill or prescription 
from provider – Note indicated 
that pharmacy could not 
dispense due to provider issue 
 
“The pharmacy said there were no 
refills on file”; “waiting for MD 
office to call it in” 
  2D Not possessing the medication 
but no reason given – Note 
documented medication was 
out, but no other reason given 
 
“did not have furosemide, Klor con or 
10 additional mg lisinopril with AM 
meds” 
 
3 Being Physically Unable to Take the Medication  
(having a barrier [i.e., decreased physical strength, decreased visual acuity, 
hearing problem or organizer issue] that leads to unintentionally missing a 
dose) 
^is an example of^ 
Code 
Number 
Definition of the Theme 
 
Exemplar 
 3A Experiencing visual problems –  
Note indicating they had trouble 
seeing the pill or missed seeing 
it there 
“I didn’t see the pill in the container”; 
“didn’t white pill on white placemat” 
 
(table continues) 
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Table 2 (continued) 
Code 
Number 
Definition of the Theme 
 
Exemplar 
 3B Experiencing dexterity problems 
– Having trouble with retrieving 
pills or with coordination to take 
pills 
“family found 3 pills on floor since 
last visit, R/t clt transferring pills 
from cup to hand” 
 
 3C Experiencing physical weakness 
– Lacking the physical strength 
or feeling too fatigued to take 
dose 
 
“fell as was in pain and did not get 
out of bed on Monday” 
 
 3D Organizer malfunctioning – 
unable to take because of 
machine malfunction or 
mediplanner issues 
 
“pill stuck to planner; pt unplugged 
machine; ” 
 3E Experiencing hearing problems 
– lacking ability to hear MD.2 
 
“client didn’t hear machine, family 
gave when they arrived” 
4 Relying on Social Facilitation 
(being dependent upon the influence, support, and/or collaboration of 
someone in order to take medication) 
^is an outcome of^ 
  4A Missing medication because CG 
did not give – Relying on family 
member who fails to follow 
through 
 
“my spouse forgot to give to me”; 
“My daughter was called into work 
and wasn’t there to give me my pills” 
  4B Taking medication incorrectly 
due to CG process error – CG 
behavior leading to an error in 
dosing or missed dose 
 
“Took meds but incorrectly set up by 
grandson”; “caregiver states he gives 
to her, but sometimes she forgets to 
take” 
  4C Experiencing nonadherence due 
to hospitalization – Missing a 
dose because of a transition in 
care  
“Has not had any meds since hospital 
D/C 5 days ago”; “? Unable to tell, clt 
not clear on exactly how many days 
he was hospitalized” 
 
 5 Experiencing Problems with Knowledge & Beliefs  
(lacking the self-efficacy, outcome expectancy, and goal congruence needed 
to stay adherent with their medication) 
^is an example of^ 
   
(table continues) 
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Table 2 (continued) 
Code 
Number 
Definition of the Theme 
 
Exemplar 
  5C Lacking knowledge about the 
medication – Missing doses 
because they did not know the 
purpose and/or process for 
taking the medication 
“I didn’t take it because I didn’t know 
what it was for; “My doctor gave me 
this medication but I didn’t know how 
to take it” 
 
6 Using Self-Regulation Skills & Abilities  
(using goal setting, self-monitoring, reflective thinking, decision-making, 
planning & action, self-evaluation to intentionally miss medication dose) 
^is an example of^ 
 6A Choosing to skip a dose – 
Missing a dose because it 
conflicted with their life 
circumstance  
 
“I know the medications are 
important, but I was going out, and 
didn’t want to deal with the side 
effects”;  
6B Recognizing they should hold 
dose – Not taking medication 
because either they or prescriber 
decided it was not warranted 
 
“Did not take warfarin past 2 days b/c 
gums were bleeding…” 
6C Feeling burden outweighing 
benefit – Not taking meds 
related to fatigue or side effects 
“Client reports she gets tired of taking 
all these pills”; “clt picks and chooses 
which meds she might want to take on 
any given am per her CG”; “meds 
give her HA” 
 
7                                       Needing Additional Information from Participant 
(Lack of clarity in participant responses in relation to nonadherence) 
^is an example of^ 
Code 
Number 
Definition of the Theme 
 
Exemplar 
7A Denying they missed 
medications – 
RN noted missed med, but client 
denied 
 
“saw one pill cup in bedroom; pt 
denies missing any doses” 
 
7B Having no reason – Either 
participant did not give a reason 
or the RN did not document a 
reason 
 
“I don’t have a reason”; no reason 
noted 
   
(table continues) 
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Table 2 (continued) 
Code 
Number 
Definition of the Theme 
 
Exemplar 
7C RN being confused due to 
participant behavior – RN noted 
that she is unsure of what 
happened or is confused by 
what she saw with regards to 
missed doses 
 
“unsure of insulin” taken; “client 
wouldn’t let me see the planner”; “No 
missed doses from MD.2; RN found 7 
full cups of pills scattered around the 
apt.” 
 
7D Taking dose during RN visit – 
Missing a dose that day, but 
willing to take once RN alerted 
them 
“did not take AM meds today; took at 
2pm while RN in home; “missed this 
AM metoprolol, brought to clt 
attention & she took it” 
 
  7E Being unsure of what happened- 
Participant unsure or unable to 
determine what happened  
“Pt unsure why”; “doesn’t remember 
why”; “couldn't remember if took 
meds this morning or not” 
 
Experiencing Cognitive Difficulties 
(Specifically exhibiting trouble with memory and/or executive functioning that affects their 
ability to take their medications as prescribed) 
^is a reason ^ 
 
8A Being confused about organizer 
– Missing a dose because of 
confusion about how to use 
organizer 
  
“got confused thought he was to start 
on Friday”; “missed with box 
change”;  
“confused about use of mediplanner” 
 
8C Unintentionally taking more 
than was prescribed – Nurse or 
participant noted that more 
medication was taken than 
prescribed 
“Pt took meds after RN left instead of 
next day; no meds until RN arrived” 
 
   
8E Having trouble remembering - 
Missing a medication because 
they have trouble remembering  
 
“I have trouble with my memory”; “I 
cannot seem to remember to take” 
  
 The next step was to count both the frequencies of the themes and categories 
within the overarching themes. Counting assisted me in “seeing” where the older adults 
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struggled the most with their medication self-management, and in maximizing my 
analytic honesty by not ignoring responses I did not anticipate (Crabtree & Miller, 1999; 
Miles & Huberman, 1994). Sandelowski (2000b) similarly notes that 
counting/frequencies can provide an additional source for confirming/validating the 
findings of a study, but this process should only be “a means to an end, not the end itself” 
(p. 338). Indeed the primary purpose of the directed content analysis was to describe the 
group’s medication self-management processes in order to deepen our understanding of 
why they were nonadherent. However, because the science still lacks an adequate 
theoretical understanding of the problem, a secondary purpose was to evaluate to what 
extent the concepts within Ryan & Sawin’s (2009) Individual and Family Self-
Management Theory explained the health behavior of medication adherence among these 
older adults.  
I then proceeded to Step 4, which was to examine how the domains/categories 
related to each other (i.e., the identification of overarching themes) in order to move the 
data inferentially to a higher level of abstraction (Miles & Huberman, 1994), and thus 
allow me to summarize/explain the processes the older adults used to self-manage their 
medications (Creswell, 2007).  In the final Step 5, overarching themes were generated 
and a data display created.  
I utilized several strategies to increase the “trustworthiness” of the analysis (i.e, 
the confirmability, dependability, credibility, and transferability of the findings) (Lincoln 
and Guba, 1985) while still allowing for the responsiveness (i.e., the creativity, 
flexibility, and insight) that is integral to the qualitative analysis (Morse et al., 2002). I 
addressed the issue of confirmability (i.e., maximizing objectivity and minimizing 
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researcher bias) by using several tactics suggested by Miles and Huberman (1994): (1) 
explicating the study’s methods and procedures; (2) attending to my own assumptions, 
values, and biases, and making them explicit in my reflective journal; (3) checking and 
rechecking the data when codes were added and/or revised; and finally (4) retaining the 
study data and making it available for future reanalysis. 
Demonstrating the dependability of the findings (i.e., the findings are consistent 
and could be repeated) included strategies such as: (1) demonstrating that the research 
questions are clearly written and connected to a theory (Miles & Huberman, 1994); (2) 
creating a preliminary code list to standardize the analysis of meaning units (i.e., 
participant reasons) into themes and categories (Creswell, 2007); (3) having a peer 
review process in place (i.e., someone outside the team reviewing the interpretations and 
findings) (Miles & Huberman, 1994); and (4) maintaining a reflexive journal to 
document issues related to both self and method so there is an audit trail and rationale for 
the methodological decisions made (Teddlie & Tashakkori, 1998). For example, The 
Individual and Family Self-Management Theory posits that multi-level factors (i.e., 
personal, familial, and cultural norms), as well as “dynamic iterative processes” are 
central to self-management health behaviors (Ryan & Sawin, 2009).  The questions for 
this study were thus written to specifically describe and explain the contextual factors and 
processes involved in medication self-management of older adults. The coding list also 
served as a guide to both the analysts involved in the study and the auditor. I maintained a 
reflexive journal of the analysis process and had a copy of this “audit trail” available to 
my outside reviewer.  
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With regard to credibility, study participants ideally serve as the experts for 
judging the credibility of the findings (Trochim, 2006). Because this was a secondary 
data analysis, however, the participants in the intervention were no longer available to 
serve in this capacity. Nevertheless, because the primary study was a 12-month home-
based intervention, there was prolonged engagement between the primary nurse 
interventionist and the participants in the previous study. The primary nurse 
interventionist, Linda D. Bub, MSN, RN, GCNS-BC therefore serve as a consultant to 
this author as a surrogate for the participant “experts” in the original study.  The 
credibility of the study was further enhanced by the following strategies: (1) keeping the 
data in context; (2) considering rival explanations; and (3) discussing negative cases (i.e., 
those that did not fit the “main pattern”) (Patton, 1999, p.1192). Keeping the data in 
context meant recognizing that medication adherence processes in this population were 
influenced by the intervention, and therefore limited the generalizability of these findings 
to older adults who are not so highly managed. Considering rival explanations meant 
providing alternative interpretations for what was going on, and discussing negative cases 
meant describing those participant responses that did not fit in the final model.  
I also used several strategies as suggested by Miles & Huberman (1994) to 
optimize the study’s transferability (i.e., the ability to draw inferences from the study 
results to real world/clinical practice). First, I fully described the study’s sample, setting, 
and processes so that the audience could make comparisons with other older adult 
populations. Second, I discuss in Chapter 6 how my findings support the existing 
literature, and how well they support to the study’s conceptual framework of medication 
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self-management. Finally, I disclose in Chapter 6 the limitations of the study, and address 
their impact on the generalizability of its findings to other populations.  
Summary 
 This mixed methods study utilized both quantitative and qualitative data for the 
purposes of gaining a more complete understanding of medication adherence in an urban 
sample of community-dwelling older adults.  The study was sequential in design with an 
emphasis placed on the quantitative component and with the qualitative component used 
to provide a more nuanced understanding of the quantitative findings (Creswell, 2009). A 
conceptual framework based on Ryan & Sawin’s IFSMT (2009) guided the analysis and 
interpretation of both the quantitative and qualitative components of the study. The 
quantitative component utilized multivariate statistics to identify significant individual- 
and family-level characteristics that predicted increased risk for medication nonadherence 
at Month 1 as well as over time. The qualitative component followed a pragmatic 
approach of “abductive reasoning” (Morgan, 2007) that included both the tenets of 
naturalistic inquiry (i.e., inductive reasoning) as well as those of deductive reasoning to 
describe the older adults’ processes of medication self-management.  The two 
components are integrated in the interpretation phase of the study (i.e., Chapter 6) with a 
discussion on how the qualitative findings explain the quantitative component’s results. 
                                                                  
 
       




The purpose of this descriptive explanatory study was to better understand the 
self-management behavior of medication adherence in a sample of frail urban older 
adults. The first research question hoped to identify protective and risk factors for 
medication adherence at Month 1. Because medication adherence has been know to drop 
over time (Benner et al., 2002; Ho et al., 2006b) the second research question attempted 
to identify risk and protective factors for medication adherence over time. This chapter 
reports the results for each of these research questions. 
Descriptive Summary 
The descriptive findings for this sample population are presented in Table 3. 
Continuous data are reported with frequency, percentage, mean and standard deviation, 
and categorical data are reported by frequency and percentage.  
Table 3 
Sample Population Characteristics (N=268) 
_______________________________________________________________ 
  Variable            N         Percentage       Mean     SD 
      
Age      
60-69 years 27 10.1% 79.69    7.68 
70-79 years 101 37.7%    
80-89 years 114 42.5%    
90-98 years 26 9.7%    
      
Gender      
     Male 85 31.7%    
     Female 183 68.3%    
      
Race      
     White 218 81.3%    
     Black 50 18.7%    
(table continues) 
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Table 3 (continued) 
Variable N Percentage Mean  SD       
      
Months in Study 268     10.80    3.81 
     
MMSE   25.21  3.53 
     Normal (30-27) 120 45.8%    
     Mild (26-21) 112 41.8%    
     Moderate (20-16) 36 13.4%    
      
PPT   14.45  4.97  
Independent (21-28) 23 8.6%    
Intermediate (20-16) 108 39.2%    
Dependent (1-15) 137 52.2%    
      
GDS        4.16 3.19  
Normal (0-4) 162 60.4%    
Mild Depression (5-8) 74 27.7%    
Moderate (9-11) 29  10.8%    
Severe (12-15) 3   1.1%    
      
MCI    39.94  23.57  
 (7-23) 68 1st quartile    
 (24-34) 66 2ndquartile    
 (35-50) 67 3rd quartile    
 (51-141) 67 4th quartile    
 
Vision 
     
     Normal 214 79.9%    
      Partial Impairment 
(can’t see labels) 
49 18.2%    
    Significantly Impaired 5 1.9%    
      
Hearing & Understanding      
None 187 69.8%    
Minimal 76 28.3%    
Moderate 5 1.9%  
 
  
Home Setting      
Alone 132 49.3%    
Significant Other 83 31.0%    
Family Member 52 19.4%    
Friend 4 1.5%    
Paid Help/Other 2 .8%    
(table continues) 
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Table 3 (continued) 
Variable N Percentage Mean  SD  
Caregivers      
Reside outside home 139 51.9%    
Lives in home 96 35.8%    
Paid help 56 20.9%    
None of the above 30 11.2%    
      
Relationship Caregiving      
No one person 37 13.8%    
SO/Spouse 57 21.3%    
Adult Child 121 45.1%    
Other Family 26   9.7%    
Friend/Neighbor 14   5.2%    
Paid 28 10.4%    
Unknown 3   1.1%    
      
Frequency of Care      
Several Day & Night 20 7.5%    
Several times Daily 69 25.7%    
Once a Day 25 9.3%    
>= 3 times/week 31 11.6%    
1-2 times/week 52 19.4%    
< once/week 22 8.2%    
Unknown 4 1.5%    
 
Type of Care 
     
ADLs 41 15.3%    
IADLs 154 57.5%    
Environmental 160 59.5%    
Psychosocial 160 59.5%    
Med Appt Advocate 129 48.1%    
POA, Financial 62 23.1%    
HCPOA 117 62%    
Unknown 3 1.1% 
      
Intervention Group      
MD.2 137 51.1%    
Mediplanner 131 48.9%  
 
  
Medication Adherence      
Adherence Month 1 268  98.5 4.9  
Month 1 (<95%) 25 9.3%    
Adherence Over Time 268  98.1 4.6  
(<98%) 44 16.4%    
                                                                  
 
       
	   	  	  80	  
 
Individual-level factors 
Individual-level factors included: age, gender, race, and length of time in the 
study. The average age of participants in this study was 79.69 years (SD=7.68). More 
than three-quarters of the participants (80.2%) were between the ages of 70 and 89 years 
with 10.1% between the ages of 60-69 years and the remaining 9.7% between the ages of 
90-98 years.  Women made up more than two-thirds of the sample (68%) and African 
Americans comprised 19% of the total sample. The intervention group assignment was 
almost equal: 51% used the MD.2 machine and 49% used the mediplanners. The average 
length of participation in study was 10.80 months (SD=3.81) with 73.9% of the 
participants completing 12-13 months of the intervention. Only two participants dropped 
out after 1 month.  
Condition-specific factors 
  Health condition-specific factors included: cognitive functioning (MMSE), 
physical functioning (PPT), psychosocial well-being (GDS), treatment complexity 
(MCI), vision, and hearing. The average MMSE score for this sample was 25.21 
(SD=3.53).  Based on current recommendations from both research (O’Bryant et al., 
2008; Ravaglia et al., 2005; Grundman et al. 2004) and clinical practice (National 
Institute for Health and Clinical Excellence [NICE], 2009), this study used the following 
cut-off scores to describe the cognitive functioning of the sample:  45.8% were within the 
normal range of cognitive function (27-30); 41.8% had mild cognitive impairment (26-
21); and 13.4% had severe cognitive impairment (16-20). Given that there has been 
mixed evidence, however, on the reliable thresholds for cognitive impairment (Crum, 
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Anthony, Bassett, & Folstein, 1993; Tombaugh & McIntyre, 1992) this study will treat 
MMSE as a continuous variable for the analysis.  
The average score on the PPT was 14.45 (SD=4.97) with a range of 1-23. 
According to Lewis and Shaw (2005), clients with scores between 21-28 are able to 
function independently and those with scores between 3-15 are considered dependent. 
The majority of the participants (52.2%) scored as functionally dependent, whereas only 
8.6% scored as functionally independent. The average score on the GDS was 4.16 
(SD=3.19) with a range of 0-15. The majority of the population scored within the normal 
range of the GDS (60.4%), but more than a quarter (27.7%) had mild depression and 
another 10.8% had moderate depression.  The mean MCI score for this sample was 39.94 
(SD=23.59) with a range of 7-141. This average is twice as high as the scores reported by 
Conn et al. (1991)’s two studies where the means were 18.42 (SD=10.08) and 16.35 
(SD=9.62). While the authors did not find a statistically significant correlation between 
MCI and medication adherence, there was a trend (p=.08) toward a negatively inverse 
relationship with medication adherence going down as MCI scores went up. Vision 
impairment affected over 20% of the participants with 18.2% having difficulty seeing 
labels and 1.9% having significant impairment. Hearing impairment was similarly 
affected with 28.3% having minimal impairment and 1.9% having moderate impairment.  
Physical and social environment 
Physical and social environmental factors included: financial factors, living 
arrangement, caregiver relationship, types and quantity of care received. Because the 
social environment variables were collected from a data form that allowed for more than 
one answer, the frequencies and percentages of these variables could total more than 
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100%. A significant majority of the participants reported no financial problems (89.6%) 
with only 7.5% reporting problems with medications or copays and 6.6% reporting 
problems with food/rent or other. Nearly half lived alone (49.3%) and nearly half lived 
with either a significant other (31.0%) or a family member (19.4%). Less than three 
percent (2.3%) lived with a friend or other.  
A majority of the caregivers for these participants lived outside the home (51.9%), 
while just over a third lived in the home (35.8%). Around 20% of the participants had 
paid help and another 11% reported none of the above. The reported relationships to 
caregivers ranged from no one person (13.8%) to unknown (1.1%). Adult children were 
the largest group (45.1%) followed by significant other/spouse (21.3%), other family 
(9.7%), and friend/neighbor (5.2%).  The quantity of care ranged from several times day 
and night (7.5%) to less than once/week (8.2%).  More than a third received daily care 
either several times daily (25.7%), or once a day (9.3%), while another third received 
care either three or more times/week (11.6%) or 1-2 times/week. The participants 
received myriad forms of assistance including:  help with ADLs (15.3%); help with 
IADLs (57.5%); psychosocial support (59.5%); medical appointment advocacy (48.1%); 
financial power of attorney (23.1%); healthcare power of attorney (62%); and 
environmental support (59.5%).  
Medication adherence 
   In this study, the participants’ mean medication adherence at Month 1 was 98.5% 
(S.D.=4.9%). Minimum adherence was 60% and maximum was 100%. Only 4.9% of the 
sample had less than 90% adherence and 9.3% had less than 95% adherence. The study 
participants’ mean medication adherence over time was similar to the Month 1: Mean 
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adherence was 98.1% (S.D.=4.6%) with a range of 61-100%. Because the data on 
medication adherence at Month 1 and overtime did not meet the assumptions of ordinary 
least squares regression (i.e., normal distribution or homogeneity of variance) (Cohen et 
al., 2003), the decision was made to measure medication nonadherence as a categorical 
dichotomy (adherence versus nonadherence) in order to build in adequate variance into 
the dependent variable. Logistic regression was then used to answer Research Question 1 
and Generalized Linear Modeling to answer Research Question 2.  
Measurement of the Dependent Variable.  To identify which context and process 
dimensions might predict risk for medication nonadherence at Month 1, a dichotomous 
dependent variable was created with 0=medication adherence rate between 100-95% and 
1=medication adherence rate <95%. Although it may have been preferable to lower the 
adherence threshold to 88% (Wu et al., 2008a), the dependent variable had constrained 
variance in this highly managed population. In this sample, N=25 (9.3%) of the 
participants missed more than 5% of their prescribed doses, with the remaining 
participants (N=243) having a Month 1 adherence rate of 95-100%  
An examination of the data also found important variation over time within 
certain participants such that even in this highly managed population, there were 
participants who still missed their medications. To identify which individual and family 
characteristics might predict risk for nonadherence over time, a dichotomous dependent 
variable was created with 0=mean monthly medication adherence between 98 and 100% 
and 1=mean monthly medication adherence <98%. In this sample, N=44 (16.4%) had a 
mean medication adherence that was less than the study’s mean of 98%.  
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Research Question 1 Results 
Research Question 1: What are the context and/or process dimensions that emerge 
as significant risk and protective factors for medication adherence at Month 1 of the 
study? 
 In Block 0 just the constant was in the model.  The initial -2 Log likelihood of the 
model was 166.197 and the overall correct classification was 90.7%. In Blocks 1, 2, 3, & 
4 the independent variables were added with individual-level variables first, the 
condition-specific variables second, the social environment variables in the third block, 
and then the process variable in the final block.  In Block 1, the individual-level 
characteristics included age, gender and race. Table 4 summarizes the regression findings 
for individual factors only. 
 
Table 4 
Month 1 Logistic Regression Model: Block 1  
 
      95% CI for Exp (B) 
Variables B S.E. Wald   Sig Exp (B) Lower Upper 
Male Gender 0.219 0.445 0.241 0.623 1.245 0.520 2.980 
Age 0.038 0.032 1.432 0.232 1.039 0.976 1.106 
Race (Black) 1.069 0.521 4.207 0.040 2.911 1.049 8.082 
Constant -5.661 2.662 4.522 0.033 0.003   
N=268 cases; Dependent Variable = Adherence Month 1; Initial -2LL =166.197; Final LL = 161.700 
(Chi-Square = 4.498; p = .212); Overall correct classification = 90.7% 
 
The -2 log likelihood of the model decreased to 161.700 indicating an increase in 
the model’s strength and predictability (Field, 2005). The Hosmer-Lemeshow test was 
not significant (Chi-square 14.532, p=.069) indicating that the observed data did not 
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differ significantly from the predicted model values (Field, 2005). The Omnibus Test of 
Model Coefficients, however, indicated that neither the block nor the model was 
significantly better at predicting Month 1 nonadherence than Block 0 (X2 =4.498, 
p=.212). The Nagelkerke R2 value which indicates the proportion of the variance 
explained by the predictors (Mertler & Vannatta, 2010) was .036. The overall percentage 
correct for this block also remained the same at 90.7%.  Among the individual factors, 
only race was a significant predictor with African Americans having nearly three times 
the risk of being nonadherent than whites (O.R.=2.911, [C.I=1.049-8.082], p=.040).   
In Block 2, the condition-specific variables of MCI, MMSE, PPT, GDS, vision, 
and hearing were entered into the model. See Table 5 for a summary of the findings. 
Table 5  
Month 1 Logistic Regression Model: Block 2 
 
          95% CI for Exp (B) 
Variables B S.E. Wald         Sig Exp (B) Lower Upper 
Male Gender 0.173 0.483 0.128 0.720 1.189 0.461 3.063 
Age 0.041 0.037 1.224 0.269 1.042 0.969 1.120 
Race (Black) 0.617 0.585 1.113 0.291 1.854 0.589 5.839 
MCI -0.005 0.012 0.211 0.646 0.995 0.972 1.018 
MMSE -0.241 0.067 13.077 0.000 0.786 0.690 0.896 
PPT 0.134 0.057 5.632 0.018 1.144 1.024 1.278 
GDS 0.062 0.067 0.848 0.357 1.064 0.933 1.213 
Vision 0.992 0.592 2.806 0.094 2.698 0.845 8.617 
Hearing 0.061 0.537 0.013 0.910 1.063 0.371 3.047 
Constant -2.310 3.723 0.385 0.535 0.099   
N=268 cases; Dependent Variable = Adherence Month 1; Initial -2LL = 166.197;  
Final LL = 143.398 (Block Chi-Square = 18.302, p = .006; Model Chi-Square = 22.800, p = .007); 
Overall correct classification = 90.7% 
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The -2 log likelihood of Block 2 decreased significantly compared to Block 1 
(143.398, X2=18.302, p=.006), and the overall model also predicted significantly better 
than the original model (X2=22.800, p=.007). The model continued to fit the data well 
(Hosmer-Lemeshow Chi-square 6.696, p=.570), and the Nagelkerke R2 quadrupled from 
.036 to .176 indicating a much larger percentage of the variance was explained. The 
overall correct classification of cases, however, remained the same at 90.7%. With the 
addition of the condition-specific variables, race was no longer a significant predictor of 
nonadherence suggesting that race in the first model might have reflected underlying 
health status differences between the two groups.  
Among the new condition-specific predictor variables, both MMSE and PPT 
scores significantly predicted a participant’s risk for nonadherence, but in opposite 
directions: Those with higher MMSE scores or higher cognitive functioning were less 
likely to be nonadherent (Wald 13.077), while those with higher PPT scores were more 
likely to be nonadherent (Wald 5.632). As expected, for example, for every unit increase 
in MMSE score, a participant was 21% less likely to be nonadherent (O.R.=.786, 
[C.I.=.690-.896], p=.000) suggesting that higher cognitive functioning was a protective 
factor against nonadherence. Conversely, higher physical functioning was a risk factor 
for nonadherence, such that for every unit increase in PPT score, the participant was 14% 
more likely to be nonadherent (O.R.=1.144, [C.I.=1.024-1.278], p=.018).The remaining 
health condition variables in Block 2 (i.e., MCI, GDS, vision and hearing), were not 
significant predictors of nonadherence at Month 1.  
                                                                  
 
       
	   	  	  87	  
Block 3 added the social environment variables (i.e., participant living alone 
versus with others, caregiver residing in the home, and participant receiving ADL and 
IADL assistance) into the model. Table 6 summarizes the regression findings for Block 3. 
Table 6  
Month 1 Logistic Regression Model: Block 3  
            95% CI for Exp (B) 
Variables B S.E. Wald Sig    Exp (B)      Lower        Upper 
Male Gender 0.152 0.510 0.089 0.765 1.165 0.429 3.164 
Age 0.054 0.039 1.905 0.168 1.055 0.978 1.139 
Race (Black) 0.631 0.615 1.053 0.305 1.879 0.563 6.270 
MCI -0.001 0.012 0.003 0.955 0.999 0.976 1.023 
MMSE -0.262 0.072 13.295 0.000 0.770 0.669 0.886 
PPT 0.159 0.062 6.528 0.011 1.172 1.038 1.323 
GDS 0.085 0.070 1.494 0.222 1.089 0.950 1.249 
Vision 0.961 0.615 2.443 0.118 2.615 0.783 8.732 
Hearing 0.044 0.550 0.006 0.937 1.045 0.355 3.071 
Lives Alone 0.885 0.591 2.240 0.134 2.423 0.760 7.719 
In-Home CG 0.904 0.664 1.855 0.173 2.469 0.672 9.070 
ADL Support 1.175 0.725 2.625 0.105 3.238 0.782 13.415 
IADL Support -1.088 0.528 4.241 0.039 0.337 0.120 0.949 
Constant   -4.195 4.129 1.032 0.310 0.015   
N=268 cases; Dependent Variable = Adherence Month 1; Initial -2LL=166.197;  
Final -2LL=134.998 (Block Chi-Square=8.40, p=.078; Model Chi-Square=31.200, p=.003); 
Overall correct classification=91.0%. 
Block 3 did not significantly improve over the preceding block (X2=8.40, 
p=.078), but the model did significantly improve in strength and predictability over the 
original model: The -2 log likelihood decreased to 134.998 [X2=31.200, p=.003] and 
Nagelkerke R2 increased to .238. The Hosmer and Lemeshow test continued to be 
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nonsignificant (p=.297). The overall model’s classification increased negligibly from 
90.7% to 91.0%, as the number of cases correctly identified as being “nonadherent” 
increased. Among the condition-specific factors, PPT and MMSE scores continued to be 
significant predictors of nonadherence. Those with higher PPT scores were again more 
likely to be nonadherent (O.R.=1.172 [C.I.=1.038-1.323], p=.011), and those with higher 
MMSE scores were less likely to nonadherent (O.R.= .770, [C.I.=.669-.886], p=.000). 
Among the three social environment factors, only receiving assistance with IADLs was a 
significant predictor of Month 1 nonadherence. Those who received IADL assistance 
were nearly two-thirds less likely to be nonadherent (O.R.=.337 [C.I.=.0120-0.949], 
p=.039). A possible explanation is that those receiving help with IADLs were indeed 
receiving assistance with taking their medications.  
The final Block 4 tested the additional direct effects of the process dimension as 
measured by the use of a cognitive prosthesis (i.e., MD.2 versus mediplanner) on 
medication nonadherence. Table 7 summarizes the regression findings for the full model.  
Table 7  
Month 1 Logistic Regression Model: Full Model 
      95% CI for Exp (B) 
Variables B S.E. Wald Sig Exp (B)        Lower Upper 
Male Gender 0.156 0.521 0.090 0.764 1.169 0.421 3.243 
Age 0.051 0.039 1.694 0.193 1.052 0.975 1.136 
Race (Black) 0.547 0.635 0.743 0.389 1.728 0.498 5.993 
MCI 0.003 0.012 0.053 0.818 1.003 0.980 1.026 
MMSE -0.275 0.075 13.404 0.000 0.760 0.656 0.880 
PPT 0.178 0.065 7.490 0.006 1.194 1.052 1.356 
 (table continues) 
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Table 7 (continued) 
      95% CI for Exp (B) 
Variables B S.E. Wald Sig Exp (B) Lower Upper 
GDS 0.089 0.071 1.592 0.207 1.093 0.952 1.256 
Vision 1.066 0.631 2.857 0.092 2.903 0.844 9.993 
Hearing 0.010 0.563 0.000 0.985 1.011 0.335 3.044 
Lives Alone 0.798 0.612 1.700 0.192 2.221 0.669 7.372 
In-Home CG 1.115 0.713 2.449 0.118 3.051 0.755 12.332 
ADL Support 1.352 0.765 3.124 0.077 3.866 0.863 17.315 
IADL Support -1.123 0.544 4.261 0.039 0.325 0.112 0.945 
Mediplanner 1.207 0.519 5.420 0.020 3.345 1.210 9.242 
Constant    -4.90 4.189 1.366 0.242 0.007   
N=268 cases; Dependent Variable = Adherence Month 1; Initial -2LL=166.197;  
Final -2LL=129.028 (Block Chi-Square=5.970, p=.015; Model Chi-Square=37.170, p=.001); 
Overall correct classification=92.2%. 
The final block significantly improved over the preceding block (X2=5.970, 
p=.015), and the final model significantly improved in strength and predictability over 
the original model: The -2 log likelihood decreased to 129.028 [X2=37.170, p=.001] and 
Nagelkerke R2 increased to .280. The Hosmer and Lemeshow test continued to be 
nonsignificant (p=.647). The overall model’s classification increased from 91% to 92.2%, 
as the number of cases correctly identified as being “nonadherent” increased. Among the 
condition-specific factors, both PPT and MMSE scores continued to be significant 
predictors of nonadherence. Those with higher PPT scores were again more likely to be 
nonadherent (O.R.=1.194 [C.I.=1.052-1.356], p=.006), and those with higher MMSE 
scores were less likely to nonadherent (O.R.= .760, [C.I.=.656-.880], p=.000). Among the 
three social environment factors, only receiving assistance with IADLs was a significant 
predictor of Month 1 nonadherence. Those who received IADL assistance were nearly 
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70% less likely to be nonadherent (O.R.=.325 [C.I.=.112-.945], p=.039). The process 
dimension was also a significant predictor: Mediplanner group participants were three 
times more likely to miss a medication dose than those in the MD.2 group (O.R.=3.345 
[C.I.=1.210-9.242], p=.020).  
 This first model was cross-sectional, and based only on the first month of the 
study. Medication adherence, however, is an “ongoing and dynamic” process (Gordon et 
al., 2007; Schulman-Green et al., 2012) so it was of equal interest, to test how these 
factors might predict a person’s risk for nonadherence over time even in this highly 
managed population.  
Research Question 2 Results 
Research Question 2: What are the context and/or process dimensions that emerge 
as significant risk and protective factors for medication adherence over the course of the 
study? 
The second model tested the effects of individual-level, condition-specific, and 
social environment factors on the risk for nonadherence over time. Given the temporal 
nature of the dependent variable (i.e., average medication adherence percentage over the 
study period), I used the Logit form of the General Linear Model as opposed to standard 
the Logistic Regression model to test this hypothesis. While the latter was suitable for 
testing the baseline cross-sectional hypothesis, the former (GLM) offers a more reliable 
estimate of the effects of the participant’s time in the study by allowing the analyst to 
specify an exposure variable. The reason being that a participant’s opportunity to deviate 
from her/his average medication adherence is, in part, a function of how long the 
participant lasted in the study. Some participants stayed, for example, three months in the 
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study, while other participants lasted 13 months. These differential exposures to time in 
the study means that the participants would have had varying opportunities to deviate 
from their averages, independent of the other measured factors. 
A form of the Generalized Linear Model that specifies a binomial distribution 
(i.e., logistic function) allows the analyst to include an “exposure” variable in the 
background, which helps standardize the potential differential effects of time on the 
outcome. In the present case, I took the log of the “number of months in study” (which 
included a range of 1-13) and specified it as an exposure variable, which then creates the 
rate of the average medication non-adherence per month (without having to include 
months in study as an independent variable). As Greene (2000) has noted, using the 
exposure method with an independent variable that does not have much variation 
produces more reliable estimates than controlling for the linear effects of time as an 
independent variable. The following reports on the results of the GLM with exposure 
analysis. 
Based on the log likelihood omnibus Chi-square goodness of fit test, the model 
was highly significant (X2=38.28; p<.001), indicating that the model reliably fits the data. 
There is, however, no reliable analog to the coefficient of determination (i.e., R2) used in 
OLS, which makes it difficult to determine how much variance the model explains 
(Cohen et al., 2003).1 Table 8 summarizes the findings of the regression model.  
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  In a separate analysis (not shown) using logistic regression to test Research Question 2, the standard logit 
model produced a Nagelkerke R2=.221. 
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Table 8  
Over Time Logistic Regression Model 
 
         95% CI for Exp (B) 
Variables B S.E. Wald Sig Exp (B) Lower Upper 
Mediplanner 
Group 
    1.057       0.392     7.250    0.007 2.877   1.333 6.207 
Race (Black) 0.475 0.514 0.856    0.355 1.608   0.588 4.401 
Gender -0.162 0.405 0.160    0.689 0.850   0.385 1.880 
Age 0.156 0.217 0.516    0.473 1.169   0.764 1.789 
MCI -0.030 0.224 0.081    0.892 0.970   0.626 1.504 
MMSE -0.571 0.203 7.900    0.005 0.565   0.379 0.841 
PPT 0.547 0.241 5.127    0.023 1.728   1.078 2.769 
GDS 0.420 0.184 5.238    0.022 1.522   1.062 2.181 
Vision 0.046 0.505 0.008    0.928 1.047   0.389 2.818 
Lives Alone 0.169 0.476 0.988    0.320 0.582   0.200 1.692 
In Home CG -1.135 0.586 3.748    0.053 0.322   0.102 1.014 
ADL Support 1.355 0.614 4.871    0.027 3.878   1.164 12.921 
IADL Support -0.946 0.419 5.108    0.024 0.388   0.171 0.882 
Constant -4.094 0.898 20.789    0.000 0.017   
N=268 cases; Dependent Variable = Nonadherence Over Time 
 
The risk and protective factors for nonadherence over time were similar to those 
found at baseline with some additional new predictors. Again, none of the individual-
level factors was significant. Among the health condition variables, three of the five 
factors (MMSE, PPT, and GDS) significantly predicted a participant’s risk for 
nonadherence over time. As with the Month 1 logistic regression model, the present 
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model found that higher MMSE scores significantly reduced the risk for nonadherence: 
(O.R.=0.565, [0.379-0.841], p=.005) and that higher PPT scores significantly predicted a 
participant’s increased risk for nonadherence (O.R.=1.728, [1.078-2.769], p=.023). 
Unlike the Month 1 logistic regression findings, however, GDS now significantly 
predicted an increased risk for nonadherence over time (O.R.=1.522, [1.062-2.181], 
p=.022).  
In the cross-sectional model, only assistance with IADLs was a significant social 
environment variable. Over time, however, three of the four family-level/social support 
variables were significant predictors of nonadherence. Having a caregiver residing in the 
home was a protective factor such that participants with a caregiver in the home were 
two-thirds less likely to be nonadherent (O.R=0.322, [C.I.=0.102-1.014], p=.053). Similar 
to the Month 1 findings, assistance with IADLs was a protective factor with those 
receiving assistance being significantly less likely to be nonadherent (O.R=0.388, [0.171-
0.882], p=.024). Receiving help with ADLs, on the other hand, was a significant risk 
factor with those needing ADL assistance nearly four times more likely to be 
nonadherent (O.R.=3.878, [1.164-12.921], p=.027). One possible explanation is that these 
older adults could not self-manage their medications alone, and were thus at risk for 
nonadherence when a caregiver was not there to assist them. Once again the process 
dimension (intervention group assignment) was a significant predictor: Mediplanner 
participants were nearly three times more likely to be nonadherent over time 
(O.R.=2.877, [C.I.=1.333-6.207], p=.007).  
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Summary 
Research Questions 1 and 2 sought to identify the protective as well as risk factors 
associated with medication nonadherence in a sample of frail older adults who received 
the nurse care coordination intervention. A comparison of the two models, finds that even 
in this highly managed population, there were several significant factors that either 
protected against or increased the risk for nonadherence. Among the condition-specific 
variables, cognitive and physical functioning were significant predictors in both models, 
but in the opposite direction: Higher MMSE scores were protective, but higher PPT 
scores were a risk. Having a higher depressive symptoms score (GDS) was also a risk 
factor, but only over time. At the social environment level, only “Receiving IADL 
Assistance” was protective both at Month 1 and over time. Two additional social 
environment level factors were significant predictors for nonadherence over time, but in 
the opposite direction: Having a caregiver in the home was protective, whereas receiving 
assistance for ADLs was a risk factor.  Finally, at the process level, using a mediplanner 
was a significant risk factor for nonadherence both at Month 1 and over time.  
These findings taken together demonstrate that even with the intensive nurse care 
coordination intervention, some older adults still had difficulty self-managing their 
medications. The significant predictors may alert us to who might be at increased risk for 
nonadherence either cross-sectionally and/or over time, however, they do not tell us why. 
Findings from Chapter 5, which includes an examination of the reasons that participants 
gave for missing their medication doses each month, may help us better understand why.  
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Chapter 5 
QUALITATIVE FINDINGS 
Research Question 3 sought to identify themes that describe the frail older adults’ 
medication self-management processes. This chapter reports the results of this qualitative 
inquiry. First is a presentation of the descriptive findings of the participant responses. 
Next is a presentation and discussion of the overarching themes and domains that 
describe the self-management processes associated with medication nonadherence.  
 Descriptive Findings 
Over the course of 13 months, the nurses documented a total of 1,459 statements 
from the participants explaining why they missed their medication dose(s). Monthly 
fluctuations occurred in both the number of participants who had a documented response 
(Range = 36-115 participants), as well as the total number of participant responses 
(Range = 56-190). Coding of the participant responses resulted in eight 
categories/domains and thirty-two associated themes. Appendix A is a frequency display 
of the themes over the course of the 13-month study. Further exploration of the 
relationships among the eight domains led to the three overarching themes and one 
remaining domain.  
Overarching Themes 
As previously noted, medication adherence is a multistep process that begins with 
a prescriber ordering a medication and ends with a client actually taking the medication 
as directed. In working with the data, I realized that one way to better understand the 
theory of the problem of medication nonadherence would be to examine the participants’ 
responses along the continuum of this multistep process and see where the breakdowns 
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occurred. Using the IFSMT as a theoretical guide, I also began examining the domain 
analysis worksheet to see how the domains might cluster (relate to each other) along this 
multistep process (Spradley, 1979). For example, I noticed that the domain “Problems 
with planning and/or action” shared similar attributes as the domain “Experiencing 
cognitive difficulty”.  In both domains, participants were “not ready” to take their 
medications because they either forgot and/or had experienced disruptions that led to 
them missing a medication. With further analysis, I then subsumed the particulars (i.e., 
seven categories and 29 themes) into the general by clustering the categories into three 
overarching themes to describe the self-management processes associated with the older 
adults’ episodes of nonadherence (Miles & Huberman, 1994). One domain “Needing 
Additional Information from Participant” did not fit in this model, but is discussed 
separately because it provides insight into the challenges to assessing a client’s 
medication adherence.  Figure 4 is a thematic representation of the older adults’ 
medication self-management processes. Table 9 is a list of the overarching themes. 
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Figure 4. Thematic Representation of Processes Associated with Nonadherence
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Table 9 
Overarching Themes of the Medication Self-Management Processes 
 
1. Not Being Ready to Take Medication 
2. Not Being Able to Take Medication 
3. Consciously Choosing Not to Take One’s Medication  
 
Overarching Theme 1: Not Being Ready to Take the Medication. A 
significant proportion of the participants had difficulty in this step of the medication-
taking process with half the older adults’ responses (N=732) having this attribute of “not 
being ready to take their medication dose” when it was due. The two Categories/Domains 
in this overarching theme included: “Experiencing Problems with Planning and/or 
Action” and “Experiencing Cognitive Difficulty”. Similar to findings in the literature 
(August, 2005; Hindi-Alexander & Throm, 1987; Vik et al., 2005), several of the themes 
within the two domains centered around the process of forgetting. The two domains were 
distinct, however, in that some responses suggested the participant had a specific problem 
related to memory and/or cognitive functioning (i.e.,  “Experiencing Cognitive 
Difficulty”) while others suggested episodic issues of forgetting (i.e., “Experiencing 
Problems with Planning and/or Action”). Because a large proportion of participant 
responses fell under the theme “forgetting, but no reason noted”, these responses were 
coded globally under “Experiencing Problems with Planning and/or Action”. It is 
possible that further description might have revealed some underlying issues with 
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memory and/or cognitive functioning.  More importantly, further description might have 
indicated what interventions were needed to improve adherence. 
Indeed, when a reason for why the participant forgot was documented, there was 
an opportunity for the nurses to document suggested strategies for improving adherence. 
For example, when a participant in Month 7 was having trouble remembering on her 
own, the nurse documented, “Reports she is going to have daughter call to remind her 
about morning pills”. The words “going to” illustrate a plan (i.e., self-management 
strategy) for how the participant could improve her medication adherence. Unfortunately 
when the participant later missed medications due to forgetting, no additional reasoning 
was noted.  We, therefore, cannot conclude that this intervention was implemented and/or 
continued. In another example, a husband and wife in Month 2 were both having trouble 
so the nurse documented “a plan” that the participants would leave their mediplanners on 
the table “to remind each other”. Despite these efforts, the couple still continued to have 
trouble remembering that month.  By Month 3, however, the participant did not miss any 
medications. Additional social facilitation appeared to solve the problem with the nurse 
noting that, “family members are ensuring the patient is taking her meds”. The 
participants subsequently withdrew from the study so it is unknown whether or not this 
intervention became a long-term strategy for them.  
 Another problem associated with “Not Being Ready” was specific to the MD.2 
group: Participants who were ready at first, but then were not. These participants when 
asked why they missed their dose(s) admitted they had dispensed their medications, but 
then had forgotten to take them. Even though only half the participants used the MD.2, 
this problem still ranked as the 7th overall response that study participants gave for 
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missing a dose. Knowing how frequently this problem occurred, not only draws our 
attention to this common barrier, but also allows us to develop future strategies to reduce 
this risk. For example, one nurse noted, “[the participant] took PM meds out of machine, 
set them down on table, and then forgot”. Another participant dispensed the medication 
as “an early dose, went to an event and then forgot to take it”. In another example, a 
nurse noted a pattern with the participant’s use of the MD.2, “missed one yesterday; pt 
not good about remembering to retrieve from the machine”. This problem highlights how 
the MD.2 often served as an effective audio and visual prompt, but did not guarantee that 
the participant would eventually take the dose once dispensed. Indeed one nurse 
wondered if the participant ever took the dose, “? Family put back in bottle, took all med 
cups from MD.2 but did not necessarily swallow meds”. 
Another common theme was “Not being home” with N=133 or 24% of the 
participant responses within this domain. Often participants were out with friends or 
family, and then did not take their medications once they returned home. For example, 
one participant would go out, not take her medications, but then planned on taking them 
when she got home. Yet, often she forgot once she returned home. This reason persisted 
for four months, and then stopped. The nurse did not document what changed, so it is 
difficult to tell what strategies she might have used to overcome this problem. 
Conversely, in another case, a participant attended an adult day care (ADC) and missed 
medications because the MD.2 was at home. The nurse noted, “Now have a pill box with 
noon doses in case this happens again”. After this nursing intervention, the participant no 
longer reported this problem. Participants who used the MD.2 often forgot to early dose, 
even when the nurse pointed that out as an option. Sometimes, the nurses were able to 
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adjust the dosing times to better accommodate the participants’ social schedule and this 
solved the problem. For example a nurse noted,  
“[Participant] out…and forgot to take when got home. Eliminated 6pm 
dispense and changed 8pm to 9:30pm so she can go out w/o worrying 
about the 6pm.” 
Participants with mediplanners, on the other hand, could take their medications 
with them, but still cited being out of the house as a reason. In most cases, they were out 
for the day and just forgot, but in other situations, they went out of town and were 
nonadherent for several days. Some of the responses suggested a lack of self-regulation 
processes (i.e., reflective thinking, planning or action):  Some of the nurses noted:  
“[Participant] left town last week & ‘grabbed a few bottles & went’ 
completely unsure of what he took”.   
“7 full days missed, participant not concerned, she has often missed 
throughout life, was out of town which threw her off”.  
“Participant admits to missing several doses while on vacation, participant 
very nonchalant about this.” 
It is unclear from the notes, whether or not the nurses further explored these responses 
during the visit to encourage the participant to develop strategies for future planning and 
action.  
Another missed opportunity noted in the participant responses was the potential 
role of family members in helping the participants self-manage. In several instances, 
participants shared that they forgot because they were out of the house spending time 
with family: 
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“Was at daughter's late and was tired, forgot to take his meds”; 
“Went to son's house and forgot to take meds with her”; 
“Forgot was at daughters”; 
“Was out at her son’s”; 
“Client was staying overnight with her brother”. 
Given the number of examples in this study where family members took an active 
role in helping the participant self-manage, it is possible that had these other family 
members been more involved/aware of participant’s medication self-management issues, 
they could have provided the necessary social facilitation by reminding the participants to 
bring their medications with them. It is also possible that some participants might not 
have wanted their family members involved in their medication management.  
Another common theme for the participants was experiencing disruptions to their 
daily schedule (N=48). Of note, 73% of these cases (35 out of 48) were due to 
participants having to go to healthcare related appointments (e.g., dialysis, dental care, 
therapy, primary care providers) and/or the emergency department.  Sometimes, the 
participants responded that they were told not to take the medication, and were thus 
following prescriber advice: “had dialysis appt in AM-instructed by MD not to take on 
those mornings”. Eight of the cases had disruptions due to getting busy doing something 
else (e.g., housecleaning or making coffee) and/or distracted by holidays. Interestingly, 
eight of the participants were not ready to take their medications because of family 
visiting or they themselves being in a caretaker role (e.g., “getting granddaughter ready 
for school”, “spouse being in the ED” or, “wife came home from the hospital”).   
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A final theme in the first domain was “Falling Asleep”.  Nurses noted for 
example, “slept through dispense”, “too tired and went to bed”, “forgot, fell asleep”. 
Sometimes solutions that worked might include: the “family dispensed the med cup when 
client was sleeping” or “dispense times changed today and client moving MD.2 to his 
bedroom”. In other instances, the problem was more complicated, such as a case where 
the spouse noted that participant was “sleeping at different interval[s]” (Month 4) and 
“sleeping erratically” (Month 12). In this case, perhaps decreasing the medications to 
once or twice daily might have given a greater window of time for dosing, or perhaps the 
sleep patterns were too difficult to work around.  
 The second domain, “Experiencing Cognitive Difficulties”, reflected specific 
problems that participants had with memory and/or executive functioning (N=48). For 
example, the nurse might think that once the mediplanner (i.e., cognitive prosthesis) was 
set up the participant could manage the rest of the process, but in some cases, confusion 
with the planner still led to nonadherence. The theme, “Being confused about organizer” 
illustrated in particular the additional cognitive functioning needed to manage a 
mediplanner versus the MD.2 (a machine that controlled the delivery of the medication 
doses): 
“Did not take any pills from 2nd MP!!!!! Said she thought I was just here 
last week, but I haven't been here for 2 wks”;  
“Had some med changes & took meds out of her box, meds were missed 
& not in correct locations”; 
“Missed 1 warfarin, thought it was a mistake”. 
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Some participants, however, recognized their confusion with their medications and 
shared with the nurses where the problems occurred: 
“Confused over if they were the right pills for him to take so put AM dose 
back in med bottles”; 
“Missed Sat, is having difficult time in the middle of the week”; 
“Skipped 6 doses of prednisone thinking she eliminated her Lasix”; 
“Thought MD told her to D/C one HS med but didn't know which one so 
stopped all HS”. 
Confusion could also lead to overdosing, although this was less common (N=11). Some 
responses nurses noted were:  
“Pt took meds after RN left instead of next day; no meds until RN 
arrived”;  
“Pt does think she took 2 AM doses in one day; cannot remember which 
day she did this”; 
“Extra insulin dose for supper missing-clt thinks she may have taken extra 
dose”; 
“Took too many pills since last visit”. 
Some participants, however, specifically admitted they had trouble with 
their memory and/or with remembering (N=8).  In one case, the participant 
admitted to being forgetful, but no intervention was noted, and she continued to 
forget doses over the course of the study. In another case, however, there was an 
attempt to overcome this barrier by enlisting the help of a family member, 
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“forgetting noon metoclopramide in the planner, son will give more verbal 
reminders”.  
Overarching Theme 2: Not Being Able to Take the Medication.  
The overarching theme, “Not Being Able to Take the Medication” was less of a 
problem for the participants in this study than not being ready: Over the course of the 
study, it accounted for approximately 8% of the responses (110 out of 1,459). 
Nevertheless, the categories and themes help us to understand where the participants had 
trouble in this stage of the medication taking process and provide insight on ways to 
improve medication adherence.  
For example, a small minority of participants had trouble with this step in the 
medication-taking process because they did not possess the medication. Indeed, there 
were only 24 out of the total 1,459 responses given. Of note, half of the instances (12 out 
of 24) occurred in the 2nd and 3rd months of the study, and then only happened 
sporadically for the remainder of the study. This finding is not surprising given that an 
important component of this nurse care coordination intervention was to assist the 
participants in obtaining their medications (e.g., call the prescriber, call the pharmacy, 
and/or inform participant or caregiver when refills were needed). Themes in this domain 
included: lacking transportation; experiencing MD or pharmacy issues; and lacking the 
finances to buy refills. In many cases, however, the nurses documented that medications 
were out, yet did not document why (e.g., “has not had ASA x 1 week”, “medication not 
available to fill in mediplanner”, or “did not have all medications last week”). As a result, 
it is difficult to understand whether they ran out of medication related to transportation, 
refill issues, or cost-related issues. Also of note, during the initial round of coding some 
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participant responses had two possible codes. For example, the documented response 
might begin with the fact that the participant did not possess the medication, but then the 
nurse would finish the note with, “denies need for med r/t not episode of reflux”. In this 
instance, the response was coded as a belief issue primarily, and then the “not 
possessing” issue as secondary. Over the course of the study, there were nine instances 
where the code “not possessing the medication” had been dropped. Some of the nurses’ 
observations of the participant responses suggested that cost may have been an issue and 
that the participant perhaps chose not to disclose it as a problem.  For example, one nurse 
charted that the participant reason was “not being home”, but then noted, “doesn't give 
explanation as to why she doesn't take when gets home, I get feeling related to cost 
savings on meds.” Without more information, however, we cannot know why the 
participant did not take the dose once she got home, and/or whether or not additional 
planning would have helped. 
On the other hand, the nurses’ notes also illustrated how the care coordination 
intervention prevented the participants from running out of medication. In one case, a 
participant (with high medication adherence) wanted to coordinate/call in her own refills, 
but then forgot to have her daughter pick up the medication before the visit. The nurse 
then went to the pharmacy and picked up the medication so the mediplanner could be 
filled. In another case, on admission, the nurse noted that there were no medications in 
the home. To facilitate medication adherence, the nurse called the pharmacy for refills, 
and then called the PCP in the morning to get the prescriber’s order for another refill. The 
nurses’ notes also described situations where caregivers facilitated the process. One 
participant’s son was highly involved in filling the mediplanner and assisting with refills 
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and physician samples. The participant did not miss any medications. Five months into 
the study, however, the nurse no longer mentions the son’s involvement, and now 
documents that medications in mediplanner are “jumbled” and “client confused over 
use”. It is unclear what happened to the son’s involvement, but the nurse assumed the 
role of social facilitator and asked the participant to wait for nurse’s visit and they would 
refill the planner together.  
The most common category/domain in this overarching theme was where the 
participant did possess the medication, but then was physically unable to take the dose 
(N=85). Responses centered around: (1) Lacking the physical ability and/or visual acuity 
to take the pills (N=37); (2) Lacking the ability to retrieve the pills from the organizer 
(N=22); and (3) Relying on social facilitation in order to take the prescribed dose (N=26). 
For those patients who lacked a physical ability, there were myriad causes such as, a 
participant who “missed 6 days [because] states she felt too tired and weak to get OOB 
and take meds”, while another, “missed 3 full days of meds…could not reach med 
cassette in cabinet so did not take”. In a third case, the participant fell…was in pain and 
did not get out of bed on Monday”.  
 Visual acuity issues were more common and centered around the difficulty in 
seeing a white pill in a white mediplanner or not seeing the pills at all: 
“Missed 4 out of last 7 days PM caduet r/t it being small white pill in 
white container”; 
“1 HS metoprolol missing, white box & white pill so client could not see 
she missed it”; 
“Very small white pill and he did not see it was left in white box”; 
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“2 missed doses of carvidolol, small pill, pt not seeing it, encouraged to 
dump out pills”. 
Here again, we can see the importance of having a caregiver or friend who might have 
been able to assist those participants who lacked the physical capacity to take them.   
Although a rare occurrence, twenty-two participants did experience episodes of 
nonadherence due to problems with the MD.2 machine or mediplanner. Again the 
participant responses provide insight into the difficulties encountered even after the 
participant remembered to take their medication. Most of the issues were with the MD.2 
such as: 
“MD.2 not dispensing and d/c from phone line so missed doses not 
alerted”; 
“[Participant said], ‘two cups came out when I pushed the button’, but I 
think she dispensed the AM pills and the HS were there”; 
“Missed 2 doses, clt reports they came out of the MD.2 in the wrong order 
so he did not take them”; 
On occasion, participants also had trouble with their mediplanners, which then led 
to missed dose(s): 
“Said I did not fill it complete”; 
“Dropped planner on the floor didn't tell dtr b/c she is busy with baby, dtr 
will check on him more often”; 
“Missed 1 lasix dose, sticks to bottom of mediplanner. New planner given 
to clt”. 
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The vast majority of these responses (15 out of 22), however, occurred during the 
first half of the study possibly indicating that the ongoing support from the nurses 
and/or caregivers helped the participants in overcoming this barrier to adherence.  
Yet another category/domain, “Relying on Social Facilitation” (N=26) further 
highlighted the importance of effective social facilitation to optimize participant 
adherence. For example, participants were instructed to call the nurse if there were 
medication changes and/or went into the hospital so not surprisingly, confusion due to 
hospitalization was very uncommon (9 out of 1,459). Nevertheless, the nurses’ notes 
highlight the problems that participants still experienced with the transitions in care as 
well as the difficulty for the nurse in assessing medication adherence,  
“Has not been taking meds as prescribed since D/C from [hospital]”; 
“? Unable to tell, client not clear on exactly how many days he was 
hospitalized”; 
“All AM slots in box 2 full, was in the hospital a few days but that means 
client at least 4 days [missed]? Hard to tell since he was hospitalized”;  
“Has not had any meds since hospital D/C 5 days ago”. 
Still other examples where the older adult relied on caregivers for assistance with 
the management of their medications illustrated how some well-intentioned caregivers 
might need, at times, additional support and/or suggested strategies from the nurses in 
order to optimize adherence: 
“4 missed: son reminds and will put back in MP if she forgets to take”; 
“Caregiver states he gives patient meds & sometimes she forgets to take”; 
“Took meds but incorrectly set up by grandson”; 
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“Pt relies on spouse to remind her & if he forgets, she doesn't take Pt & 
spouse both forgot”. 
One solution that a nurse tried was to change the dosing schedule to reduce the risk for 
nonadherence, “[Significant Other] dispensed noon dose for her two times this week. 
Now will have only one dispense daily.” This instance happened at the end of the study, 
so we cannot tell whether or not the intervention solved the problem.  
Overarching Theme 3: Consciously Choosing Not to Take One’s Medication.  
In nearly one out of ten responses, (140 out of 1,459) participants acknowledged 
that they had consciously chosen not to take their medications. Their responses were 
captured by two categories/domains: “Experiencing Problems with Knowledge and 
Beliefs” (N=15) and “Utilizing Self-Regulation Skills” (N=125).  Knowledge and belief 
issues occurred less frequently, which is not surprising given that a primary component of 
this intervention was to educate the participants on their medication regimen. 
Nevertheless, participants still struggled at times with not believing the medications were 
important. For example, the nurses noted: 
“Pt said doesn't want to take daily as he feels same if he takes them or 
not”; 
“Client is taking plavix from some cups and only taking that; feels she 
doesn't need other meds”; 
“Denies need for med r/t not episode of reflux”; 
“Did not take meds after MD.2 empty; does not feel important to miss a 
few days” 
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“Continues to occasionally skip PM cellcept when not experiencing 
symptoms”. 
The Individual and Family Self-Management Theory (Ryan & Sawin, 2009) helps 
us to understand how knowledge and beliefs impact goal congruence for our participants. 
For example, if the goal was medication adherence, but the participants did not believe 
the medications were important, then they experienced goal incongruence. In some cases, 
further discussion with the nurse might have resolved this problem and promoted goal 
congruence.  
Less frequently, the participants lacked knowledge about their medication 
regimen, and this in turn led to a lack of self-efficacy to take their doses as ordered. 
Indeed, the nurses’ notes support this explanation as it appears that once the participants 
received the necessary education they were willing to take the medication. The following 
examples thus highlight the importance of access to health care providers, including 
pharmacists, to facilitate older adults’ self-management of their medications: 
“She thought 2 of the meds would upset her stomach or interact with other 
meds; patient education re: this, patient will resume taking”; 
“RN was not able to get RN over the weekend. Client did not take new 
medications”; 
“Did not get a hold of RN with new meds after visit last week. Did not 
take until visit today”; 
“Does not know how to take warfarin & am unsure”. 
 In nearly 90% percent of the instances (125 out of 140), however, participants 
utilized self-regulation skills and abilities to consciously choose not to take their 
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medications. Sometimes participants chose to skip a dose because it conflicted with their 
life circumstance. In these cases, the nurses’ notes suggest that the participants wanted to 
go about living and enjoying their life, and if they didn’t have time to take them, or if the 
medication side effects interfered with their plans, then they didn’t take their dose(s). 
Nurses noted for example: “Reports pills make her feel dizzy and tired and she was going 
out” or “Missed one dose while on vacation, was very busy and wasn't able to get to his 
meds”. The vast majority of the time, the competing demands were because the 
participants wanted to leave the house and didn’t want to deal with the need for finding a 
bathroom. As a result, they would choose not to take their diuretic as prescribed.  
“[Participant] did not take furosemide because had to go out to pick up 
meds”; 
“One am dose of diuretics b/c was going to see lawyer”; 
“Does not take furosemide when he has to leave house”; 
“Missed 1 dose each of Lasix & Metolazone r/t being out of the house 
without access to a BR”; 
“Thought she was skipping lasix as she was going out frequently”; 
“Missed water pills Sunday AM b/c she went out to breakfast 
going out and didn't want to be urinating”. 
While “Choosing to skip a dose” wasn’t a significant problem during most of the 
study (N=24), it is interesting to note that the majority of the instances occurred in the 
last three months of the study. Perhaps as participants became more comfortable with 
their nurse, they were more willing to make their own decisions about which dose to take 
or not take. More importantly, this highlights the importance of patients discussing the 
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lifestyle effects of taking diuretics, and then negotiating with the prescribers on a dosing 
schedule that is more congruent with their activities of their daily life.  
In contrast, other participants utilized self-regulation skills to recognize that 
because of health reasons, they should hold their next dose. In nearly one-third of the 
time (N=47), participants held off taking their medication dose(s) because they or their 
provided decided it wasn’t warranted:  
“[Participant] told to hold Aggrenox in urgent care”; 
“Missed 7 HS doses; MD said she can skip QOD b/c meds give her HA in 
the am”; 
“Reports she was ‘took sick’ to take them. MD aware that client doesn't 
always take her pills as Rx'd”; 
“Missed whole wk. pt had flu was vomiting. Ready to resume regimen”; 
“Did not take warfarin past 2 days b/c gums were bleeding profusely on 
Wednesday when she had INR drawn”. 
One case in particular, highlights the importance of health care providers regularly 
checking in with clients about their medication self-management. A nurse noted: 
 “[Participant] has not taken coumadin in 11 days b/c she had HA and said 
she was told to hold it when that happens and get INR drawn but she never 
got the INR drawn.”  
Here we see that a participant had the correct knowledge about her medication, but 
perhaps social facilitation would have helped her get her INR drawn sooner. Conversely, 
without the nurse’s visit, it is possible the participant would have gone longer without 
this critical medication.  
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The final theme, “Feeling burden outweighing benefit” was much more common. 
Indeed, more than a third of the time, (54 out of 140 instances) the participants 
consciously decided for themselves that the burden of taking the medication outweighed 
the benefit. Through the nurses’ notes, we learned that participants were tired of taking 
all these medications or believed they were taking enough of what they needed:  
“Client reports she gets tired of taking all these pills”; 
“[Client] didn't feel like taking them”; 
“Client never really gives a reason for missed doses. ‘well I was taking 
cough syrup…and some [antibiotics] and that was enough medicine for 
me.’ I don't think she forgets”; 
“Missed several potassium & iron pills by choice as he does not like to 
swallow them”; 
“[The participant] Gave me a tumbler full of pills she took out of MD.2 
but never took!!! Just doesn't feel like taking her meds sometimes”. 
These participant responses can help us reflect on the benefit versus burden of taking 
multiple medications, as well as recognize the importance of ongoing dialogue between 
healthcare providers and patients if we are to move toward a model of shared decision 
making and optimal adherence.  
One case, in particular, demonstrates the challenging aspects of optimizing a 
person’s medication self-management. This case also serves as an excellent illustration of 
the Individual and Family Self-Management Theory’s proposition that there exists an 
inter-relationship between the theoretical constructs of self-regulation and social 
facilitation (Ryan & Sawin, 2009). The case involved a participant in his late 60s with 
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kidney disease and severe vision impairment who was taking over 350 doses a month. He 
lived alone without a caregiver. During the first four months of the study, his monthly 
adherence rates were 95% or higher, but beginning in month 5, his adherence rates 
dropped to an average of 38%. Through the nurse’s notes, we hear the participant’s 
frustration, the healthcare team’s concerns, and the resulting nonadherence. The nurse’s 
notes also illustrate some strategies the participant’s healthcare team tried to improve 
adherence: 
“Did not take 10 of the 14 doses. He stated that he didn't do much the last 
few weeks and that he was not in a good way. RN to see next week though 
he doesn't need to be filled”; 
“Pt confronted by his nephrologist about his labs and pt admit he has not 
been taking his pills. RN to start calling to check on pt”; 
“Only missed 2 am and 2 pm. Friend over that spends time with pt, she is 
encouraging him to take and will check on pt”; 
“Just does not take them. Enc pt to be more compliant and he said he 
would try”; 
“Pt aware of need to take but is frustrated with the amount he needs to 
take and often dispenses and just piles up”. 
 Even with all the healthcare team’s social facilitation efforts, the participant continued to 
have high monthly rates of nonadherence. It is unclear if a full team meeting with the 
participant and caregivers might have led to fewer pills and greater medication 
adherence. 
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Domain 7: Needing Additional Information from Participant.  
The three overarching themes help us to understand when and/or why participants 
encountered problems with their medication self-management process. However, despite 
the ongoing and consistent monitoring by the intervention nurses, approximately 40% of 
the participant responses (595 of 1,459) belonged to the category/domain of, “Needing 
Additional Information from Participant”. This category had five themes to describe why 
more information was needed. Of the five themes, “Having No Reason (N=293) was the 
most numerous and accounted for nearly half the participant responses in this category. 
As previously noted, the nurses would simply document, “no reason” and/or “1 missed 
dose” and not include a reason. Further dialogue with either the participant and/or family 
member might have led to a better understanding of why the medications were missed, 
and perhaps the identification of effective strategies to improve medication adherence.  
The next most common theme, “Being unsure of what happened” (N=115), was 
also one of the most common themes for this group of frail older adults: It was 
consistently one of the top five themes for 12 out of the 13 months of the study. “Being 
unsure of what happened” is distinct from “forgetting” because it reflects the participant’s 
inability to explain what happened. Most of the responses were documented as, “unsure 
what happened”, “cannot say why”, or “unsure as to why”. An examination of those 
participants who were at times “unsure”, found that their other responses often varied. 
For example some of them would later say they missed a dose because they were out, 
while others simply said they forgot. In these types of client situations, the clinician 
might have to continue to assess for a pattern in order to identify the underlying reason 
for nonadherence before suggesting specific self-management strategies. 
                                                                  
 
       
	   117	  
Another common theme among both intervention groups was the participant, 
“Denying Missing Medications” (N=80). With the MD.2 group, some participants would 
deny missing a medication dose. Instead, they would acknowledge they were late, but 
then assure the nurse they took the medication: 
“[Missed] one yesterday, out shopping took when she got home”; 
“Niece gave from holding area”; 
“Took medication when she got up per her report”; 
 
“Watching TV and lost track of time; took from holding area”; 
 
“Participant did take AM cup out of dispenser & then lost it, reports took 
meds from bottle that day”. 
These responses nonetheless help us to see one problem with the controlled dosing of the 
MD.2: The machine might record nonadherence, but according to the participants they 
eventually took their doses so they were late, but still adherent. Sometimes, however, the 
nurses would see pills in MD.2 cups in the home, wonder if these were missed doses, but 
still the participant would deny it: “Saw one pill cup in bedroom; pt denies missing any 
doses” or “found a Cozaar & warfarin in separate used cups, client doesn't recall missing 
these doses”.  
Similarly, with the mediplanner group, the nurses might note that pills were still 
in the planner, but the participants would deny they missed any doses: 
“Client states she takes meds out of bottles b/c easier for her”; 
“pt states she took meds from bottle not planner, 2 full days”; 
“Participant forgets, but then insists she takes”; 
“Said I put 2 tabs in some of the days (synthroid)”. 
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Equally as common (N=79) was the theme, “RN being confused due to 
participant behavior”. In these instances, the nurses would document what they 
encountered in the home as well as their confusion about the participant’s adherence: 
“Pt had meds sitting out for RN in cups. Missed most of her meds if these 
are her current pills. Will update MD today at appt”; 
“Son alerted RN to cups in medicine cabinet in cups and bottles. RN 
removed, unsure how long in there”; 
“Vague about what she did for pills (last filled MP for 2wks was 3wks 
ago)”; 
“??!!! Reports she filled her box last week, however, date on bottle…she 
should have run out, [but] has 10 days worth”; 
“not able to accurately determine which meds are missing due to pt not 
taking them from correct boxes”. 
In many cases, the lack of agreement between what the nurse believed were 
missed doses, and the participant’s denial of any missed medications led to some overlap 
between the two themes: “Denying they missed medications” and “Nurse being confused 
due to participant behavior”. The following examples illustrate the need more 
information to better understand the participant’s medication self-management: 
“Pt seemed to take additional doses but denied this”; 
“? missed 7? Says she put the pills in the box when she saw it was getting 
low”; 
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“Unsure what happened, appears she missed 3 days of meds in a row, but 
pt denies this”; 
?!! Clt has not had enough meds for awhile but reports she is taking them. 
? Says she has been taking them but unless she had some bottles 
hidden…meds ran out over a week ago”; 
“?Doing her own thing!!!!! Says she used BP on vacation but I cannot 
really tell what she took and didn't take”; 
These examples also illustrate the difficult challenge that the nurses faced when 
attempting to optimize medication adherence with a client who denies that a 
problem exists. It is unclear in most cases whether or not the nurses had reached 
out to family and/or caregivers to clarify the situation, but in some cases, even the 
family members were confused: 
“Completely unsure, pt son? Set up a week's worth of meds in cups on the 
table. Not set up correctly”; 
“Missed some HS and pm meds. Son put in cup for RN but couldn't 
remember if fell out or pt missed”. 
The last theme in this domain was, “Taking dose during RN visit” (N=28). 
Responses were coded under this theme if it was unclear why the older adult 
missed their medication dose, but the nursing note documents that the participant 
took the dose during the visit.  On the one hand, this theme could demonstrate the 
importance of social facilitation for two reasons: (1) The responses suggest the 
participants did not realize they missed a dose until the nurse brought it to their 
attention, (e.g., “thought he had taken his meds last night but did not”); (2) The 
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responses suggest that the participants appeared willing to take the medication 
once the nurse offered the dose(s) to them:  
“Did not take meds yet today. Took during visit”; 
“2:42pm RN had pt take meds during visit; dispensed but had not taken yet”; 
“Had pt take meds during visit”; 
“Pt not taken AM pills before today's visit (son instructed pt to take them 
& she complied)”; 
“Did not take AM meds today; took at 2pm while RN in home”; 
“Had not taken morning meds as of 3 pm; did not take his insulin”. 
These instances suggest that if social support from someone such as a caregiver or nurse 
had been available (i.e., social facilitation) the participant might have been more 
adherent. On the other hand, there is also the possibility that the participant did not want 
to take the medication, but took the dose(s) with the nurse because he/she did not want to 
disappoint and/or contradict the nurse. Interestingly, participants in both the MD.2 and 
mediplanner groups had instances where the nurse had to instruct the participant to take 
their missed dose.  
Summary  
A template approach using a domain analysis to code and classify the participant 
responses led to the identification of thirty-two themes clustered within eight distinct 
domains. Further analysis of the domains and their relationships to each other led to the 
identification of three overarching themes that described when and/or why the 
participants’ experienced trouble with the multistep process of medication adherence. 
Seven of the eight domains were categorized into one of three overarching themes. The 
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remaining domain, “Needing Additional Information from Participant” was nonetheless 
important because it highlighted the challenges of assessing medication adherence in the 
community setting. Chapter 6 integrates the qualitative findings with those in the 
quantitative component in order to: (1) Enhance our understanding of medication 
nonadherence in this group of frail older adults; and (2) Evaluate how well the theory 
explains this health behavior. The final chapter then offers direction for clinical practice 
and future research. 
                                                                  
 
       
	   122	  
Chapter 6 
DISCUSSION 
This descriptive explanatory study attempted to advance the science with a better 
understanding of medication adherence in a group of frail urban older adults. The study 
used a combination of quantitative and qualitative methods to analyze data from a larger 
twelve-month study of a nurse care coordination intervention. This chapter first 
summarizes the results of the quantitative and qualitative analyses, and then integrates the 
findings in order to enrich our understanding of the context and processes involved in 
medication self-management.  The chapter concludes with a discussion on the study’s 
strengths and limitations as well as recommendations for clinicians and researchers. 
Protective and Risk Factors for Medication Nonadherence 
Research Question 1: What are the context and/or process dimensions that emerge as 
significant risk and protective factors for medication nonadherence at Month 1 of the 
study? 
Using logistic regression to test the effects of the participants’ context and process 
dimensions on medication nonadherence at Month 1, the study results provided mixed 
support for previous research findings. For example, similar to other researchers’ findings 
(Russell et al., 2011; Vik et al., 2004; Wu et al., 2008b), the individual-level 
characteristics, age and gender, were not significant predictors of nonadherence. 
Conversely, unlike prior research (Bosworth et al., 2006; Egede et al., 2011; Krousel-
Wood et al., 2005; Wu et al., 2008b), African American race was not a significant 
predictor: Whereas the initial model for Month 1 found African American race to be a 
risk for nonadherence, this relationship disappeared once controlling for condition-
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specific factors (e.g., physical functioning, cognitive functioning, psychosocial well-
being, vision, and hearing). While none of the individual-level characteristics in the 
overall model were significant predictors, it is possible that other individual-level 
characteristics, (i.e., ones that might more accurately measured one’s ability to self-
manage medications), could have been significant predictors. Indeed, previous research 
has found that low health literacy (Armstrong, 2010; Kripalani et al., 2006) and lower 
education levels (Catz et al., 2001; Schoenthaler et al., 2009) increase an individual’s risk 
for nonadherence. 
Among the five condition-specific variables included in the model, only two were 
significant predictors at Month 1: cognitive and physical functioning. The strongest risk 
factor for medication nonadherence in this group of frail older adults was the 
participant’s baseline MMSE score. Similar to findings in the literature (Cooper et al., 
2005; Insel et al., 2006; Jerant et al., 2011; Park et al., 1994; Stilley et al., 2010), 
decreased cognitive functioning was significantly and positively associated with 
nonadherence. This is an important finding particularly for community-dwelling older 
adults because more recent nursing interventions have excluded older adults with 
cognitive impairment (Barnason et al., 2010; Ruppar, 2010; Wu et al., 2012). This study, 
on the other hand, included participants with mild cognitive impairment. As a result, the 
mean MMSE of this frail group older adults was only 25.21 (S.D.=3.53), and more than 
half the participants scored in the mild to moderate range of cognitive impairment. 
Despite this significant risk factor, however, the mean adherence at Month 1 was very 
high 98.5% (S.D.=4.9) demonstrating that even those with mild cognitive impairment can 
maintain high levels of adherence if given the proper support. 
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Higher physical functioning (i.e., higher PPT score) was also a significant risk 
factor, and supported the findings by (Schuz and colleagues, [2011a & 2011b]) that 
higher functioning adults are more likely to be nonadherent with their medications. Schuz 
and colleagues (2011a & 2011b) identified that necessity beliefs about medications 
mediated the relationship between health and adherence: Higher functioning older adults 
were less likely to believe in the necessity of taking some or all of their medications. 
Given the ongoing interaction between the nurses and participants in this study, it is 
possible that the older adults believed that their medications were necessary, but that 
those with higher physical functioning were more likely to leave the house and/or engage 
in activities during the day, and these disruptions interfered with their medication-taking 
regimens. 
Among the four social environment factors included in the model, only one (receiving 
IADL assistance) was a significant and protective factor against nonadherence at Month 
1: Participants receiving IADL assistance were only one-third as likely (O.R.=0.33) as 
those not receiving this assistance to be nonadherent. This finding is consistent with the 
extensive body of research demonstrating that social support is a critical factor in an older 
adults’ maintaining healthy lifestyle behaviors (Carlson et al., 2012; Hopman-Rock, et 
al., 2012; Resnick et al., 2002). Wu and colleagues (2008b) similarly found that 
perceived social support was a significant protective factor against nonadherence among 
older adults living with heart failure. This study contributes to this literature by directly 
testing IADL assistance, which includes assistance with medications, and supports 
findings by Scheurer, Choudry, Swanton, Matlin, & Shrank (2012) that practical support 
increases medication adherence.  
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A final important finding at Month 1 was the significant protective effect of the MD.2 
machine (a process dimension) against medication nonadherence. In this study, the 
Mediplanner participants were three times more likely to be nonadherent (O.R.=3.3) than 
those who used the MD.2. This finding is similar to Buckwalter, Wakefield, Hanna, & 
Lehmann’s report (2004) where MD.2 users (over the course of six months) had missed, 
on average, less than half as many doses as those using the mediplanner (2.9 vs. 7.3 
doses). For the participants in this study, it is possible that the MD.2 was a more effective 
cognitive prosthesis because of its audio/visual alerts. These alerts may have cued the 
older adults’ memory throughout the day, and thus reduced their risk for forgetting to 
take their medication. While the mediplanner also served as a memory prompt, it still 
required the older adult to remember to go to the planner and take their scheduled dose. 
The effect of the MD.2 as a cognitive prosthesis was significant even after controlling for 
participants’ cognitive functioning. It should be noted, however, that the mediplanner 
worked well for the majority of participants, and that those in which the machine helped 
were only a small percentage of the older adults in the study. 
Research Question 2: What are the context and/or process dimensions that emerge as 
significant risk and protective factors for medication adherence over time? 
  A GLM with exposure analysis of medication adherence over time made similar 
findings as the cross-sectional model, but also expanded on them with three additional 
factors to explain nonadherence. First, a participant’s baseline psychosocial well-being 
score (GDS) was now a significant predictor, and similar to the findings in the literature 
(Gonzalez et al., 2007; Kronish et al., 2006; Wu et al., 2008b) a higher depressive 
symptom score was a risk factor for nonadherence. A second identified risk factor was 
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the participant receiving ADL assistance. This level of assistance is needed when a 
person can no longer compensate for cognitive and/or functional disability. It is not 
surprising then that those frail older adults needing ADL assistance would be more likely 
to experience difficulty at some point along the multistep process of taking a medication. 
For example, without a caregiver to assist at the time that a medication is due, the older 
adult would be at risk for either not remembering to take their medication, and/or having 
physical difficulty with self-administering the medication. As a result, over time those 
participants who received ADL support were nearly four times more likely to be 
nonadherent (O.R.=3.8) than those not receiving such assistance. To further support this 
explanation, having a caregiver living in the home was a significant protective factor and 
decreased a participant’s risk for nonadherence by two-thirds (O.R.=0.32).  
These social environmental findings are particularly important because most 
medication adherence interventions target the individual. Yet, a survey of caregivers for 
adults over the age of 50 found that 48% of recipients needed assistance with taking their 
medications (National Alliance for Caregiving [NAC], 2009). A review by Maidment, 
Fox, Boustani, & Katona, (2012) found that even though caregivers play an important 
role in medication management for adults diagnosed with dementia, evidence on effective 
interventions is still lacking. To add to the significance of this issue, While, Duane, 
Beanland, and Koch (2013) found in their qualitative study that many dementia 
caregivers expressed both a need and desire for more formal education about medication 
management skills in order to assist their care recipients.  
In summary, both models were consistent with the progressive proposals by 
researchers that human health behavior must be considered within the context of a 
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person’s ecology of health (Schneider & Stokols, 2009) and/or personal systems (Russell 
et al., 2011), and that interventions targeting only individuals are incomplete (Ruppar, 
2010a). The models also add support to Ryan and Sawin’s (2009) theoretical proposition 
that a person’s self-management behavior is influenced by both the contextual (i.e., 
condition-specific factors, and social environments), and process (i.e., cognitive 
prosthesis) dimensions of one’s life.  
Research Question 3: What are the themes that describe the participants’ medication self-
management processes? 
 A directed content analysis identified three overarching themes to describe the 
participants’ struggles along the multistep process of medication adherence. The 
overarching theme, “Not Being Ready to Take Medication”, was the most common issue 
for participants in this study. While it was primarily the most vulnerable participants who 
struggled with this stage of the medication-taking process, many of the participants still 
had problems at some point with forgetting, and/or being out and about, and then missing 
their medication doses. A less common overarching theme, although still important, was 
“Not Being Able to Take” one’s medication. Review of the nurses’ notes found that 
family member support spanned across all steps of the medication-taking process. In 
some cases, family members would divide up the tasks and each would take 
responsibility for a step in the process. For example in one case, one son would pick up 
the prescriptions, another son would fill the mediplanner, and both would help the 
participant with obtaining samples and looking into prescription plans. In another case, 
the participant had three children providing ADL and IADL care. Both these overarching 
themes illustrated how physical and/or cognitive disabilities can increase an older adult’s 
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risk for unintentional nonadherence, especially in the absence of caregiver assistance. Of 
note, despite a large body of research on the problem of cost-related nonadherence, only a 
small number of participants in this study had trouble with “not possessing” their 
medication. This finding is not surprising, however, given the study’s intensive nurse 
care coordination, which included assisting the participants with ordering and refilling 
prescriptions.  
The final overarching theme, “Consciously Choosing Not To Take One’s 
Medication” is similar to themes described by Voils and colleagues (2006) of “intentional 
nonadherence” and by Weintraub (1981) of “intelligent noncompliance”. The 
participants’ intentionality in this study also highlights an important assumption of the 
Individual and Family Self-Management Theory that, “Persons engage in behaviors for 
personally meaningful responses that may or may not be directly related to optimizing 
their health status” (Ryan & Sawin, 2009, p. 21). Community-dwelling older adults, 
living with chronic conditions, are charged with the day-to-day responsibility of 
monitoring their own health and well-being: They are responsible not only for taking 
their medications, but also monitoring for any development of worsening symptoms 
and/or medication side effects.  
The participant responses in this study provided insight into the processes older 
adults used to self-manage their medications including self-monitoring, reflective 
thinking, and decision making. This overarching theme also reminds us that the 
medication self-management process requires ongoing clinical assessment and support if 
clients are to remain adherent. A final domain in the qualitative analysis, “Needing 
Additional Information from Participant” illustrated the challenge for both client and 
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clinician in identifying the barriers to achieving optimal self-management. Without the 
additional information, it appeared difficult for the nurse and/or client to then develop 
targeted strategies for improving the participant’s medication self-management.  
Integration of the Findings 
Research Question 4: How do the qualitative data help explain the quantitative 
findings and contribute to a more complete understanding regarding the participants’ 
medication adherence?  
The findings from the quantitative component of this study help both clinicians 
and scientists by identifying several context and process dimensions that can put frail 
older adults at greater risk for medication nonadherence. The study’s conceptual 
framework aided in the interpretation of these quantitative relationships, however, it is 
the qualitative data that helps us to understand why certain context and process 
dimensions were significant protective or risk factors for medication nonadherence.  
In practice, prescribers often work under the assumption that once their clients 
have the knowledge and skills to take their medications, they are then ready and capable 
of being 100% adherent. This study demonstrated that for a majority of the older adults 
the assistance of the nurse care coordination and cognitive prostheses made such a goal 
achievable: 52% of the participants had perfect adherence and another 23% achieved 
99% adherence over the course of the study. In fact, whereas the participants might have 
missed some doses over the course of the study, only twenty-one participants (7.8%) had 
an average monthly adherence rate of less than 95%. Further examination of the study’s 
vulnerable adherers (i.e., having <95% adherence either at Month 1 and/or over time) 
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alongside their responses for missing medications can help us to better understand the 
challenges of medication self-management among frail urban older adults. 
For example, a review of the literature found that African American race was a 
significant predictor of nonadherence.  An examination of the study data found that 
African American participants were indeed more likely to be nonadherent at Month 1: 
They comprised 18.7% of the population, but were 32% of the nonadherent participants. 
This significant relationship, however, disappeared once condition-specific variables 
were added into the model. A closer examination found that the African American 
participants’ MMSE scores only ranged from 18-23, whereas the nonadherent White 
participants had MMSE scores that ranged from 29-16, suggesting that a higher rate of 
cognitive impairment might explain this disparity. Another possibility is that a lower 
educational attainment and/or quality of education among the African American 
participants might have led to lower MMSE scores (Crum et al., 1993; Pedraza et al., 
2012). Examination of participant responses further explained this risk: Both African 
American and White participants with low MMSE scores were more likely to have 
missed medications because they forgot, were confused, and/or had no reason.  
The quantitative models also found that those with impaired cognitive functioning 
(i.e., lower MMSE scores) had lower adherence rates.  In general, among those 
participants with normal to high cognitive capacity, their responses clustered around 
being disrupted, being out of the house, choosing not to take, or having no reason. 
Participants with mild cognitive impairment, on the other hand, were more likely to 
report that they forgot, were unsure why, or dispensed but then forgot to take. One 
participant with a MMSE score of 24 had a daughter who frequently needed to remind 
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her. This same participant often needed the nurse’s prompting as well in order to take her 
prescribed dose.  
In the quantitative models, we also saw that participants with higher physical 
functioning scores (PPT) were more likely to be nonadherent. It is possible that higher 
functioning participants had a greater ability to engage in activities outside the home that 
disrupted their medication-taking routine. Examination of the vulnerable participants’ 
self-management processes, helped explain why physical functioning was a significant 
contextual predictor. First, those who were classified as physically dependent (i.e., PPT 
scores between 3-15) were more likely to cite responses that reflected their frail health 
(both physically and cognitively) such as: had difficulty seeing the pill in the 
mediplanner; saw dose too late; denied they missed any; or was unsure as to why. Most 
of the time, however, they had no reason or had forgotten. As physical functioning 
increased, we begin to see its effect on routine. Among those with intermediate range 
PPT scores, (i.e., scores between 16-20) the participants were more likely to report being 
out of the house and/or choosing not to take their medication. There were only five 
vulnerable participants who scored in the independent range, (i.e., 21-28) and again their 
responses were similar to the intermediate functioning: They were busy with activities, 
forgot, or no reason.  
These results support findings by Park and colleagues (1999) where middle-aged 
older adults are more likely to miss their medications. For these healthier adults they may 
also be more likely to be out of the house or experiencing competing demands, and thus 
miss their medications. There is also the hypothesis that healthier patients may not be 
symptomatic and/or have conditions with symptoms that would prompt them to stay 
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adherent to their medications (Schuz et al., 2011a; Schuz et al., 2011b). More research is 
needed to support these hypotheses, and then tailor an intervention that targets the 
medication self-management of more active older adults.   
In the literature, depression has been found to be a risk factor for nonadherence 
(Gonzalez, 2007; Kronish et al., 2006; Wu et al., 2008b), and in this study decreased 
emotional well-being was similarly a risk factor. Among the participants who scored 
within the normal range of the GDS, most of their responses were either forgetting or 
unsure as to why. Just over a third of participants, however, scored as mild or moderately 
depressed. In general these participants either forgot or gave no reason. Looking closer at 
the three participants in the overall study who scored as “severely depressed” on the 
GDS, all three had similar levels of cognitive and physical function. Only one of these 
participants maintained 98% adherence over time, and was the only one among them with 
a caregiver living in the home. The other two either denied they missed, had no reason, or 
consciously chose not to take. Given what is known in the literature, it is possible that 
older adults with severe depression may need additional nursing intervention such as 
exploring the reasons why they miss their medications, and/or identifying a support 
person to encourage them to take their medications.  
Surprisingly, MCI was not a significant predictor. One possibility is that the 
nurses corrected for the treatment complexity challenge when they filled the machines 
and mediplanners. What was seen in some of the nursing notes were patients who learned 
to do it themselves, and when the nurses checked there were no errors or very few. These 
nursing notes, however, were mostly recorded later in the study. The qualitative data 
again help to explain why MCI was not as strong a predictor as the other risk factors: 
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Participants with lower MCI scores (10-19) and who missed doses were more likely to 
report that they had forgotten or had no reason. They were also more likely to be unsure 
as to why they missed suggesting they’d had trouble remembering what had actually 
happened. Indeed, among those participants with low MCI scores who experienced 
nonadherence at Month 1, most of them also had MMSE scores of 23 or less. As MCI 
scores increased (e.g., scores ranging from 20-39), the participant responses began to 
vary across all stages of the medication taking process from being confused, to being out 
and about, to consciously choosing not to take. As the MCI scores continued to increase 
(e.g., ranging from 44-68), however, the participant responses clustered around not being 
ready (i.e., being out and about, forgetting) and/or having no reason. This trend continued 
among those with the highest MCI counts (ranging from 82-112): The participants either 
reported they forgot or had no reason suggesting that the complexity of the regimen itself 
might have made it difficult to maintain 100% compliance on an ongoing basis.  
Vision and hearing issues were also not significant predictors of nonadherence, 
and among the responses given, sensory/motor issues accounted for only 2 out of the 82 
responses (2.4%) at Month 1 and only 37 out of the 1,459 responses (2.5%) over time.  
Nevertheless, examination of the participant responses highlighted the importance of 
assessing a client’s ability to see the pills in the mediplanner or cup as well as the 
physical dexterity to take pills. In particular, participants in this study noted trouble with 
seeing white pills in a white mediplanner. Those with decreased visual acuity might 
benefit from additional caregiver support with their medication self-management. 
The process dimension tested in this study (i.e., the use of a cognitive prosthetic) 
was also a significant predictor: Participants using a mediplanner were three times more 
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likely to be nonadherent than those using the MD.2. An examination of the responses 
showed that the most common reason why the mediplanner users missed their 
medications was “Forgetting” to take their dose. Other responses included: being unsure; 
relying on social facilitation or choosing not to take. Whereas both types of users had a 
high frequency of “No Reason” responses, it was rare for the MD.2 users to miss because 
they forgot. They were more likely to report being out of the house, being disrupted, or 
consciously choosing not to take. It is possible that the MD.2’s use of audio/visual 
prompts functioned similarly to a caregiver reminder, and thus these participants were 
less likely to forgot. Nonetheless, the machine could not confirm that the participant 
physically took the medication. As a result, when the MD.2 users did forget; they said it 
was because they “dispensed” the medication and then forgot to take it. In these cases, 
nonadherence still occurred. For the two vulnerable MD.2 users who said they had 
dispensed and then forgotten, both had mild cognitive impairment, lived alone, and 
received little support. 
The qualitative data also helped to explain the difficulty in quantitatively 
predicting which participants were at risk for being nonadherent. Many of the participants 
in this study had myriad responses for why they did not take their medications, 
suggesting that barriers to medication adherence can vary from day to day depending on 
what other life circumstances have come up. In addition, the quantitative models did not 
include assessments of the participants’ knowledge, attitudes or beliefs about their 
medications, which are often important reasons for medication nonadherence (Ruppar, 
Dobbels, & De Geest, 2012; Wheeler et al., 2014).  
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Support for the individual & family self-management theory. The findings 
from this study also validated the proposed concepts and conceptual relationships in Ryan 
and Sawin’s (2009) Individual and Family Self-Management Theory. The theory posits 
that contextual factors (i.e., individual-level, condition-specific, and social environmental 
factors) impact on a person’s ability to self-manage their health behavior (i.e., the 
proximal outcome dimension). For this group of frail urban older adults, cognitive and 
physical functioning, psychosocial well-being, and caregiver assistance each had a 
significant impact on the participants’ risk for medication nonadherence. In addition, to 
the contextual risk and protective factors, Ryan and Sawin’s theory (2009) posits that 
there are three process dimensions (knowledge and beliefs, self-regulation skills and 
abilities, and social facilitation) that can positively affect a person’s ability to self-
manage their health. Results from the quantitative analysis do support the theoretical 
proposition that increases in self-regulation and skills, (i.e., the process of using of a 
cognitive prosthesis) can significantly improve one’s self-management. In this case, the 
use of the MD.2 machine was both significantly and positively associated with the health 
behavior of medication adherence. 
The qualitative component of this study also supported Ryan & Sawin’s (2009) 
theory by demonstrating the theory’s ability to explain the medication self-management 
processes within this group of frail urban older adults.  Among the eight domains in this 
study, five reflected aspects of the theory’s three process components of self-
management: “social facilitation”, “knowledge and beliefs”, and “self-regulation skills”.  
                                                                  
 
       
	   136	  
For example responses from the participants suggested that they sometimes had difficulty 
with the self-regulation skills such as “planning ahead” (i.e. early dosing and/or taking 
their medications with them before going out) and/or “reflective thinking” (i.e., unsure 
what happened, unable to say why). Given the number of participants in this study with 
mild to moderate cognitive impairment, this is not surprising, but does illustrate the need 
for social facilitation and/or cognitive prostheses in order to compensate for an 
individual’s own decreased ability to self-manage.  
Strengths of the Study 
This is the largest (in terms of sample size), as well as longest, nursing study to 
date to examine both the contexts and processes of medication-self management in frail 
urban older adults. Each of these factors (i.e., size and duration of study) contributes new 
findings to the science. First, the size of the study provided the power to test several 
individual and family-level factors associated with medication adherence. Second, the 
study measured participant monthly adherence rates up to thirteen months, which then 
increased our ability to assess this dynamic health behavior over time. Indeed, the 
quantitative examination of nonadherence over time, found three additional predictors 
and provides further insight how this health behavior can change over time. The ability to 
examine participant responses over time also helped us to better understand why 
adherence went up or down for some participants in the study despite the nurses’ support. 
Another strength of this study was its use of several standardized and validated 
data collection instruments that are commonly used in clinical practice (e.g., MMSE, 
GDS, PPT, and OASIS-B1 Discharge Version). The use of these clinical tools meant that 
the present findings can be readily translated to, and adopted for clinical practice. The use 
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of these instruments also made it easier to compare the effects of this study with findings 
in the literature.  
This study is also the first nursing intervention to both test and explain the role of 
caregivers in helping older adults’ manage their medications. These findings support 
Ryan and Sawin’s (2009) theoretical proposition that older adults are part of a social unit, 
and that self-management interventions should address both individual and family-level 
contexts and processes. The important role of caregivers in helping frail older adults 
manage their medications further strengthens Russell and colleagues’ (2011) argument 
for behavioral scientists to move toward a personal systems approach when designing 
medication adherence interventions. Current self-management programs for persons 
living with chronic disease, however, still have not capitalized on the family as a resource 
(Jonsdottir, 2013).  
  The study is also the first to link participants’ nonadherence rates with responses 
for why they missed. Several descriptive studies have reported the reasons that 
participants gave for missing their medications (Kennedy et al., 2008; Rifkin, 2010; Vik 
et al., 2005), but they did not link them to specific individual and/or family-level factors. 
As a result, we could only know part of the story. As Wolcott (1994) notes, however,  
“The effective story should be ‘specific and circumstantial’, but its 
relevance to a broader context should be apparent. The story should make 
a point that transcends its modest origins.” (p. 98). 
This study’s mixed-methods design allowed us to better understand the health behavior of 
medication self-management by examining why certain participant characteristics were 
significantly associated with medication nonadherence. The story that emerged is that 
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while a significant majority of these frail older adults maintained near perfect adherence 
over the course of the intervention, there were some who still struggled to maintain their 
adherence.  The ability to link the contextual dimensions of these participants to their 
medication self-management processes provided the opportunity to better understand 
medication nonadherence in frail older adults, identify the risk and protective factors, and 
begin to develop interventions that target individuals and their family 
members/caregivers. 
Limitations of the Study 
Because this study utilized data previously collected for a larger study, it was 
subject to several limitations that impacted interpretation of its findings. For example, in 
the quantitative component of the study, the dependent variable (i.e., medication 
adherence) was not collected on participants in the usual care group even though the 
original study was a randomized-controlled trial design. During the design of the original 
study, the decision was made not to collect data on the usual care group’s medication 
adherence because the process of assessing monthly adherence was an active ingredient 
of the nursing care coordination. Therefore, all the participants in this study received the 
intervention, and as a result the group as a whole had near perfect adherence rates both at 
Month 1 and over time. There was also no run-in period to measure medication 
adherence prior to the intervention. It is possible that had there been medication 
adherence data from a run-in period, there might have been greater variance in the 
dependent variable than that seen in Month 1 of this study. 
Another limitation stems from the complexity of trying to test models involving a 
human health behavior like medication adherence because it is comprised of both 
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intentional and unintentional behaviors (Lehane & McCarthy, 2007).  Intentional 
behaviors are conceptualized as a person’s purposeful actions and often include not 
taking medication(s) based on one’s knowledge, attitudes and/or beliefs about the 
medication (Ho et al., 2009).  Conversely, unintentional behaviors are conceptualized as a 
person’s inability to be adherent because of physical or mental limitations.  Because the 
larger study’s focus was on unintentional behaviors, data on the participants’ knowledge, 
attitudes, or beliefs about medications were not explicitly collected. The inability to test 
this important factor in the quantitative analysis might be a reason for the large amount of 
variance not explained by the study’s two models. Indeed, even though the amount of 
variance explained in the Month 1 model was similar to, or better than, those seen in 
other nonadherence models (Schectman, Bovbjerg, & Voss, 2002; Wu et al., 2008b), 
models that have had stronger explanatory power (Schuz et al., 2011a; Horne & 
Weinman, 1999) have also found client beliefs and attitudes toward medications to be the 
strongest predictors. Our understanding of intentional nonadherence was also limited to 
only those participants who willingly reported that they chose to not take their 
medications. There is always the possibility that clients will give alternative reasons (i.e., 
forgot, unsure, deny) rather than disclose their intentionality to a provider, regardless of 
the quality of the relationship (Cushing & Metcalfe, 2007; Unni & Farris, 2011).     
Another issue was that the Supportive Assistance construct was measured by two 
OASIS-B1 variables: “ADL assistance” and “IADL assistance”. On the OASIS-B1 form, 
however, examples of IADL assistance included: (medications, meals, housekeeping, 
laundry, telephone, shopping, and finances). It is possible the primary caregiver gave 
some type of IADL assistance other than medication assistance. A more specific measure 
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of medication management assistance such as the type and quantity of the medication 
management assistance provided might have produced a stronger effect.  
The qualitative portion of the study also had limitations, which stem from how the 
data were collected for the primary study. For example, while nurses documented the 
reasons older adults gave for not taking their medications, they did not audiotape the 
older adults’ responses.  As a result, it is unknown if the “reasons” recorded by the nurses 
included the exact wording used by the older adult, making it impossible to determine the 
authenticity of the older adults’ “voice” or “perspective” on medication nonadherence.  In 
addition, the participant reasons correspond to a single question with no follow up 
questions by the nurses, which then limited the ability to make contextual interpretations 
(i.e., a fuller understanding of why the participant was nonadherent).  
Another limitation was that the only participant responses documented were those 
to explain why medications were missed. Further insights might have been gleaned by 
having the intervention nurses also document the self-management processes that the 
participants used to achieve their high rates of adherence. Finally, additional 
documentation on the participants’ medication beliefs and/or the skills that they or their 
caregivers possessed might have helped us better understand the interaction between the 
context and processes of the older adults’ medication self-management.  
Implications for Nursing Practice 
The findings from this study help nurses as well as other healthcare professionals 
better understand the complex issues facing older adults in the self-management of their 
medications. Nurses in this care coordination intervention worked with the participants to 
develop strategies to successfully manage this multistep process (i.e., having the 
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medication, being ready, and being able to take their medications). The strategies mainly 
targeted the participants’ unintentional reasons for missing their medications such as 
running out of medication, taking the wrong medication/dosage, and/or forgetting. 
Results from this mixed-methods study showed that the clients who were most at risk for 
unintentional medication nonadherence were those with decreased cognitive functioning, 
decreased psychosocial well-being, and/or physical impairments. At the same time, there 
was a subset of participants, i.e. a group with higher physical functioning scores, who 
missed medications because of being away from home and not having the medications 
available to take. Nurses working with healthier, more active, older adults could try self-
regulation strategies such as scheduling medication doses around the time of day when 
the client is most likely to be home, choosing to early dose, and/or carrying a portable 
medication organizer when away from home. 
The results from this study also demonstrated that ongoing clinical case 
management/support can lead to near perfect adherence rates, even in a group of frail 
urban older adults (i.e., a group traditionally at risk for medication nonadherence).  Thus, 
screening for these myriad risk factors might alert a healthcare team for the need to 
conduct a more in-depth assessment of a client’s ability to self-manage the medication 
regimen. The results from this study also showed that family and/or caregivers can be an 
important source of support for older adults with their medication self-management, 
especially for those with cognitive and/or physical impairment.  Clinicians in both the 
acute care and community settings should therefore assess both the client’s and the 
caregiver’s ability to effectively manage the prescribed medication regimen.  
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The qualitative findings also showed, however, that some participants who had 
the capacity to take their medications, consciously chose not to take them. In some cases, 
the participants needed additional education on how to take the medication and/or 
understand why they would benefit from taking it.  Still others, despite the nurses’ best 
efforts did not want to take the medication. Indeed, some participants shared that they 
were sick and tired of taking their medications. As a result, even with the nurse’s, 
caregiver’s, and/or family’s assistance, these participants remained nonadherent. Thus in 
order to optimize medication adherence, prescribers might consider a more patient-
centered approach when working with their clients.  
As a first step, the healthcare providers would assess the client’s personal 
values/beliefs about health and well-being in order to gain insights into their decision 
making (Zoffmann, Harder, & Kirkevold, 2008). With this understanding, providers 
could then try to engage the client in shared decision making about their prescribed 
medication regimen. Prescribers and clients could try discussing the benefit versus 
burden of each medication, and then based on the client’s preferences develop a mutually 
agreed upon regimen. The concept of medication adherence/compliance might then 
develop into a more democratic concept that reflects this mutual decision making. In the 
United Kingdom there is already a movement toward “medication concordance”: A term 
that connotes a mutual decision about the client’s medication regimen versus the client 
adhering to a prescriber’s decision (Cushing & Metcalfe, 2007; Horne et al., 2005). Once 
the client and prescriber have developed a mutually agreed upon regimen, the team might 
then suggest self-management behaviors that best reflect the client’s personal 
values/beliefs as well as capacities. For those clients who still continue to have trouble 
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and/or lack the capacity to self-manage their medications, the team could then try 
enlisting the help of family to optimize the individual’s medication self-management.  
Nurses also need to know that assessment of a client’s medication adherence 
continues to be a challenge, and that currently there is no “gold standard”. In the 
community setting, older adults use a variety of medication organizers including bottles, 
mediplanners, and bubble packs. In this study, the older adults used either the 
mediplanner or the MD.2 to organize and administer their medications. For a large 
percentage of the participants, the mediplanner was an effective, cost-efficient system for 
managing their medication regimens. Indeed, over the course of the study, only 16 of the 
131 mediplanner users had an adherence rate that averaged less than 95% over the course 
of the study. An examination of the participant responses, helps us to understand why 
these mediplanner users might have been more vulnerable. The most common reason was 
they had forgotten. Other common reasons were being unsure of why they missed their 
dose, being confused about the organizer, and/or not taking the dose until the RN visit.  
These reasons highlight the extra cognitive challenge that the mediplanner users faced in 
order to remember which medications to take and when. These users each possessed one 
or more significant risk factors including: lower cognitive capacity, higher physical 
functioning, decreased psychosocial well-being, no IADL assistance, and/or no caregiver 
in the home. Only five of the most vulnerable participants were in the MD.2 group. Most 
of their responses were “no reason noted”. Of those that said that they had forgotten, they 
also had mild cognitive impairment.  
Thus, from the study findings it appears that for the vulnerable older adult, the 
MD.2 offers several advantages over the mediplanner including: serving as an 
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audio/visual prompt; controlling client access to only the scheduled dose, and alerting a 
caregiver if a dose is missed. Another benefit to optimizing medication self-management 
is the MD.2’s ability to record when and/if a medication is dispensed. Indeed the MD.2 
data could help clients see patterns in their medication-taking processes. From this 
information, clients could then increase their self-regulation skills (e.g., reflective 
thinking, planning and action) by identifying strategies to increase medication adherence. 
Similar to the adherence strategies used by some of the more successful MD.2 
participants in this study, those clients who are still very active could either choose to 
early dose, and/or bring their medications in a pill case when they go out. For clients who 
cannot master this additional cognitive effort, it is important for the nurse to help the 
client plan ahead, and have systems in place to administer medications if the MD.2 is not 
available.  In the study, the nurses also enlisted the support of family members and/or 
caregivers in identifying family-centered strategies to optimize the medication self-
management process. 
Finally, the study findings suggest that even with the intensive nurse care 
coordination, there was still a small number of participants and their caregivers who 
experienced problems and/or needed assistance at some point along the multistep 
medication self-management process. These findings support Schulman-Green and 
colleagues (2012) proposition that self-management is an “ongoing and dynamic” process 
that varies over time. Indeed, participants in this study utilized myriad self-management 
processes in order to take their medications, and these processes varied over time. The 
study results thus further highlight the need for ongoing assessment by the client’s 
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healthcare team as life events change in order to optimize a person’s medication self-
management.  
Implications for Future Research 
C. Everett Koop wisely observed, “Drugs don’t work in patients who do not take 
them.”2 We know that effective management of most chronic conditions includes 
pharmacotherapy, and that nonadherence to one’s medication regimen leads to greater 
morbidity and mortality. Yet after decades of research directed at the problem of 
medication nonadherence, few interventions have proven effective, especially among 
older adults with cognitive impairment (Campbell et al., 2012). The near-perfect 
adherence rates achieved by this group of frail urban older adults, however, demonstrate 
that the nurse care coordination study is an effective intervention even among those 
adults living with cognitive impairment. Based on the combined quantitative and 
qualitative findings, there are several suggestions for future research.  
First, the lack of theory to explain the process of medication adherence has 
limited the development of effective interventions (Banning, 2009; Haynes, 2008). To 
effectively target changes in health behaviors, (e.g., medication adherence) we need to 
develop theory-based interventions that move beyond an individual-level approach and 
toward a multi-level approach (i.e., person, family, provider, healthcare system) (Ruppar, 
2010a, Schneider & Stokols, 2009). Researchers in the field of medication self-
management recognize the need for this paradigm shift and are calling for the 
development of interventions involving a personal system’s approach (Jonsdottir 2013; 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  This research was unable to locate a source that directly attributes this quote to C. Everett Koop. Many 
researchers, however, consistently attribute this quote to the late Surgeon General (e.g., Kocurek, 2009; 
Schneider, Hess, & Gosselin, 2011; Silverman, Schousboe, & Gold, (2011). 	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Russell et al., 2011). Theory-based interventions, however, require the inclusion of 
critical inputs (i.e., those factors necessary for the intervention to produce the predicted 
changes) (Sidani & Braden, 1998). Whereas the findings of the primary study provided 
preliminary support for the self-management concepts and conceptual relationships in 
Ryan & Sawin’s IFSMT (2009), the quantitative models in this study could only test one 
of the intervention’s components, i.e. the use of a cognitive prosthesis (MD.2 or 
mediplanner), aimed at supporting the concept of “self-regulation skills and abilities”. 
Nevertheless, in the primary study, the nurse care coordination intervention did include 
all three IFSMT process constructs of “knowledge and beliefs”, “self-regulation skills 
and abilities”, and “social facilitation”.  Interventions to enhance medication adherence, 
however, are often multidimensional, and thus the testing of each component may not be 
practical.  
In this study, participants often cited family reasons for why they missed their 
medications (e.g., visiting family, staying with family, being out with family, or being 
distracted by family). Therefore, a second recommendation would be to include the 
family whenever possible in the client’s medication self-management process. Helping 
the family to plan medication management, especially when the client leaves the home is 
an important task.  Continual reinforcement of planning and action is also needed to 
ensure medication adherence when routines are disrupted. Indeed, without proper training 
themselves, some family members could unintentionally contribute to an older adult’s 
nonadherence. Whenever possible the nurses in the study assisted clients and their 
families in this planning and action, and evidence beyond this study shows that practical 
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support from family members significantly increases medication adherence (Scheurer et 
al., 2012).  
As such, in order to maximize the caregiving value of family members, future 
testing of this nurse care coordination intervention could include enrolling family 
members along with the clients. The nurses would then work with client-caregiver dyads 
to increase medication adherence through enhanced knowledge and skills development. 
The person’s self-management capacity would then increase at both the individual- and 
family-levels. This should be feasible as the nurses’ notes suggested that some families 
were already doing this informally, and that the nurses found this very helpful. In a recent 
feasibility study of caregiver/HF patient dyads, Sebern & Woda (2012) found that patient 
self-care scores increased after the dyad’s participation in the intervention, but the 
number was too small to test for causality. Research also suggests that interventions using 
frequent human reminder systems rather than nonhuman reminders may be more 
effective in improving medication management (Campbell et al., 2012).  
The review of the literature found that most intervention studies experienced a 
ceiling effect by including participants who already had high rates of adherence. 
Similarly, in this study’s highly managed population the mean medication adherence rate 
at both Month 1 and over time was greater than 98%. Because there was no run-in period 
prior to the nurse care coordination intervention, it was difficult to determine the 
participants’ baseline level of nonadherence. One of the inclusion criterion for the 
original study was based on the OASIS-1 item M0780 which assesses an individual’s 
ability to take their oral medications, but not their compliance (Shaughnessy, Crisler, 
Hittle, & Shlenker, 2002).  In addition, the intervention was designed to target problems 
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related to unintentional nonadherence. One suggestion then would be to replicate the 
nurse care coordination study with frail older adults whose providers have identified as 
“super-utilizers” (i.e., those who “cycle in and out of the hospital”) (Gawande, 2011) 
because of intentional nonadherence issues. Targeting those clients who are most in need 
because of knowledge and belief issues could then expand the intervention’s application 
to other populations. Similar to the first study, the outcomes of interest would be 
medication adherence, client health and well-being, and healthcare costs.  
A final suggestion specific to the nurse care coordination intervention would be to 
expand upon the nurses’ exploration with participants for the reasons why they missed 
their medication(s). In this study, the domain, “Needing Additional Information from 
Participant” was very common with approximately 40% of all participant responses being 
categorized as either: “Having no reason”, “Denying they missed medication(s)”, “RN 
being confused”, “Taking dose during RN visit” or “Being unsure of what happened”. 
The lack of clarity in the participant responses (i.e., an explanation of what had 
happened) resulted in a lost opportunity to better understand the participant’s medication 
self-management process.  Refining this part of the intervention protocol would not only 
develop the client’s self-regulation skills of self-monitoring and reflective thinking, but 
could also help the client with the planning and action skill. A next step then could be to 
develop a more formative set of probing questions that might assist the participants in 
discovering reasons they didn’t even realize they had for missing their medications. 
These reasons could then help the nurse, client, and family better understand why doses 
were missed and develop strategies to overcome this problem. 
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Conclusion 
Frail older adults depend upon medications to manage their chronic conditions, 
yet often lack the cognitive and/or physical ability to independently self-manage their 
prescribed regimens. Findings from this study suggest that caregiver assistance with 
IADLs reduces the risk for medication nonadherence. Clinicians, researchers, and 
policymakers need to recognize the significant challenges associated with medication 
self-management among frail older adults: Nearly 1/3 of caregivers for adults (over the 
age of 50) report that their recipient suffers from dementia and/or mental confusion, and 
this subset of caregivers is also more likely to report having a high burden of care (13%) 
than those providing care to adults with cancer (10%) or simply old age (6%) (NAC, 
2009). Still, few researchers have included caregivers in their intervention designs. Future 
interventions therefore need to not only capitalize on the caregivers’ expertise, but just as 
importantly, also work to reduce their high burden of care. Behavioral health researchers 
working with frail community-dwelling older adults would do well to partner with 
programs that serve this vulnerable population (e.g., home healthcare agencies, Program 
for All-Inclusive Care for the Elderly (PACE), caregiver support groups, adult day care 
centers, and Area Agencies on Aging) to develop and test more multi-level interventions. 
A community-based participatory research approach might also prove more effective than 
the provider-focused models that have been tested to date. With the largest cohort of 
adults entering into Medicare, and its program expenditures already accounting for 21% 
of national health expenditures (CMS, 2014), we need to find more cost efficient models 
of care. The time is now. 
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